Promoters, enhancers and insulators for improved mosquito transgenesis by Gray, Christine Elizabeth
  
PROMOTERS, ENHANCERS AND INSULATORS FOR IMPROVED  
MOSQUITO TRANSGENESIS 
 
 
A Dissertation 
 
by 
 
CHRISTINE ELIZABETH GRAY 
 
 
 
 
Submitted to the Office of Graduate Studies of 
Texas A&M University 
in partial fulfillment of the requirements for the degree of 
DOCTOR OF PHILOSOPHY 
 
 
 
 
August 2005 
 
 
 
Major Subject:  Genetics 
    
 
PROMOTERS, ENHANCERS AND INSULATORS FOR IMPROVED 
 
 MOSQUITO TRANSGENESIS 
 
 
 
A Dissertation 
 
by 
 
CHRISTINE ELIZABETH GRAY 
 
 
 
 
Submitted to the Office of Graduate Studies of  
Texas A&M University 
in partial fulfillment of the requirements for the degree of 
 
DOCTOR OF PHILOSOPHY 
 
 
 
 
Approved by: 
 
Chair of Committee, Craig J. Coates 
Committee Members,   Ellen W. Collisson 
   Timothy C. Hall 
   Dorothy E. Shippen 
Chair of Genetics Faculty,  Geoffrey Kapler 
 
 
 
August 2005 
 
 
Major Subject:  Genetics 
 
 
iii
ABSTRACT 
 
 
Promoters, Enhancers and Insulators for Improved  
Mosquito Transgenesis.  (August 2005) 
Christine Elizabeth Gray, B.S., DePaul University 
Chair of Advisory Committee:  Dr. Craig J. Coates 
 
 Low level and variable transgene expression plague efforts to produce and 
characterize transgenic lines in many species.  When transformation efficiency is high, 
productive transgenic lines can be generated with reasonable effort.  However, most 
efforts to date in mosquitoes have resulted in suboptimal levels of transformation.  This, 
coupled with the large space and intensive labor requirements of mosquito colony 
maintenance makes the optimization of transformation in mosquitoes a research priority.  
This study proposes two strategies for improving transgene expression and 
transformation efficiency.  The first is to explore exogenous promoter/enhancer 
combinations to direct expression of either the transgene itself, or the transposase 
required for insertion of the transgene into the genome.  An extension of this strategy is 
to investigate the use of a powerful viral transactivating protein and its cognate enhancer 
to further increase expression of these targets.  The second strategy involves the 
identification of an endogenous boundary element for use in insulating transgenes and 
their associated regulatory elements.  This would mitigate the inappropriate expression 
or silencing of many transgenes inserted into “unfavorable” genomic environments as a 
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consequence of an inability to specifically target the integration of transposons currently 
used in mosquito transgenesis. 
 The IE1 transactivating protein and its cognate enhancer from a baculovirus were 
shown to significantly increase expression of a reporter gene from three different 
promoters in cultured mosquito cells.  Other heterologous enhancer/promoter 
combinations resulted in minimal increases or insignificant changes in expression.   
 Orthologues of the vertebrate insulator-binding factor, CTCF, were cloned and 
characterized in two mosquito species, Aedes aegypti and Anopheles gambiae.  The 
expression profile of mosquito CTCF is consistent with its role as a putative insulator-
binding protein.  Preliminary binding site studies reveal a C/G-rich binding site 
consistent with that known in vertebrates and indicate that CTCF may bind widespread 
sites within mosquito genomes. 
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1.  INTRODUCTION 
 
 
1.1.  Defining the Problem 
 
1.1.1.  Mosquito-vectored pathogens 
 
 Numbering greater than 3500 species and subspecies, mosquitoes are an 
enormously diverse and widespread group of mostly anantogenous dipterans, and, as 
such, are arguably the most important arthropod group of medical and veterinary 
significance (Eldridge, 2005).  The females of some species preferentially blood-feed on 
particular host species and have co-evolved with various viral, protozoan and nematode 
pathogens, resulting in the ability to efficiently transmit a multitude of vertebrate 
pathogens.  This study directly involves two of the most potent mosquito vectors of 
human pathogens, Aedes aegypti, commonly known as the Yellow Fever mosquito, and 
Anopheles gambiae, commonly known as the Malaria mosquito. 
1.1.2.  Ae. aegypti:  life cycle, distribution and human impact 
 The mosquito, Ae. aegypti, inhabits virtually all tropical and sub-tropical areas of 
the world (Centers for Disease Control, 2005).  Sprawling urbanization, increasing 
human population density, insecticide resistance, and an increasingly favorable climate 
continue to favor further expansion of the Ae. aegypti range (Gubler, 1998).  Ae. aegypti 
females, like all anautogenous mosquitoes, require the large amounts of protein found in 
a vertebrate blood meal in order to complete egg development and maturation prior to 
oviposition  (Eldridge, 2005).  In addition, Ae. aegypti females are day-biting,  
____________________ 
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urban-dwellers, and have a distinct preference for humans (Gubler and Clark, 1999).  
Once a viremic blood meal is ingested, viral particles must successfully infect the cells 
lining the midgut, replicate, escape the midgut and then migrate to and invade other 
tissues for dissemination, particularly the salivary glands.  Though they usually mate 
only once, females retain enough sperm for the fertilization of several batches of eggs, 
each requiring a new blood meal.  Once infected with a virus, the female will remain 
infected for the duration of her life (Blair et al., 2000). 
 Ae. aegypti is the principal vector of two important flaviviruses, the causative 
agents of Dengue Fever (DF) and Yellow Fever (YF).  DF is the most widespread 
vector-borne human viral disease with as much as one third of the world’s population at 
risk (Stephenson, 2005).  50 to 100 million cases of DF and several hundred thousand 
cases of the more severe Dengue Haemorrhagic Fever (DHF) occur annually across the 
globe (Centers for Disease Control, 2005).  Approximately 5,800 cases of Yellow Fever 
(YF) are reported, but its incidence is likely higher and rising.  It is predicted that urban 
epidemics of Dengue and Yellow fever may recur, because nearly all major urban 
centers have been reinfested with Ae. aegypti over the past 20 years (Gubler and Clark, 
1999).  Though an effective and cost-effective vaccine exists for YF, efficient delivery to 
disease-endemic areas is problematic.  Because four distinct serotypes of Dengue virus 
exist, each with several genotypes, an effective vaccine against DF is unlikely to be 
produced.  Immune responses to successive Dengue virus infections caused by different 
serotypes often exacerbate rather than mitigate the disease due to a phenomenon known 
as antibody-mediated disease enhancement (ADE) (Stephenson, 2005).   
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1.1.3.  An. gambiae:  life cycle, distribution and human impact 
 Of approximately 400 anopheline mosquito species, 60 serve as potential vectors 
of human malaria parasites, with ~30 of these posing a significant threat to human health 
in over 100 countries inhabited by roughly 40% of the world’s population (World Health 
Organization, 2002).  As many as 300 million cases of malaria occur across the globe 
each year, resulting in more than one million deaths.  Upwards of 90% of the fatalities 
occur in sub-Saharan Africa, with most of these being children under the age of five 
(World Health Organization, 2003).  The causative agent of human malaria is one of 
four protozoan species:  Plasmodium vivax, P. ovale, P. malariae and P. falciparum, 
with P. falciparum causing the most severe disease.  It is no coincidence that the most 
effective P. falciparum vector, An. gambiae, resides in sub-Saharan Africa where many 
countries lack the infrastructure and financial resources to mount effective and 
sustainable anti-malarial campaigns (World Health Organization, 2003).  Exceedingly 
anthropophilic, An. gambiae essentially co-habitates with human populations, and thus 
feeds almost exclusively upon them.  In addition, plasmodium-infected An. gambiae 
females tend to take more blood meals than non-infected individuals (Koella et al., 1998).  
Malaria parasites exhibit a complex lifecycle requiring both mosquito and vertebrate 
hosts.  Upon ingestion of gametocytes in an infective blood meal, Plasmodia must 
complete their sporogonic cycle within the mosquito.  To do so, the parasites must 
successively invade the midgut, escape the midgut and invade the salivary gland tissues.   
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1.1.4.  Current control strategies are inadequate 
 Control of mosquito vectors must be multi-faceted and integrated.  This requires 
mobilization of considerable financial and human resources, as well as constant public 
education and awareness.  Currently, control of mosquito vectors includes chemical 
insecticides, environmental management and biological control, however serious 
drawbacks are associated with each of these strategies.   
 Economics drives the insecticide market to focus primarily on insects of 
agricultural importance with different formulations of these same insecticides being 
produced for use in human health applications (Hemingway and Ranson, 2005).  As such, 
many insect vectors have already been exposed to all four major classes of insecticides 
(organochlorines, organophosphates, carbamides and pyrethroids) through breeding and 
resting in agricultural areas (Hemingway and Ranson, 2005).  Repeated exposure of 
insect vectors to the same insecticides drives selection of those individuals with mutant 
alleles conferring insecticide resistance, eventually rendering an insecticide largely 
ineffective.  Multiple examples of this have been described (Hemingway and Ranson, 
2000; Brooke et al., 2002; Chandre et al., 1999).  Arguably the cheapest, and possibly 
the most effective insecticide for use in mosquito control is the organochlorine, DDT.  
DDT poses significant environmental risk however, due to its excellent stability and  
bioaccumulation in the fat tissues of many non-target organisms further up the food 
chain (reviewed by Jaga and Dharmani, 2003).  The greater expense associated with 
other classes of insecticides greatly impacts poor nations who must often choose 
between food production and efficient vector control.  Certainly, the scope of 
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compounds exploited for chemical control could be expanded to include developmental 
inhibitors, attractants, repellents and chemosterilants (World Health Organization, 1982). 
 Knowledge of the specific environmental requirements of a particular vector 
species allows one to manipulate the environment in order to make it less hospitable.  
Mosquitoes all require water at some point in their life cycle—most often for both larval 
and pupal development.  The connection between aqueous habitat and mosquito-borne 
disease incidence has been known for a long time (Ronald Ross’ study of anophelines 
and malaria transmission in the 1890’s and Finley and Reed’s study connecting Ae. 
aegypti and Yellow Fever transmission in the early 1900’s) and was suspected as far 
back as the 1st century, yet the advent of synthetic insecticides seems to have engendered 
apathy in environmental control efforts (Small, 2005).  Each species prefers certain 
water conditions with optimal turbidity, organic content, oxygen content, salinity, 
temperature and surrounding vegetation of optimal density (reviewed by Small, 2005).  
Marshes and ponds can be drained or filled, while streams and rivers can be impounded 
or channeled into canals.  Vegetation can be cleared or cut back to alter the ground cover 
and shade characteristics of the surrounding habitat.  Care must always be taken to not 
trade one problem for another by creating conditions favorable to other endigenous 
vector species, as well as to avoid wholesale destruction of native ecosystems.  
Continued urbanization has introduced new incidental breeding sites such as flower pots 
and vases, discarded plastic containers, water cisterns, hoof- and footprints and used tires, 
while rice cultivation and wetlands preservation in residential areas provide ample 
breeding sites nearer to human populations (Small, 2005).  Most importantly, enlisting 
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the help of the general population through community-wide education and awareness 
programs will significantly reinforce publicly-funded control measures.   
 Biological control efforts may include the introduction of a predator, pathogen, 
parasite, competitor or microbial toxin in order to reduce the target pest population 
(Hemingway, 2005).  Greater species specificity makes this strategy desirable, though 
most efforts to date have been focused on agricultural pest species.  Introduction of the 
mosquito fish, Gambusia affinis, in the early 1900’s provided initial larval control, but 
was largely supplanted by use of insecticides such as DDT in the 1940’s (reviewed by 
Hemingway, 2005).  As concerns grew over the long-term effects of insecticides upon 
the environment and non-target species, the nematode Romanomeris culicivorax and the 
protozoan Nosema algerae were extensively studied as potential vehicles for larval 
control (reviewed by Kaya and Gaugler, 1993; Chapman, 1974; Legner, 1995).  Field 
trials with these organisms met with mixed success, and ultimately, high production 
costs and difficulties in shipping and storage made these organisms unacceptable 
(Hemingway and Ranson, 2005).  The single most effective biological agent for 
mosquito larval control to date is the toxin produced by Bacillus thuringiensis subsp. 
israelensis (Bti).  The toxin is highly specific for mosquito larvae, and the development 
of slow-release briquettes and floating granules has increased its persistence in the 
environment, making it more economically feasible for widespread use (Hemingway, 
2005; Becker and Ascher, 1998).  An extension of biological control is genetic control 
via sterile-insect technique (SIT), similar to the campaign that eradicated the screw 
worm fly from all of North America, much of Central America, and, more recently, in 
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Libya (Wyss, 2000; Lindquist et al., 1992).  Thus far, attempts to control vector 
mosquito populations have largely failed due to high population density and massive 
immigration/emigration patterns of target populations, failure to produce enough sterile 
males on a daily basis to achieve effective sterile to wild-type ratios and inefficient 
sexing mechanisms to ensure the release of males only (reviewed by Wood, 2005).  
Though potentially a powerful tool, biological control is not sufficient in itself to reduce 
the disease burden imposed by mosquito vectors.   
1.2.  A Proposed Ideal Solution 
1.2.1.  Creation of strains incapable of pathogen transmission 
 In the last 15 years, scientific focus has shifted from population elimination to 
population modification using an alternative control strategy to genetically engineer 
strains of mosquitoes that are refractory to pathogen transmission (Meredith and James, 
1990; James, 2000).  The advent of stable transformation technologies in mosquitoes 
(Jasinskiene et al., 1998; Coates et al., 1998) provided the key tool to make this possible.  
Researchers have succeeded in the creation of refractory strains of anopheline 
mosquitoes in which transmission of Plasmodium parasites is greatly reduced, but not 
completely eliminated (Ito et al., 2002; Moreira et al., 2002; Kim et al., 2004).  In Ae. 
aegypti, RNA interference (RNAi), a natural anti-viral defense in a wide-range of 
organisms, is being investigated and has shown great promise in targeting viral-specific 
transcripts necessary for viral replication (Travanty et al., 2004; Sanchez-Vargas et al., 
2004).  Recently, stable and heritable gene silencing via RNAi triggered from stably-
integrated transgenes with an inverted repeat configuration was demonstrated in An. 
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stephensi, an important malaria vector in Asia (Brown et al., 2003).  None of the 
refractory strains created thus far completely abolishes the possibility of transmission, 
leaving a window for the development of counterstrategies of transmission by surviving 
pathogens.  It is difficult to assess this risk however, because the experimental viral 
load/parasite numbers are typically much higher than occur in nature.  This highlights 
the importance of continued investigation in an effort to identify and characterize 
multiple gene targets directed at multiple stages in the infection cycle that, when 
combined, will eliminate pathogen transmission.  Single-chain antibodies, molecules 
involved in innate immune responses, antiparasite toxins and synthetic peptides could all 
potentially be exploited (Nirmala and James, 2003).  Molecules associated with 
mosquito host-seeking behaviors (Zwiebel and Takken, 2004) could also be further 
characterized for use as potential transgene targets.  Finally, the reality of parasite and 
viral co-evolution in response to host vector defense-mechanisms demands a much better 
understanding of the molecular interface between the pathogen and the mosquito vector.  
Introduction of additional genetic material will potentially trigger pathogen responses 
which may not be anticipated.  
1.2.2.  Movement of refractory genes into natural mosquito vector populations 
 Once suitable laboratory strains refractory to pathogen transmission are possible, 
the next step would be to introduce the refractory genes/alleles into natural populations 
in an attempt to replace competent vectors with incompetent ones.  This task poses 
multiple problems and demands genetic drive mechanisms beyond simple Mendelian 
genetics.  Mendelian transmission would take far too long to establish an introduced 
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gene.  Assuming that introduced individuals are homozygous for the transgene, in one 
generation of mating with the wild population, all offspring of the introduced insects 
would be heterozygous.  These heterozygous individuals that then mate with each other 
would produce 25% of offspring homozygous for the wild-type gene, 50% of offspring 
heterozygous like themselves and only 25% of offspring true-breeding for the transgene.  
The chances that the offspring mate with a wild-type insect rather than with a sibling 
would also be much higher due to sheer numbers.  It would not be possible to introduce 
sufficient numbers of transgenic individuals to ensure that more individuals mate with 
the introduced individuals, thus further increasing the numbers of progeny homozygous 
for the transgene.  If the goal is to drive the transgene to fixation in the natural vector 
population, Mendelian genetics will fail miserably on its own.  Some mechanisms that 
could potentially be employed include active transposable elements (TEs), meiotic drive, 
endosymbiotic bacteria, viruses and male-specific insecticide resistance (reviewed by 
Braig and Yan, 2002).   
 The first, and perhaps most obvious choice is making use of the TEs that are used 
in the creation of transgenic individuals.  TEs, first described by Barbara McClintock in 
maize (McClintock, 1950), are naturally-occurring, mobile elements capable of 
spreading rapidly within populations.  Perhaps the most poignant example of this 
occurred with the spread of the P-element throughout the world’s Drosophila 
melanogaster populations over a period of approximately 30 years (Kidwell et al., 1983; 
Anxolabehere et al., 1988).  Prior to 1950, D. melanogaster wild-type populations 
contained no P-elements, while all natural populations sampled after 1978 carried 
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multiple copies of P-elements, introduced by horizontal transfer from D. willistoni  
(Anxolabehere et al., 1988; Ribeiro and Kidwell, 1993).  Despite hybrid dysgenesis, 
which causes massive reductions of reproductive fitness upon initial introduction into 
some strains (M cytotype) due to increased genomic instability in the germ-line (Engels, 
1989; Rio, 1990), P-elements replicate, presumably via DNA repair machinery, to high 
levels in the permissive strains (P cytotype).  Active TEs, like P-elements, invade non-
homologous chromosomes by targeting short, frequently occurring target-sites and 
ultimately stabilize with multiple copies per genome.  Stabilization is hypothesized to be 
mediated by a balance between positive selection for greater replicative events and 
negative selection against unfavorable genome rearrangements and gene interruption 
caused by TE insertion (Kidwell and Lisch, 2000).  Clearly TEs could provide a 
powerful tool for genetic drive, but these must be studied in the context of the target 
species in terms of both regulation and the unique genomic environment.   
 Meiotic drive results from the interaction between two genetic elements, a driver 
locus and a responder locus, causing the destruction or disabling of part, or all of the 
homologous chromosome and production of a disproportionate number of gametes 
carrying the linked alleles.  The best-studied example of meiotic drive is the segregation 
distorter (SD) system of D. melanogaster, where males heterozygous for the SD 
chromosome and the wild-type SD+ chromosome normally produce in excess of 95-99% 
SD-carrying sperm (Hartl et al., 1967).  Nearly all naturally-occurring populations of D. 
melanogaster examined possess SD chromosomes carrying SD, E(SD) (Enhancer of 
Segregation Distortion) and highly insensitive Rsp (Responder) alleles with much less 
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polymorphism within the immediate genomic region where these three alleles reside 
(reviewed by Akio et al., 2004).  It appears that all closely-linked loci are simultaneously 
selected in a type of “genetic hitchhiking” effect (Palopoli and Wu, 1996).  A meiotic 
drive system, with interesting parallels to the SD system in D. melanogaster (Wood and 
Newton, 1991), has long been known in Ae. aegypti (Hickey and Craig, 1966; Wood and 
Ouda, 1987).  Sex is determined by a pair of alleles, M and m, on chromosome 1, where 
Mm results in males and mm results in females (Gilchrist and Haldane, 1947).  The 
meiotic drive gene (MD) produces a gene product that acts in trans upon an unknown 
gene, mi/s, tightly-linked to the sex-determining locus.  When the sensitive allele, ms, is 
present, fragmentation of the ms-carrying chromosome results (Newton et al., 1976).  
Renewed interest in the mechanisms of meiotic drive led to the establishment of a new 
laboratory strain, T37, from a natural population sample collected in Trinidad that will 
enable further characterization of this system in Ae. aegypti (Akio et al., 2004).  Much 
remains unknown with regards to other alleles which may influence the interaction 
between MD and ms, as well as the natural frequencies of susceptible versus insensitive 
strains, yet meiotic drive represents a powerful strategy for driving refractory transgenes 
into native Ae. aegypti populations within a very short period of time. 
 An obligate intracellular bacterium, Wolbachia, spreads rapidly through 
populations of many different arthropod species, most commonly via cytoplasmic 
incompatibility (CI), producing patterns of crossing sterility within or between 
populations.  Unidirectional CI results when infected males mate with uninfected 
females, resulting in complete or partial sterility, while the reciprocal cross is fully fertile.  
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This favors the production of infected offspring by infected females thus increasing the 
numbers of infected individuals with each additional generation (reviewed by Sinkins 
and O'Neill, 2000).  CI likely results from the targeting of cell cycle regulatory proteins, 
as illustrated in the asynchronous nuclear envelope breakdown of the male and female 
pronuclei of the wasp, Nasonia vitripennis, with subsequent loss of the male 
chromosome complement (Curtis, 1976).  Controlled, outdoor cage studies with the 
urban filariasis vector Culex quinquefasciatus established proof of principle that 
cytoplasmic replacement is possible, yet older males exhibited incomplete CI, making 
further studies necessary (Curtis, 1976).  Improved and cheaper drug regimens for 
filarial infections have shifted the focus of disease control to treatment rather than 
elimination of transmission via vector control, so these studies remain incomplete 
(Curtis and Sinkins, 1998).  Naturally-occurring Wolbachia infections, with wide tissue 
distribution, have been described in numerous Culex and Aedes species, but not in 
anophelines.  It remains to be determined if Anopheles species can support Wolbachia 
and CI, as it is unclear if they have natural refractoriness or if the ecological conditions 
necessary for interspecific transfer have simply not been present naturally (Sinkins, 
2004).  Superinfections of two or more Wolbachia strains within individuals also 
commonly occur with different strains of Wolbachia showing no discernable host 
species preference (Sinkins, 2004).  While much remains to be learned about specific 
Wolbachia-host interactions, two distinct strategies have been envisioned for using 
Wolbachia as an effective transgene drive mechanism:  introduction of stably-
transformed Wolbachia, or transformation of mosquitoes with both the desired transgene 
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and genes able to induce/rescue CI.  Finally, superinfection and bidirectional CI make 
use of Wolbachia attractive, as a failed attempt could be rescued by introduction of an 
additional genetically-engineered Wolbachia strain (Sinkins, 2004). 
 Transduction involves the use of viruses to package and deliver genes of interest 
to cells via their natural route of infection.  Of many possible viral transducing agents, 
densoviruses evoke the most interest as vehicles for the introduction and spread of 
transgenes within target mosquito populations.  Densoviruses infect arthropods, 
primarily insects.  Specific viruses within this group exhibit a narrow host range making 
them less likely to infect non-target species (Carlson et al., 2000).  Infectious clones 
have been constructed for the Ae. aegypti densovirus (AeDNV).  These have proven to 
be easily manipulated to carry genes of interest, are capable of infecting multiple tissues 
in adult mosquitoes, and have shown some potential for vertical transovarial 
transduction (reviewed by Olson et al., 2005).  AeDNV is among the best-characterized 
of these viruses, yet much remains unknown regarding its molecular biology.  This 
promising avenue continues to demand much attention from vector biologists. 
 Finally, a recent study describes the feasibility of linking a transgene to a male-
specific insecticide resistance allele (Sinkins and Hastings, 2004).  The construct would 
be propagated in both sexes, but the insecticide resistance mechanism would be linked to 
a male-specific promoter or splicing event, thus creating a fitness advantage in males 
that is greater than the genetic load imposed on females.  The authors propose a number 
of attractive features:  release of only non-biting males, release of small numbers of 
transgenic individuals, and positive selection pressure only in the presence of the 
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insecticide, thus allowing investigators to control the area of spread.  Removal of the 
selective pressure by changing the class of insecticide would result in rapid loss of the 
transgene construct allowing reversal of a failed control strategy. 
1.3.  Mosquito Transgenesis:  The Current State of Affairs 
1.3.1.  The P-element paradigm  
 The successful germ-line transformation of D. melanogaster using P-element 
derived vectors (Rubin and Spradling, 1982) provided a powerful tool for the 
development of the vinegar fly as a model genetic organism.  P-element transformation 
has directly facilitated gene discovery and characterization, investigation of gene 
interactions at the DNA, RNA and protein levels and elucidation of gene regulatory 
mechanisms in this insect (reviewed by Coates, 2005).  The lure of such a powerful tool 
perhaps hindered efforts to transform other insect species by restricting the focus of 
researchers to the P-element system.  Two possible reasons have been proposed to 
explain the failure of P-elements to transform nondrosophilid insects:  a.) the wide 
distribution of P and P-like elements in genomes has triggered the evolution of specific 
repression mechanisms to mitigate the mutagenic properties of transposon mobility; b.) 
host-specific factors that both mediate and regulate P-element activity are largely 
confined to D. melanogaster and closely-related sibling species, while the structure of 
the cleaved termini generated during the transposition process is not typical of other 
class II transposable elements (Atkinson and James, 2002).  This drove the search for 
other class II TEs that could be harnessed for transgenesis and as drive mechanisms in 
medically-important mosquitoes and in other species of medical and agricultural interest.  
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Although P-elements proved unacceptable for transgenesis in nondrosophilid species, 
the basic binary transformation system utilized in P-element transformation remains the 
paradigm for transformation with subsequently identified TEs.   
 All transgenic insects produced thus far harness the components of a class II 
transposon (Finnegan, 1985) and are generated via microinjection of a mixture of two 
plasmid DNAs into preblastoderm embryos.  Endogenous class II TEs catalyze their own 
movement within the host genome via a “cut and paste” mechanism with canonical 
transposition marked by duplication of the target site upon integration.  In insect 
transgenesis, the system is partitioned into two plasmids (Fig. 1).  The first plasmid, 
termed the donor plasmid, consists of the transposons inverted terminal repeats (ITRs), 
any internal sequences necessary for transposition, a marker gene and its promoter and a 
gene of interest along with its regulatory sequences.  The second plasmid, termed the 
helper plasmid, carries the coding sequence for the transposase along with a strong, 
constitutive or inducible promoter to direct its expression at high levels within the cells 
of the early embryo.  The transposase, in-trans, catalyzes the movement of the donor 
cassette from the donor plasmid into a target site within the genome.  If the integration 
occurs in a germ-line cell, the donor cassette will be inherited by the progeny of the 
individual, as a dominant allele, in a Mendelian fashion.  This only occurs for a small 
fraction of integration events, with the vast majority being somatic integrations that 
affect only the current generation.  The helper plasmid cannot integrate, thus the ability 
to produce the transposase is lost with subsequent cell division and dilution/degradation  
of the helper plasmid.  Assuming that the host species does not possess active, 
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endogenous copies of a similar  TE, the donor element will remain stably integrated at 
its new site. 
 
 
 
Fig. 1.  Use of class II transposable elements (TEs) for stable germ-line transformation.  (A) Class II 
Transposons move autonomously via the enzymatic gene product (transposase) encoded by the open 
reading frame.  This product recognizes the Inverted Terminal Repeats (ITRs) and moves the entire 
element into a new site within the genome.  (B)  Binary Transposable Element System involves the 
production of transposase by a non-integrating helper plasmid.  This transposase recognizes the ITRs 
flanking the transgene  cassette in the donor plasmid and catalyzes the movement of the transgene into the 
target genome at a cognate target site.  This movement is characterized by a target site duplication.  
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1.3.2.  Mosquito transgenesis 
 
 The failure of P-element transformation in mosquito species led researchers to 
test newly-identified and characterized class II TEs, Hermes, MosI, Minos and piggyBac 
(Atkinson et al., 1993; Medhora et al., 1991; Franz and Savakis, 1991; Fraser et al., 
1996), using in vivo interplasmid transposition assays (Sarker et al., 1997).  These assays 
are used to assess the mobility of the TE within the target species, prior to investing the 
significant time and effort required to generate stable transgenic lines.  In these assays, 
the donor and helper plasmids are injected into preblastoderm embryos along with a 
target plasmid.  Twenty-four hours later, the target plasmid is recovered and analyzed by 
restriction analysis and/or PCR amplification for integrations of the donor cassette.  
Following the development of universal, fluorescent marker genes with no host cell 
requirements (Pinkerton et al., 2000; Horn and Wimmer, 2000; Horn and Peterson, 
2002), several different class II TEs have subsequently been used to generate germ-line 
transformants in a number of medically important mosquito species (Table 1).  
Nonetheless, mosquito germ-line transformation is largely inefficient, labor intensive 
and costly compared to Drosophila transformation.  Typical mosquito transgenesis 
experiments begin with 10-20 fold more injected embryos, but result in far fewer stable 
lines.  Maintenance of mosquito colonies also requires much more space due to the 
different environmental conditions needed for rearing each life stage, and the actual 
physical segregation of life stages requires much time.  Single-pair matings are all but 
impractical, and the blood meal required for egg production necessitates the care and 
maintenance of numerous vertebrate hosts.  With the exception of Ae. aegypti and a few 
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related species, for which egg papers can be stored for a period of time, mosquito lines 
must be continuously maintained, making the prolonged study of more than a few 
transgenic lines impractical, even in large insectaries.  While there will likely never be 
genetic transformation studies on the scale possible for Drosophila, further optimization 
of mosquito transformation would advance both the understanding of mosquito vector 
biology and the development of genetic control strategies for important vector species. 
 The reasons for such low transformation efficiencies are likely complex.  It has 
become apparent that TEs do not always behave as expected in the context of different 
genomic environments.  The Hermes, MosI and piggyBac TEs all occasionally show 
non-canonical integration events where the entire donor cassette along with some or all 
of the flanking plasmid sequence inserts into the germ-line in Ae. aegypti (reviewed by 
Tu and Coates, 2004).  A similar phenomenon occurs with Hermes insertions into the Cx. 
quinquefasciatus genome (Allen et al., 2001).  Large, unstable tandem arrays of the 
piggyBac TE are observed in approximately 50% of Ae. aegypti transgenic lines 
(Adelman et al., 2004).  Attempts to remobilize integrated transgenes in the germ-line by 
supplying an exogenous source of transposase have largely been ineffective (O'Brochta 
et al., 2003).  Recent whole genome sequencing projects have revealed a diverse range 
of TEs in mosquitoes, so these unexpected observations could reflect interactions 
between endogenous and exogenous TEs with similar ITR sequences (Tu and Coates, 
2004).  Clearly, the “black box” of endogenous TE regulation must be better understood 
in mosquito species. 
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     Table 1 
     Medically-important mosquito species transformeda 
Species Transposable Element (host 
species) 
Marker 
Gene/Promoter 
Transformation 
Efficiencyb 
(published) 
Reference 
Aedes aegypti Hermes (Musca domestica) cn+ ~8% (Jasinskiene et al., 1998) 
 MosI (Drosophila mauritiana) cn+ ~4% (Coates et al., 1998) 
 piggyBac (Trichoplusia ni) EGFP/3 X P3 ~5-10% (Kokoza et al., 2001) 
 Tn5 (Escherichia coli) DsRed/3 X P3 0.22% (Rowan et al., 2004) 
Culex quinquefasciatus Hermes EGFP/Actin5C ~12% (Allen et al., 2001) 
Anopheles stephensi Minos (Drosophila hydei) EGFP/Actin5C ~7% (Catteruccia et al., 2000) 
 piggyBac DsRed/Actin5C ~4% (Nolan et al., 2002) 
Anopheles gambiae piggyBac EGFP/Hr5-IE1 ~0.5% (Grossman et al., 2001) 
Anopheles albimanus piggyBac EGFP/PUBnls 20-43% (Perera et al., 2002) 
     aOnly the first published account of each species transformed with a particular element is represented. 
     bRepresented as the number of transgenic lines per fertile G0 offspring.
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 A number of efforts have been made to increase the frequency of germ-line 
integration events.  Alternative sources of transposase have been used, such as purified 
recombinant protein (Coates et al., 2000) and in vitro transcribed RNA (Kapetanaki et al., 
2002), in an effort to circumvent inefficient heterologous promoter utilization, avoid 
codon bias and to reduce the time required from injection to integration.  Both efforts 
resulted in greater observed transformation frequencies, however both strategies 
highlighted the need to investigate endogenous regulation of TEs and how those 
unknown regulatory mechanisms might impact TE-mediated transgene integration.  
Recently, creation of transgenic Ae. aegypti using the Tn5 TE from E. coli harnessed 
pre-formed synaptic complexes—intermediates formed in the “cut and paste” integration 
process (Rowan et al., 2004).  Though not effective in this case, the strategy certainly 
warrants further investigation as a means to facilitate the required interaction between 
the transposase and donor DNA.  Current research focuses on identification and 
utilization of endogenous, germ-line-specific promoters and developmental mRNA 
targeting sequences to maximize transposase expression at developmentally appropriate 
times and in specific regions of the early embryo.  In this project, heterologous 
promoter/enhancer combinations were tested in cultured cells for potential use in 
producing higher levels of transposase, as well as for their potential to drive high-level 
expression of transgenes. 
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1.3.3.  Addressing variable expression of transgenes due to position effect and position 
 effect variegation 
 Transgene expression often varies both between and within transgenic lines due 
primarily to two well-known phenomena, position effect (PE) and position effect 
variegation (PEV).  Position effect arises as a direct consequence of different integration 
sites (Wilson et al., 1990), due to the transcriptional status of the site and/or the 
influence of nearby enhancers or repressors of gene expression (Fig. 2).  An example of 
this is particularly evident in the early transformation experiments in Ae. aegypti, where 
the kynurenine hydroxylase gene (cinnabar) from D. melanogaster was used as the 
transgenic marker in the white-eyed kwh (Bhalla, 1968) strain, and different transgenic 
families exhibited marked variation in eye color, from light orange to very dark 
purple/black that was nearly indistinguishable from wild-type (Jasinskiene et al., 1998; 
Coates et al., 1998).  The only difference from one family to the next was the integration 
site of the transgene.  Position effect variegation results when expression is varied 
between siblings of a family with a single, common insertion site that likely borders a 
euchromatic/heterochromatic boundary (Fig. 3).  It can also be observed as “mosaic”-
type expression within a particular tissue of a single individual as heterochromatin 
boundaries are not rigidly fixed (reviewed by Grewal and Elgin, 2002).  Both types of 
variable expression have been observed in transgenic mosquito lines (Jasinskiene et al., 
1998; Coates et al., 1998).  This phenomenon complicates efforts to identify and 
characterize transgenic lines in organisms like Ae. aegypti and other culicine mosquitoes, 
where there are large amounts of interspersed heterochromatin throughout the genome 
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(Knudson et al., 1996).  Perhaps the most promising strategy lies in the identification of 
endogenous insulators or boundary elements which could be used to insulate transgenes 
from the effects of their genomic environment. 
 
 
Fig. 2.  Position effect.  Due to different insertion points of a transgene (orange triangle) into the genome, 
one of three different expression patterns may result:  (A) over expression of the transgene due to the 
influence of an upstream enhancer (green diamond), (B) no expression of the transgene due to the 
influence of an upstream silencer (black/yellow cross), (C) normal expression due to the absence of 
endogenous gene regulatory elements in the adjacent chromatin. 
 
 
Fig. 3.  Position effect variegation.  Within a single transgenic family or within individual cells of a single 
tissue, heterochromatin (purple/pink ovals) boundaries may be variable with reference to the transgene.  
No expression (A) results when heterochromatin encroaches upon the transgene, normal expression (B) 
results when the transgene is clearly within open chromatin, partial expression (C) results when the 
heterochromatin boundary coincides with the position of the transgene. 
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 Insulators, also referred to as boundary elements, vary widely in their DNA 
sequence and in the proteins that bind to them.  Nonetheless, they have at least one of 
two properties (Fig. 4) related to barrier formation:  ability to block the action of 
neighboring enhancers/repressors and/or ability to inhibit position effects (Bell et al., 
2001).  A number of different DNA sequences with insulating activity have been 
identified in both invertebrate and vertebrate species:  scs/scs’ (Udvardy and Maine, 
1985) and a portion of the gypsy retrotransposon from D. melanogaster (Geyer and 
Corces, 1992), sites in the sea urchin histone H3 genes (sns) (Palla et al., 1997), human 
Matrix Attachment Regions (MARs) (Namciu et al., 1998), the chicken β-globin genes 
(cHS4) (Chung et al., 1993), the ribosomal RNA genes of Xenopus (Robinett et al., 
1997), and the human T cell receptor (TCR)-α/δ locus (Zhong and Krangel, 1997).  All 
of these insulating elements occur between genes with independent expression profiles, 
consistent with their ability to protect genes from neighboring regulatory elements (Bell 
et al., 2001).  Several of these insulators occur in conjunction with DNase I-
hypersensitive sites at the outermost boundaries of genes, consistent with their ability to 
protect genes from the encroachment of silencing heterochromatin.  cHS4 has been used 
to generate consistent expression levels in transgenic rabbits, mice and cell lines 
(reviewed by Bell et al., 2001).  In addition, a study of the specific binding site of the 
boundary element-associated factor (BEAF) protein in Drosophila has revealed an entire 
class of insulators, that includes scs’, with the simple sequence motif of CGATA.  Up to 
this point, insulators did not appear to have notable sequence homologies or common 
binding properties (Cuvier et al., 1998).  Increasing evidence also points to regulation of  
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Fig. 4.  Boundary elements.  Functional boundary elements possess one or both of the functions depicted.  
(A) Enhancer-blocking and (B) Barrier Activity. 
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insulators (reviewed by Bell et al., 2001).  Several mechanisms have been proposed to 
explain insulator activity, but a dominant model is one of binding proteins anchoring  
specific segments of DNA to the nuclear matrix and other proteins perhaps further 
cordoning off a region of DNA, thereby causing the formation of looped domains and 
specific regions within these domains.  No enhancer or silencer could then act outside its 
own domain, nor could encroaching heterochromatin advance beyond this barrier.  The 
anchoring proteins and the proteins further subdividing the domains into smaller regions 
could then be regulated differently, perhaps accounting for differential expression during  
development or in response to environmental stimuli (Bell et al., 2001).  This study 
focuses on the identification and characterization of a mosquito protein orthologous to a 
well-known vertebrate insulator-binding protein, CCCTC-binding factor (CTCF).  It is 
hoped that insulator sequences bound by this protein can be utilized to protect transgene 
constructs from PE and PEV in mosquitoes.  Future study of this protein will also likely 
reveal important information regarding genome organization and the regulation of gene 
expression in these critical disease vector organisms.  
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2.  HIGH-LEVEL GENE EXPRESSION IN Aedes albopictus CELLS USING A 
BACULOVIRUS HR3 ENHANCER AND IE1 TRANSACTIVATOR 
 
2.1.  Introduction 
 
 Through the efforts of many individuals in the past few years, it has become 
possible to genetically transform a wide variety of non-drosophilid insects of medical 
and agricultural importance (Robinson et al., 2004).  The ability to genetically transform 
mosquito species allows researchers to better understand mechanisms of vector 
competence, design novel methods to disrupt vector-pathogen relationships and develop 
new insect control strategies ((Collins and James, 1996); (Beerntsen et al., 2000); Blair, 
2000; (Alphey and Andreasen, 2002).  New molecular methods could potentially 
augment continued traditional efforts to control malaria and other re-emerging 
arthropod-borne diseases.  Similar approaches may also be used to stem the devastating 
infestation of economically important crops by insecticide-resistant pest strains.   
 Mosquitoes transmit to humans some of the most debilitating and deadly diseases 
known.  According to the World Health Organization, malaria alone is responsible for 
one million deaths annually (World Health Organization, 2003).  Additionally, the 
transmission of yellow fever, dengue fever, West Nile virus and a variety of other 
encephalitis viruses permanently disrupt or end untold numbers of lives.  Both 
anopheline (Catteruccia et al., 2000; Grossman et al., 2001; Nolan et al., 2002; Perera et 
al., 2002) and culicine (Jasinskiene et al., 1998; Coates et al., 1998; Pinkerton et al., 
2000; Kokoza et al., 2001; Allen et al., 2001; Lobo et al., 2002; Ito et al., 2002) 
mosquito species have been successfully transformed.  In all cases, the process is labor-
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intensive with a few successful experiments yielding transformation efficiencies ranging 
from 0.5% to 13%.  These transformation efficiencies are low compared to the nearly 
50% previously reported in Drosophila with vectors up to 8 kb in size (Spradling, 1986).  
Additionally, transgene expression in the yellow fever mosquito varies considerably both 
between and within families (Coates et al., 1998; Jasinskiene et al., 1998; Coates et al., 
1999), likely due to differences in the transcriptional environments of specific insertion 
sites within the genome, such as the proximity of the transgene to enhancers or 
heterochromatic stretches of DNA.  This phenomenon is of particular concern in the Ae. 
aegypti genome given its large size (~780 Mb) and its apparent pattern of short-period 
interspersion where single copy genes (1 to 2 kb) alternate with short (200-600 bp) or 
medium (1-4 kb) length repetitive sequences (Knudson et al., 1996).  The problem is 
complex; however, transposition has been shown to be dependent upon the amount of 
transiently available transposase to catalyze vector integration (Kapetanaki et al., 2002; 
Davidson et al., 2003).  Also, the effective use of genetically-altered mosquitoes to 
augment current disease vector control requires the ability to create and maintain 
transgenic lines with consistent, predictable and high-level expression patterns of 
effector transgenes. 
 With a view to maximizing the transcription of transgenes that insert into 
favorable genomic environments and to potentially increase the levels of transiently 
available transposase, we tested the ability of three different enhancer elements; SV40 
(Moreau et al., 1981), copia ULR (Drosophila) (Matyunina et al., 1996) and Hr3 
(Bombyx mori nuclear polyhedrosis virus or NPV) (Lu et al., 1997), to increase the 
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levels of transcription from each of three heterologous promoters from the following 
genes:  actin5C (Thummel et al., 1988) and polyubiquitin (Ubi-p63E—hereafter referred 
to as pUb) (Lee et al., 1988) from Drosophila and the intermediate early gene (IE1) 
(Pullen and Friesen, 1995) from the Autographa californica multicapsid nuclear 
polyhedrosis virus (MNPV).  Additionally, we tested the ability of the B. mori 
baculovirus IE1 gene product (Lu et al., 1996), which binds to repetitive sequences 
within the baculovirus homologous regions (Hrs) (Guarino and Summers, 1986; Kremer 
and Knebel-Mordsdorf, 1998) and has previously been shown to function as a powerful 
transactivator in transfected lepidopteran cells (Lu et al., 1996), to yet further increase 
gene expression in mosquito cells. 
2.2.  Materials and Methods 
 
2.2.1.  Construction of the luciferase expression plasmids 
 
 Maps for all plasmid constructs built in this study can be found in Appendix A, 
in the order in which they are mentioned in the text.  A 2.7-kb HindIII-SalI fragment 
from pGL2-Basic (Promega, Madison, WI 53711), containing the firefly luciferase 
coding region and the SV40 poly-Adenylation signal, was inserted into the 
corresponding sites of pBCKS+ (Stratagene, LaJolla, CA 92037) to create pBCLuc (A-
1).  A 2.7-kb SmaI-SalI fragment from pBCLuc was inserted into the SmaI-SalI sites of 
pSLfa1180fa (Horn and Wimmer, 2000) to create pSLLuc (A-2).  The Drosophila 
Actin5C promoter was excised from pHermesA5CEGFP (Pinkerton et al., 2000) by PstI 
and BamHI digestion and inserted into the corresponding sites of PSLLuc to create 
pSLAct5CLuc (A-3).  The SacII site was removed from pIE1-3 (Novagen, VWR 
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International, Bristol, CT 06011) and then the 657-bp EcoRI-BamHI fragment 
containing the AcMNPV IE1 promoter was inserted into the corresponding sites of 
pSLLuc to create pSLIE1Luc (A-4).  A 2-kb KpnI-BamHI fragment from pB[pUB-nls-
EGFP] (Handler and Harrell, 2001) containing the Drosophila polyubiquitin promoter 
was inserted into the corresponding sites of pSLLuc to create pSLpUbLuc (A-5).  The 
copia ULR was amplified by polymerase chain reaction (PCR) from copia LTR-ULR-
CAT (Wilson et al., 1998) using the primers copiaULRForw and copiaULRRev (Table 
2), cleaved by digestion with HindIII and SacII and inserted into the corresponding sites 
of pBCKS+ to create pBCcULR (A-6).  The HindIII-SacII fragment from this plasmid 
was then inserted into the corresponding sites of pSLAct5CLuc and pSLIE1Luc to create 
pSLcULRAct5CLuc (A-7) and pSLcULRIE1Luc (A-8).  pBCcULR was digested with 
HindIII and the site filled with the Klenow fragment of DNA polymerase I (Promega), 
then digested with SacII and ligated into pSLpUbLuc which had been cut with NotI and 
the site filled with Klenow fragment, then cut with SacII to create pSLcULRpUbLuc (A-
9).  The SV40 enhancer region from pRL-SV40 (Promega) was PCR-amplified using the 
primers SV40Forw and SV40Rev (Table 2), digested with HindIII and SacII and 
inserted into the corresponding sites of pBCKS+ to make pBCeSV40 (A-10).  The 
HindIII-SacII fragment of pBCeSV40 was then inserted into the corresponding sites of 
pSLAct5CLuc and pSLIE1Luc to create pSLeSV40Act5CLuc (A-11) and 
pSLeSV40IE1Luc (A-12).  pBCeSV40 was digested with HindIII, the site filled with 
Klenow fragment, then digested with SacII and ligated to pSLpUbLuc digested with 
NotI, the site filled with Klenow fragment and subsequently digested with SacII to 
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produce pSLeSV40pUbLuc (A-13).  A 1.2-kb PstI-BamHI fragment containing the B. 
mori NPV Hr3 enhancer from p153 (Lu et al., 1997) was inserted into the corresponding 
sites of pBCKS+ to create pBCHr3 (A-14).  The PstI-BamHI fragment of pBCHr3 was 
inserted into the corresponding sites of pSLAct5CLuc to create pSLHr3Act5CLuc (A-
15).  The HindIII-SacII fragment of pBCHr3 was inserted into the corresponding sites of 
pSLIE1Luc to create pSLHr3IE1Luc (A-16).  The EcoRV-SacII fragment of pBCHr3 
was ligated to pSLpUbLuc digested with NotI, the site filled with Klenow fragment, and 
then digested with SacII to create pSLHr3pUbLuc (A-17).  phsp82RenillaLuc 
(Mohammed, unpublished) was created by inserting a 1-kb KpnI-BamHI fragment from 
pKhsp82 (Coates et al., 1996) into the corresponding sites of pBCKS+ and then inserting 
the KpnI-PstI fragment from this plasmid into the corresponding sites of pRL-SV40.  
ppUbRenillaLuc (A-18) was created by first digesting pSLpUbLuc with NotI, filling in 
the site with Klenow fragment, then digesting with PstI to produce a 2-kb fragment 
which was ligated to pRL-SV40 prepared by digestion with BglII, the site filled with 
Klenow fragment and then digested with PstI. 
 
Table 2 
Primers for section 2 
Identifier Sequence 
copiaULRForw 5’ aagcttgggcccagtccatgccta 3’ 
copiaULRRev 5’ ccgcggattacgtttagccttgtc 3’ 
SV40Forw 5’ aagcttctgaggcggaaagaacca 3’
SV40Rev 5’ ccgcggaaaattagccagccatgg 3’
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2.2.2.  Cell cultures and transfections 
 
 Aedes albopictus C7-10 cells were maintained at 25ºC with 5% CO2 in Eagle’s 
media plus 5% fetal calf serum with the following additions per liter:  10 mL 10% 
(wt/vol) D(+)glucose, 10 mL 200mM L-glutamine, 10 mL MEM vitamin solution, 20 
mL MEM non-essential amino acids, 10 mL Penicillin/Streptomycin (10,000 U/mL), 
29.3 mL sodium bicarbonate (7.5% w/v) (Shih et al., 1998).  400 µL of cells at a density 
of 2 x 106 cells/mL were seeded into 24-well microtiter plates and incubated at 25ºC for 
24 hrs.  Cells were transfected with 0.4 µg total DNA and 0.8 µL LipofectAMINE 2000 
(Invitrogen, Carlsbad, CA 92008) in 10 µL serum-free, antibiotic-free media.  
phsp82RenillaLuc and the firefly constructs were transfected at a 1:2 ratio.  The IE1 
transactivator plasmid (Lu et al., 1997) was present as 1/10 of the total DNA amount.   
2.2.3.  Luciferase assays 
 
 Transfected cells were assayed 24 hrs. post-transfection using a Turner Designs 
20/20 luminometer and a Dual Luciferase Assay (Promega).  The manufacturer’s passive 
lysis protocol was followed.  In addition, cell lysates were snap-frozen in liquid nitrogen 
immediately after lysis to minimize luciferase protein degradation.  All samples were 
diluted 20-fold in 1X PLB (passive lysis buffer) in order to obtain a reading within the 
range of the luminometer.   
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2.3.  Results 
2.3.1.  The Hr3 enhancer and the IE1 transactivator increase reporter gene activity in 
 transiently transfected C7-10 Ae. albopictus cells 
 In transiently transfected C7-10 cells, the Act5C promoter resulted in the highest 
luciferase reporter activity in comparison with the remaining promoters alone (Fig. 5A).  
The level of measured activity directly corresponds to the amount of luciferase protein 
expressed by the transfected cells and thus presumably the level of transcription. Among 
the enhancers, Hr3 improved luciferase expression by 4-fold, 47-fold and 22-fold over 
the basal level expression from the Act5C, IE1 and pUb promoters respectively; cULR 
improved luciferase expression over basal level from the Act5C, IE1 and pUb promoters 
2-fold, 11-fold and 10-fold respectively; and eSV40 resulted in 2-fold, 8-fold and 7-fold 
increases respectively in luciferase expression from the Act5C, IE1 and pUb promoters 
(Fig. 5A).  Addition of the IE1 transactivator unexpectedly resulted in large increases in 
expression from the Renilla control plasmid, as well as from the Hr3-containing reporter 
plasmids.  This is seen in the apparent drop of expression indicated by the red-shaded 
bars in Fig. 5A.  This was confirmed in several independent experiments and was seen 
even with decreased concentrations of the Renilla plasmid (Fig. 6).  In order to 
determine the relative effect of the IE1 transactivator on expression from the 
Hr3/promoter constructs, the raw firefly luciferase values were converted to a percentage  
of average pSLIE1Luc expression and plotted on a log scale (Fig. 5B).  Firefly luciferase 
expression increased 50 to 200-fold over the basal level expression of all of the 
promoters with the addition of the IE1 transactivator. 
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Fig. 5.  Firefly luciferase expression from various promoter/enhancer plasmids in Aedes albopictus C7-10 cells.  Cells 
were assayed for luciferase expression 24 hrs. post-transfection.  The averages of five replications are reported and 
error is reported as +/- 1 standard error.  Bars in red indicate the presence of the IE1 transactivator.  (A) To normalize 
for differences in transfection efficiency and cell cycle state within the experiment, the firefly luciferase luminescence 
values for each construct were divided by the corresponding Renilla luciferase luminescence values measured in a 
dual luciferase assay.  The Hr3 enhancer clearly outperforms both the cULR and the eSV40 enhancers in combination 
all  promoters.  (B) Raw firefly luciferase values are reported as a % of sSLIE1Luc expression on a log scale.  
Addition of the IE1 transactivating protein (Hr3+) increased firefly luciferase expression 2.5-4-fold over all Hr3-
promoter combinations alone and 50 to 200-fold over basal promoter expression. 
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Fig. 6.  The IE1 transactivator significantly affects expression from the Renilla luciferase control plasmid.  
Cells were transfected as detailed in the methods with 0.27 µg Hr3Act5CLuc (firefly) plasmid, 0.04µg IE1 
transactivator plasmid and the indicated amount of Renilla luciferase control plasmid.  Because this is a 
control plasmid with no Hr3 enhancer element present, one would expect the expression levels to parallel 
those shown in the absence of the IE1 transactivator (solid bars). 
 
 
2.3.2.  IE1 transactivator interacts with promoter sequences in addition to the Hr3 
 enhancer 
 Analysis of multiple experiments (Fig. 7, Table 3, and data not shown) revealed 
an interesting trend regarding the effect of the IE1 transactivating protein upon the 
promoters themselves.  This effect was different for each promoter when co-transfected 
with an identical plasmid expressing the Renilla luciferase control.  Addition of the IE1 
transactivator resulted in a 17-fold increase in expression of firefly luciferase from the 
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Act5C promoter over its basal level expression and a concomitant 30-fold increase from 
the Renilla luciferase reporter under the control of the hsp82 promoter from Drosophila 
pseudobscura (Blackman and Meselson, 1986).  When the IE1 promoter was used to 
drive expression of firefly luciferase, expression increased 169-fold over the basal level 
expression, while Renilla luciferase expression from the hsp82 promoter increased 138-
fold.  Finally, firefly luciferase expression increased 11-fold relative to basal level 
expression from the pUb promoter with a corresponding 202-fold increase in Renilla 
luciferase expression from the hsp82 promoter. 
 
 
Table 3 
Change in basal luciferase expression from promoters with the addition of the IE1 
transactivator 
Promoter Firefly Luciferase Renilla Luciferase Ratio 
Act5C ↑   17 x ↑   30 x ↓   1.9 x 
IE1 ↑ 169 x ↑ 138 x ↑   1.2 x 
pUb ↑   11 x ↑ 202 x ↓ 18.3 x 
 
This summary of the data presented in Fig. 5 shows the fold change of firefly luciferase expression from 
each basal promoter following addition of the IE1 transactivator, the fold-increase in expression from the 
control Renilla luciferase plasmid under control of the hsp82 promoter and the overall change in ratio. 
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Fig. 7.  Differential effect of the IE1 transactivator on the transcription levels from various promoters.  
Each promoter-Luc construct was co-transfected with phsp82RenillaLuc, both in the absence and presence 
of the IE1 transactivator, and assayed for both firefly and Renilla luciferase expression, 24 hrs. post-
transfection.  One experiment with six replicates was performed with the same batch of cells, 
DNA/liposome complexes and luciferase reagents.  Error is reported as +/- 1 standard error.  Each set of 
data is plotted both on a linear and a log scale.  (A) Addition of the transactivator (+) caused a 16-fold 
increase in firefly luciferase expression from the Act5C promoter, a 169-fold increase in expression from 
the IE1 promoter and an 11-fold increase in expression from the pUb promoter.  (B) The same data as 
shown in (A) but plotted on a log scale.  (C) Addition of the transactivator resulted in different levels of 
expression from the phsp82RenillaLuc construct depending upon which promoter was used to drive 
expression of the firefly luciferase construct.  (D) The same data as shown in (C) but plotted on a log scale. 
 
 
 
2.4.  Discussion 
 
2.4.1.  The IE1 transactivator interacts with the Renilla luciferase promoter 
 
 Unexpectedly, the internal control for transfection and protein recovery, Renilla 
luciferase, could not reliably be used as such in the presence of the transactivator.  The 
data presented reveal a differential effect of the IE1 transactivator (Fig. 7 and Table 3) 
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that profoundly affects expression levels from the two luciferase plasmids in an 
enhancer/promoter-dependent manner.  This compromises the ability to compare 
expression values both within an experiment where IE1 is present in some samples but 
not in others and between experiments where different batches of cells and assay 
reagents are employed.  The results of a single experiment involving the transactivator 
are reported here, however additional experiments show similar results.  The ratio of 
firefly to Renilla luciferase is reported for all promoter/enhancer combinations to allow 
accurate comparison of the three promoters alone and in combination with each of the 
three enhancers.  It should be noted that the addition of the transactivator does 
significantly increase firefly luciferase expression from all three promoters with the Hr3 
enhancer sequence, though this is masked by the simultaneous increase in expression 
from the Renilla luciferase control plasmid.   
2.4.2.  The IE1 transactivator differentially interacts with exogenous promoters 
 independently of the Hr3 enhancer 
The IE1 transactivator is clearly interacting with the promoters in trans, even in 
the absence of the Hr3 enhancer element (Fig. 7, Table 3 and data not shown).  This 
observation agrees with previously published data that the cytoplasmic A3 actin gene 
promoter of B. mori was upregulated as much as one hundred-fold by the co-transfection 
of a plasmid encoding the B. mori IE1 gene product (BmIE1) (Lu et al., 1996).  When 
the Hr3 enhancer is present, there is a cooperative effect, and luciferase expression 
increases as much as 200-fold (Fig. 5) over that of the promoter alone.  This 
cooperativity is consistent with results obtained with Hr3-enhanced CAT expression 
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cassettes driven by the B. mori cytoplasmic actin gene promoter co-expressed with the 
BmIE1 protein in lepidopteran cell lines Bm5 and Sf21 (an increase of up to three orders 
of magnitude) (Lu et al., 1996). 
The significant differences seen in expression from each of the promoters tested 
(Fig. 7 and Table 3) reveal that not all promoters are affected in the same manner, nor is 
the co-transfected plasmid.  The presence of the Hr3 enhancer region upstream of the 
promoter driving expression of the IE1 transactivator protein, results in high levels of 
IE1 protein from a relatively low amount of plasmid DNA.  Despite this abundance of 
IE1 protein, it appears that transcription from the pUb promoter, in the absence of the 
Hr3 enhancer, increases only 11-fold (Fig. 7A and Table 3), while transcription from the 
hsp82 promoter driving Renilla luciferase expression is exceptionally high (Fig. 7B and 
Table 3).  The simplest explanation is that the IE1 protein has different affinities for 
binding sites on the various promoters and/or the IE1 protein is sequestering necessary 
basal transcription factors.  It has also been observed that some viral promoters, IE-0, IE-
2 and PE-38, are inhibited by IE1 expression (Carson et al., 1991; Kovacs et al., 1991; 
Leisy et al., 1997).  Clearly, the actions of the IE1 transactivator in this study are 
consistent with its ability to bind Hrs (Guarino and Dong, 1991, 1994; Rodems and 
Friesen, 1995).  In addition, the protein has two independent functional acidic activation 
domains and two potential positively-charged inhibitory domains (Choi and Guarino, 
1995; Slack and Blissard, 1997), consistent with its observed ability to both enhance and 
inhibit expression from different promoters.  Also, lower concentrations of the plasmid 
bearing the IE1 gene sequence in these transient assays result in greater increases in 
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luciferase expression (Fig. 8).  This observation is consistent with the mechanism of 
negative regulation by the IE1 protein previously proposed (Leisy et al., 1997) where the 
cooperative binding of the Hrs occurs at a lower concentration than that required for 
binding to the half sequence regions (Hs) present in negatively regulated promoters.  It is 
also consistent with the presence of the Hr3 enhancer sequence on the plasmid producing 
the IE1 transactivating protein, which results in up-regulation of IE1 transcription, 
consequently reducing the number of plasmid copies needed to produce optimal protein 
levels.  When this experiment was repeated using pUb to drive Renilla luciferase 
expression (data not shown and Fig. 9), significant differences between promoters were 
also observed, though not the same differences described above with the hsp82-Renilla 
expression plasmid.   Finally, it should be noted that each of the enhancers alone also 
differentially affected the expression from each promoter.  These data collectively 
highlight the value of evaluating the effects of new promoter/enhancer/transactivator 
combinations on the expression of a reporter gene within a related cell line, prior to 
investing significant time and effort in the creation of transgenic lines.  Though cell lines 
do not completely mimic the cellular and nuclear environment of an entire organism, 
they can yield significant insight into both the potential interaction between regulatory 
elements driving transgene expression and the potential impact of unknown endogenous 
transacting factors. 
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Fig. 8.  Lower concentrations of the IE1 transactivator result in greater expression from both target and non-target 
promoters.  Expression is indicated in relative light units (RLU) from (A) the Hr3Actin5C (firefly luciferase) and (B) 
the hsp82 (Renilla luciferase) promoters.  (C) indicates the ratio of firefly to Renilla luciferase expression.  Cells were 
transfected as detailed in the methods with 0.27 µg Hr3Act5CLuc (firefly) plasmid, 0.14 µg hsp82RenillaLuc plasmid 
and the indicated amount (µg) of IE1 transactivator plasmid.   
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Fig. 9.  The hsp82 promoter versus the pUb promoter for Renilla luciferase expression.  Cells were 
transfected as detailed in the methods with the only difference being the promoter used to drive expression 
of the Renilla luciferase control plasmid.  (A) The pUb promoter seems to be upregulated more than the 
hsp82 promoter in the presence of the transactivator.  Interestingly, the corresponding expression from (B) 
the Hr3Act5C firefly luciferase plasmid is less when the pUb Renilla plasmid is co-transfected.  Other 
differences were seen when this experiment was repeated with Hr3IE1 and Hr3pUb firefly luciferase 
plasmids.  Clearly, the IE1 transactivator binds sequences other than the Hr3 enhancer sequence in 
eukaryotic promoters and the effect is dependent upon the combination of promoters present. 
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2.5.  Conclusions 
 
 Clearly, we have shown that the baculovirus homologous region, Hr3, along with 
the IE1 transactivating protein, significantly increases transgene expression from each of 
the three heterologous, constitutive promoters tested in mosquito cells.  Some concern 
does exist that endogenous promoters might be down-regulated by the presence of the 
IE1 protein, and that available host cell transcription factors might be sequestered by 
complexes stabilized by the IE1 transactivator, however a lower concentration of IE1 
transactivator would likely mitigate these effects.  Preliminary transposition assays 
confirm the ability of the Hr3 enhancer/IE1 transactivator combination to function in 
syncytial preblastoderm mosquito embryos and to significantly increase observed 
transposition frequencies when used to drive transposase expression (Coates, et al., 
unpublished data).  Use of tissue-specific promoters/enhancers and/or inducible 
expression may effectively reduce any potential fitness load imposed by interactions of 
the IE1 protein with endogenous regulatory elements.  Perhaps the most promising 
application is the use of HR/IE1 in helper plasmids transiently expressing transposase in 
an attempt to increase the number of stable transgene integration events by increasing 
the amount of available transposase, particularly if germ-line-specific promoters were 
used to express the transactivator protein.  The HR/IE1 strategy is a promising tool for 
high-level transgene expression and/or increased transposition frequency in culicine 
mosquitoes and possibly other insect species as well. 
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3.  CLONING AND CHARACTERIZATION OF cDNAS ENCODING PUTATIVE 
CTCFS IN THE MOSQUITOES, Aedes aegypti AND Anopheles gambiae 
 
3.1.  Introduction 
 
 CTCF (CCCTC-binding factor) was originally identified as a transcriptional 
repressor in studies of the chicken lysozyme silencer (Baniahmad et al., 1990) and the 
regulation of the chicken c-myc gene (Lobanenkov et al., 1990).  Since that time, CTCF 
has been extensively characterized in vertebrates as a ubiquitously-expressed, highly-
conserved, multivalent transcription factor that utilizes different zinc finger (ZF) 
combinations to specifically bind to diverse nucleotide sequences, resulting in the 
repression or activation of target genes, creation of hormone-responsive silencers and in 
the formation of enhancer-blocking boundary elements (reviewed by Ohlsson et al., 
2001).  Multiple, independent studies have established vertebrate CTCF as a central 
player in the regulation of gene expression via its association with every known 
vertebrate insulator (Ohlsson et al., 2001; West et al., 2002; Filippova et al., 2001).  
Further characterization of these proteins revealed their function to be:  (a) constitutive 
to the insulation of the chicken β-globin 5’HS4 site (Bell et al., 1999; Recillas-Targa et 
al., 2002) and the 5’ boundary of the human apolipoprotein B gene (Antes et al., 2001), 
(b) a role in imprinting via methylation-sensitive binding to the Igfr2-H19 control locus 
(Bell et al., 1999; Hark et al., 2000; Ishihara and Sasaki, 2002; Fedoriw et al., 2003; Du 
et al., 2003; Schoenherr et al., 2003; Pant et al., 2003), the DM1 locus (Filippova et al., 
2001) and the DLK1/GTL2 locus (Wylie et al., 2000), and (c) as part of a more complex, 
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multipartite insulator regulated by ligand binding (Lutz et al., 2003).  Most recently, 
CTCF-dependent insulators have been identified in transitional chromatin, with high 
levels of H3 acetylation and essentially no CpG methylation, between escape genes and 
inactivated genes on both mouse and human inactive X chromosomes (Filippova et al., 
2005).  Finally, Tsix and CTCF have been proposed to comprise a regulated epigenetic 
switch for X-inactivation in mammals (Chao et al., 2002).  Clearly, CTCF plays a 
pivotal role at multiple levels of gene regulation and genome organization in vertebrate 
organisms.   
Long thought to be exclusive to vertebrates, a CTCF orthologue was recently 
characterized in Drosophila melanogaster with domain structure, binding site specificity 
and transcriptional repressor activity similar to that of vertebrate CTCF (Moon et al., 
2005).  Significantly, these researchers also demonstrated that a known Drosophila 
insulator, Fab8, mediates enhancer-blocking via CTCF in both Drosophila and 
vertebrate cell lines.  We have cloned and characterized two mosquito CTCF-like 
cDNAs encoding polypeptides with significant similarity and insulator binding 
properties to both the vertebrate and Drosophila CTCFs.  Analysis of available genome 
sequence from numerous invertebrate species yields promising candidates for additional 
CTCF orthologues.  Clearly, this versatile protein has more ancient roots than once 
thought.    
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3.2.  Materials and Methods 
3.2.1.  Isolation of RNA and preparation of cDNA by reverse-transcriptase PCR 
 
 Total RNA was isolated from ~30 mg each of Ae. aegypti, An. gambiae and D. 
melanogaster larvae using the RNeasy® Mini Kit (Qiagen, Valencia, CA 91355), 
followed by DNase I-treatment with DNA-free™ (Ambion, Austin, TX 78744) and was 
used to synthesize first strand cDNA using the SuperScript II™ reverse transcriptase 
(Invitrogen, Carlsbad, CA 92008) following the manufacturer’s instructions.  Briefly, 0.2 
μM c-anchor dT-primer (Table 3), 1.03 μg total RNA, 1 μl of 10 mM dNTPs were 
brought to a total volume of 12 μl with ddH2O, heated to 65 ºC for 5 minutes and quick-
chilled on ice.  After a brief centrifugation, 5X 1st strand buffer, 10 mM DTT and 40 
units of RNase OUT™ Recombinant Ribonuclease Inhibitor (Invitrogen) were added 
and the mixture incubated at 42 ºC for 2 minutes.  After addition of 200 units of 
SuperScript II™ (Invitrogen), the reaction was incubated for 50 minutes at 42 ºC 
followed by heat inactivation (70 ºC for 15 minutes).  The product was digested with 
RNase H (Promega, Madison, WI 53711) to produce single-stranded cDNA and stored 
at -20 ºC.  In order to increase the efficiency of the reverse-transcription reaction, 150 
ng/μL of T4 Gene 32 Protein (Villalva et al., 2001) was added to the 1st strand buffer.   
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Fig. 10.  Degenerate PCR primer design.  (A) Schematic of CODEHOP primers.  (B) Block G and 
suggested CODEHOP primers before being edited (bases in red).  (C) Four CODEHOP primers used in 
this study along with their degeneracies.  The CLAMP is in upper case while the degenerate core is in 
lower case.  Inosine was utilized where necessary to reduce the degeneracy of the primer.  In some cases, 
additional bases were added to the 5’ CLAMP in order to increase the melting temperature to match a 
partner primer. 
 
 
3.2.2.  Isolation of Ae. aegypti CTCF by degenerate PCR amplification 
 
 The amino acid sequences of all known and predicted CTCFs (EAA11339.1, 
AAL78208, AAG40852, NP_031820, NP_114012, P49711 and Q08705) were identified 
using the BLAST search algorithm at the National Center for Biotechnology Information 
(NCBI) website (http://www.ncbi.nlm.nih.gov) and aligned using the ClustalW 
algorithm in the Vector NTI™ Suite (InforMax, Inc., 1999).  Two completely nested and 
degenerate PCR primer pairs (Fig. 10, Table 4) were designed to a highly-conserved 168 
amino acid region using CODEHOP (Rose et al., 1998; Rose et al., 2003).  A 504 base 
pair nested PCR product was obtained from Ae. aegypti larval cDNA using G-1F and K-
1R primers in the first PCR reaction, followed by a nested reaction with primers G-2F 
and J-1R.  Each reaction was performed with 2 mM MgCl2, 0.2 μM each primer, 10 mM 
dNTPs, 0.5 μL cDNA or 1st reaction product and 2.5 units of Taq polymerase 
 B.. 
Block G and suggested CODEHOP 
H    K    C    H    L    C    G    R    A    F    R    T    V    T    L    L    Q    N    H    L    N    T    H    T    G    T    R    P    H    K    C    
                                                                                                                                                          G1F    5’ CGGCACCCGGccncaymrntg 3’ 
                                                                             G3F    5’ GCTGCAGAACCACCTGAACacncayayngg 3’ 
                                                                   G2F    5’ CCCTGCTGCAGAACCACCTnaayacncaya 3’ 
3’ Degenerate 5’ CLAMPPool of Primers: 5’ 3’ A. 
Corresponds to 3-4 
conserved amino acid
C. 
 
G1F 5’ CATTCCGAGGACCCGccncayaartg 3’  degeneracy = 16 
G2F 5’ GGCCGCTGCAGAACCACCTiaayacncaya 3’  degeneracy = 16 
K1R 5’ CCAGGTCCAGCAGCTGCykytgickraa 3’  degeneracy = 32 
J1R 5’ CGCACTGCTCGCACCTGwancayttytc 3’  degeneracy = 32 
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(Continental Lab Products, San Diego, CA 92111).  The following touchdown PCR 
conditions were used:  96 ºC for 4’; 2 cycles of 96 ºC for 20”, 72 ºC for 1’; 11 cycles of 
96 ºC for 20”, 71 ºC –1.0 ºC/cycle for 15”, 72 ºC for 45”; 25 cycles of 96 ºC for 15”, 59 
ºC for 15”, 72 ºC for 45”; final extension at 72 ºC for 2’.  The product was visualized on 
a 1% agarose gel, extracted from the gel, cloned into a pGEM-T (Promega) vector and 
its sequence determined on an ABI 3100 capillary sequencer. 
 
Table 4 
Primers for section 3 
Identifier Sequence 
c-anchor 5’ gctaatacgtacgatcggtcgacaagttttttttttttttttttv 3’ 
G-1F 5’ cattccgaggacccgccncayaartg 3’ 
G-2F 5’ ggccgctgcagaaccacctiaayacncaya 3’ 
J-1R 5’ cgcactgctcgcacctgwancayttytc 3’ 
K-1R 5’ ccaggtccagcagctgcykytgickraa 3’ 
AgaCTCFfor 5’ caaacgccatatggaggacgtggagctgatat 3’ 
AgaCTCFrev 5’ attacctcttgcggccgcttccgtggagaggataaact 3’ 
AgaCTCFseq-a 5’ gccacctcaaaacgcactcc 3’ 
AgaCTCFseq-b 5’ tgtccgcactgtacgtacgc 3’ 
AgaCTCFseq-c 5’ tgcacgcgaaaacgcacgag 3’ 
AgaCTCFseq-d 5’ agtcgacggtgagcaaggag 3’ 
AgaCTCFseq-e 5’ gagtgcgaaaaaagaaccgg 3’ 
DmelCTCFfor 5’ gaaggcatgattaatgccaaggaggacaaaaaag 3’ 
DmelCTCFrev 5’ attacctcttgcggccgcggtcactagttgagcaag 3’ 
DmelCTCFseq-a 5’ ccgaggatctgcagaccttc 3’ 
DmelCTCFseq-b 5’ ccaccaataaatccatcaat 3’ 
DmelCTCFseq-c 5’ ctgaggtctacgaatttgag 3’ 
DmelCTCFseq-d 5’ aaagcgccttcaccaccagc 3’ 
DmelCTCFseq-e 5’ acctgcgcgttcacattaaa 3’ 
DmelCTCFseq-f 5’ gttgtccgcgggagtttacc 3’ 
DmelCTCFseq-g 5’ gaaaagcagccgatgatcat 3’ 
DmelCTCFseq-h 5’ ctcctgaaaacaaaagctaatggat 3’ 
AaeGSP1 5’ gtctgtcttgcgcccacatgttg 3’ 
AaeGSP2 5’ cgaaagcacgtttacaacttctgg 3’ 
AgaGSP1 5’ ccacaggtcgtcgggcagagtttgca 3’ 
AgaGSP2 5’ caatcggagtaagattgtccgaagaaaggtct 3’ 
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Table 4 continued 
Identifier Sequence 
AaeCTCFseq-a 5’ agtgtgaatgtgcgagcaat 3’ 
AaeCTCFseq-b 5’ gtgtggaagatgaattttgg 3’ 
AaeCTCFseq-c 5’ atgcttcgatttcggcgcgc 3’ 
AaeCTCFseq-d 5’ aagtgtcggcgatgcaacaa 3’ 
AaeCTCFseq-e 5’ tctatccgacgaaatgctta 3’ 
AaeCTCFSouthernForw 5’ actcactatagggcaagcagtggtatcaa 3’ 
AaeCTCFSouthernRev 5’ tgtgatttatcccgccagtggatt 3’ 
AaeRT-Forw 5’ gtgtttcattgcgagctttgcc 3’ 
AaeRT-Rev 5’ tgtctcgatcctccggaatg 3’ 
S17RT-Forw 5’ cgaagcccctgcgcaacaagat 3’ 
S17RT-Rev 5’ cagctgcttcaacatctccttg 3’ 
DmelRT-Forw 5’ atggagactcacgatgattcgg 3’ 
DmelRT-Rev 5’ ctcgtcgccattaaccagct 3’ 
Rp49RT-Forw 5’ gcgcaccaaggacttcatc 3’ 
Rp49RT-Rev 5’ gaccgactctgttgtcgatacc 3’ 
5’HS4Forw 5’ gagctcacggggacagcccccc 3’ 
5’HS4Rev 5’ aagctttttccccgtatccccc 3’ 
Fab8Forw 5’ ggcacaatcaagttaatgttgg 3’ 
Fab8Rev 5’ gcaagcgaagagttccattc 3’ 
 
 
3.2.3.  PCR-amplification and cloning of An. gambiae and D. melanogaster CTCFs  
 
 The predicted ORF of the An. gambiae CTCF was PCR amplified from ~100 ng 
of cDNA with 0.2 μM each of the primers AgaCTCFforw and AgaCTCFrev (Table 4), 
10 mM dNTPs and 2.5 units of Herculase® Hotstart DNA Polymerase (Stratagene, La 
Jolla, CA 92037) in a 50 µL reaction using the following conditions:  95 ºC for 2’; 5 
cycles of 95 ºC for 30”, 55 ºC for 30”, 72 ºC for 2’45”; 25 cycles of 95 ºC for 30”, 65 ºC 
for 30”, 72 ºC for 2’45”; final extension at 72 ºC for 5’.   
 The D. melanogaster CTCF orthologue was PCR-amplified from ~100 ng of 
cDNA with 0.2 μM each of the primers DmelCTCFfor and DmelCTCFrev (Table 4), 10 
mM dNTPs and 1 µL of Advantage2 Polymerase Mix (BD Biosciences Clontech, Palo 
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Alto, CA 94303) in a 50 µL reaction using the following conditions:  95 ºC for 4’; 5 
cycles of 95 ºC for 30”, 55 ºC for 30”, 72 ºC for 3’; 25 cycles of 95 ºC for 30”, 65 ºC for 
30”, 72 ºC for 3”; final extension at 72 ºC for 5’.  An aliquot of each of the PCR 
products was visualized on a 1% agarose gel to confirm the correct size, and the 
remainder of the product was purified using the QIAquick® PCR Purification Kit 
(Qiagen).  The purified PCR products were double-digested with NdeI and NotI 
restriction endonucleases (Promega) and cloned into the altered pET-30 vector described 
below.  The sequence was determined on an ABI 3100 capillary sequencer with the 
primers AgaCTCFseq-a, b, c, d and e and the primers DmelCTCFseq-a, b, c, d, e, f, g 
and h (Table 4) for the resulting clones AgaCTCFpET (A-19) and DmelCTCFpET (A-
20) respectively.   
 The pET-30 LIC/Xa Vector (Novagen, VWR International, Bristol, CT 06011) 
was altered by filling in the LIC sites with 2.5 units of Klenow Polymerase (Promega) 
and 10 mM dNTPs, followed by self-ligation with T4 DNA ligase (Promega).  The 
resulting plasmid was propagated in electrocompetent DH10B cells, purified and the 
sequence of its multiple cloning site (MCS) confirmed.  This vector was then double-
digested with NdeI and NotI restriction endonucleases (Promega) and the 5’ terminal 
phosphates removed with calf-intestinal phosphatase (CIAP) (Promega).  This digested 
vector was used to clone both the An. gambiae and D. melanogaster CTCF orthologues. 
3.2.4.  Rapid amplification of cDNA ends (RACE) in Ae. aegypti and An. gambiae 
 
 Total RNA was prepared from freshly collected and snap-frozen larvae using the 
RNeasy® Mini Kit (Qiagen) and immediately DNase I-treated with DNA-free™ 
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(Ambion) according to the manufacturers’ instructions.  The BD SMART™ RACE 
cDNA Amplification Kit (BD Biosciences Clontech) was then used to prepare first-
strand cDNA and to amplify 5’ and 3’ RACE products according to the manufacturer’s 
instructions.  See Table 4 for gene-specific primers (GSPs) used for each species. GSP1 
indicates the primer used for 5’ RACE reactions while GSP2 indicates the primer used 
for 3’ RACE reactions.  Reaction conditions were as follows:  94 ºC for 5’; 5 cycles of 
94 ºC for 10”, 72 ºC for 3’; 5 cycles of 94 ºC for 10”, 70 ºC for 10”, 72 ºC for 3’; 25 
cycles of 94 ºC for 10”, 68 ºC for 10”, 72 ºC for 3’; final extension at 72ºC for 8’.  
RACE products were visualized on a 1% agarose gel, gel purified, cloned into pGEM-T 
(Promega) and their DNA sequence determined using an ABI 3100 capillary sequencer 
with M13 (-20) and M13 Reverse primers followed by primer walking.  All species-
specific sequencing primers are listed in Table 4.  The sequences were first edited to 
remove all vector sequences, assembled into complete sequence contigs and then 
translated using the Vector NTI™ Suite 8 (InforMax, Inc., 1999) software package.  At 
least 3 different clones were analyzed for each RACE product.   
3.2.5.  Multiple sequence alignment and analysis 
 
 One vertebrate CTCF amino acid sequence (Homo sapiens, P49711) was aligned 
with the amino acid sequences of the three putative dipteran CTCF sequences from this 
study using the ClustalW algorithm in the Vector NTI™ Suite 8 (InforMax, Inc., 1999) 
package.  Each of the sequences was independently submitted to each of the following 
databases in order to identify any potential conserved protein motifs:  Conserved 
Domain Database ( CDD) (Marchler-Bauer et al., 2003), Pfam (Protein families database 
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of alignments and HMMs) (Bateman et al., 2004), SMART (Simple Modular 
Architecture Research Tool) (Schultz et al., 1998; Letunic et al., 2004) and Interpro 
(Mulder et al., 2003). 
3.2.6.  Phylogenetic analysis 
 
BLAST searches of the non-redundant databases at the National Center for 
Biotechnology Information (NCBI) (http://www.ncbi.nlm.nih.gov/BLAST/), Ensembl 
(http://www.ensembl.org/), Flybase (http://bugbane.bio.indiana.edu:7151/blast/) and 
Baylor College of Medicine Human Genome Sequencing Center 
(http://www.hgsc.bcm.tmc.edu/) yielded additional putative orthologues.  All putative 
orthologues were determined to possess the eleven highly-conserved C2H2 zinc finger 
domains in the central region of the protein as well as greatest similarity to known 
CTCFs when analyzed individually by BLAST at the NCBI website. 
All putative orthologues were aligned using several algorithms:  MultAlin 
(Corpet, 1988), DCA (Stoye et al., 1997), PRRN (Berger and Munson, 1991), T-Coffee 
(Notredame et al., 2000) and Poa (Lee et al., 2002).  The resulting alignments were 
inspected and the best one chosen based upon alignment of the conserved residues 
within the eleven zinc finger domains.  Both MultAlin and T-Coffee produced very good 
alignments though MultAlin introduced fewer gaps.  Consequently, the MultAlin 
alignment, using the Blosum62 model with a gap opening penalty of 35, a gap extension 
penalty of 0.5 and no end gap penalty, was chosen for use in the construction of a 
phylogenetic tree for this gene.  This alignment was refined by submitting it to RASCAL 
(Thompson et al., 2003) in order to remove any poorly aligned or divergent regions.  The 
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refined alignment was submitted to Gblocks (Castresana, 2000) in order to identify and 
assemble blocks appropriate for phylogenetic analysis of this gene.  The Gblocks output 
was converted to algorithm-specific formats using ReadSeq 
(http://bimas.dcrt.hih.gov/molbio/readseq/).  Ultimately, the alignment was limited to the 
eleven zinc fingers plus five flanking amino acid residues.   
The resulting alignment was analyzed using the Phylip software package 
(Felsenstein, 1989):  bootstrapped (5000 replicates) with Seqboot, a distance matrix 
computed using Protdist (5000 datasets), the matrix submitted to Neighbor or Fitch 
(5000 trees), a consensus tree determined using Consense and the tree drawn using 
Drawgram.  The MultAlin alignment was also submitted to Tree-Puzzle (Strimmer and 
von Haeseler, 1996) with 200,000 replicates and to BAMBE (Larget and Simon, 1999) 
with 200,000 cycles and 20,000 burn-in.   
3.2.7.  Preparation of genomic DNA  
 
 If mosquito DNA is to be used for PCR, the heads must be removed prior to 
homogenization due to an eye pigment that inhibits Taq DNA polymerase activity.  3 
female and 3 male mosquitoes, or 5 females, or 7 males were ground in 80 μL of Bender 
buffer (0.1 M NaCl; 0.2 M Sucrose; 0.1 M Tris-Cl, pH 9.1; 0.05 M EDTA; 0.5% SDS) 
in a 1.7 mL sterile microtube with a Kontes pestle and Pellet Pestle® Motor (Kontes).  
After addition of 20 μL of 20 mg/mL Proteinase K (Promega), the tube was incubated at 
50ºC overnight.    The sample was then gently (so as not to shear the DNA) extracted 
twice with 200 μL Phenol/Chloroform/Isoamyl alcohol (25:24:1) and once with 
Chloroform/Isoamyl alcohol (24:1).  The DNA was precipitated by addition of 4 μL of 
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3M NaOAc (pH 4.8) and 200 μL isopropanol, mixing gently for 5 minutes and 
centrifugation at 14,000 x g for 10 minutes.  The pellet was washed with 70% ethanol, 
spun 5 minutes and air dried.  The pellet was resuspended in 230 μL of nuclease-free 
water for digests or 100μL for PCR and stored at -20ºC.  Alternatively, the protocol just 
described can be scaled up to extract genomic DNA from 175 to 200 mosquitoes by 
grinding in ~15 mL Bender buffer with a mortar and pestle, using 1 mL of proteinase K, 
100 μL of 3 M NaOAc, pH 4.8 and 10 mL of isopropanol.  The final pellet is 
resuspended in ~5 mL of nuclease-free water.     
3.2.8.  Southern blotting  
 
 Approximately 10µg of genomic DNA was completely digested overnight at 37 
°C with 10 units of a restriction endonuclease (EcoRV, HindIII, SalI or XhoI) (Promega).  
After phenol/chloroform extraction and ethanol precipitation, the digested DNA was 
size-fractionated on a 0.8% TAE agarose gel at 105 V for 1.25 hours, stained with 
ethidium bromide, destained with ddH2O and imaged.  The DNA in the gel was prepared 
for Southern transfer by:  a.) depurination in 0.25 N HCl for 15-30 minutes, b.) 
denaturation in 0.5 N NaOH + 1.5 M NaCl for 30-60 minutes, c.) neutralization in 1 M 
Tris-HCl (pH 7.5) + 1.5 M NaCl for 30-60 minutes.  A Stratagene PosiBlot® 30-30 
Pressure Blotter (Stratagene) was used, according to the manufacturer’s instructions, to 
transfer the DNA to a nylon membrane (Nytran +) overnight in 10X SSC buffer.  The 
DNA was crosslinked to the membrane using a UV Stratalinker 2400 (Stratagene) on the 
auto-crosslink setting. 
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3.2.9.  Probe preparation and hybridization 
 
 A 736 base pair fragment was PCR-amplified and labeled by incorporation of 
800 Ci/mmol α-32-dCTP (Amersham Pharmacia Biotech, Piscataway, NJ 08855) from 
~5 ng of 5’RACE clone #15 with the 0.2 µM each of the primers 
AaeCTCFSouthernForw and AaeCTCFSouthernRev (Table 4), 0.5 mM dNTPs (minus 
dCTP) and 0.5 µL of Taq DNA polymerase (Continental Lab Products) according to the 
following conditions:  94 °C for 5’; 30 cycles of 94 °C for 30”, 60 °C for 30”, 72 °C for 
1’; 72 °C for 5’.  The probe was cleaned up using a QIAquick® Nucleotide Removal Kit 
(Qiagen) according to the manufacturer’s instructions.  The blot was prehybridized for 2 
hours at 68 °C in 12.5 mL of Church’s buffer (1% Fraction V BSA, 1 mM EDTA, 0.5 M 
Na2HPO4—pH 7.2, 7% SDS), 625 μL 100X Denhardt’s solution (2% w/v Ficoll 400, 
2% w/v polyvinylpyrrolidone, 20 mg/mL Fraction V BSA) and 0.5% Non-Fat Dry Milk 
(NFDM).  The prehydridization solution was replaced with fresh solution of the same 
composition, the probe was added and the probe was hybridized to the blot overnight at 
68 °C.  The blot was washed at 68 ºC for 30 minutes each:  2X SSC/0.1% SDS, 1X 
SSC/0.1% SDS, 0.3X SSC/0.1% SDS and exposed overnight on a phosphor screen.  The 
screen was scanned on a STORM phosphorimager. 
3.2.10.  Reverse-transcriptase polymerase chain reaction (RT-PCR) analysis/ 
 developmental profile in D. melanogaster and Ae. aegypti 
 Total RNA was prepared from freshly collected and snap-frozen samples using 
the RNeasy® Mini Kit (Qiagen) and immediately DNase I-treated with DNA-free™ 
(Ambion) according to the manufacturers’ instructions.  Sterile, nuclease-free, 
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disposable pestles were used along with a hand-homogenizer (Kontes) to grind the tissue 
finely.  The concentration and 260/280 ratio of each RNA sample was determined using 
a spectrophotometer (Beckman Coulter, Fullerton, CA  92834).  Reverse-transcriptase 
reactions were performed as described in 3.2.1.   
 Polymerase chain reactions (PCR) were assembled with 100 ng cDNA, 10X 
buffer, 1.5 µL 10 mM dNTPs, 0.2 µM each primer (Table 4) and 1 µL Advantage2 Taq 
Polymerase (BD Biosciences Clontech) in a total volume of 50 µL.  Reaction conditions 
were as follows:  95 ºC for 5’; 20, 25 or 30 cycles of 95 ºC for 15”, 55 ºC for 15”, 72 ºC 
for 30”; final extension at 72 ºC for 2’.  Products were resolved on a 2% agarose gel, 
stained with ethidium bromide, destained with ddH2O and imaged.  The constitutively 
expressed D. melanogaster Rp49 gene (153 bp product) and Ae. aegypti S17 gene were 
used as controls.   
3.2.11.  Generation of polyclonal antibody against An. gambiae CTCF 
 
 The coding sequence of a C-terminal region (amino acid residues 444-680) was 
PCR amplified and cloned into the pET-30 plasmid (Novagen) to create AgaC-
termCTCFpET (A-21), expressed in E. coli (BL21-DE3) and His-tag purified on a Ni-
NTA column (Novagen).  The purified protein was used to immunize two New Zealand 
white rabbits following standard procedures at the Texas A&M University Laboratory 
Animal Research Resources (LARR) facility.  Sera was separated from whole blood by 
centrifugation, aliquoted and stored at -70 ºC. 
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3.2.12.  Immunoblotting 
 
 Bacterial pellets were resuspended and lysed in 1X disruption buffer (50mM 
Tris-HCl, pH 8.0; 4 % SDS; 4% β-mercapto-ethanol; 10% glycerol; 1 mg/mL 
bromophenol blue) by forcing the cells through a 25-gauge needle.  The whole cell 
lysate was then sonicated at 30% output power for 3 cycles of 10 seconds each, with 
samples cooled on ice between sonication cycles. 
 Ten microliters of each sample were separated on a denaturing gel (8% 
separating gel and 4% stacking gel) in 1X Running Buffer (25 mM Tris-HCl, pH 8.0; 0.2 
M glycine; 0.1% SDS) at 20 mA for ~2 hours.  Kaleidoscope Prestained Standards (Bio-
Rad, Hercules, CA 94547) were run in an adjacent lane and used to estimate the sizes of 
the resulting immunostained bands as well as to assess the transfer efficiency of the 
protein from the gel to the membrane.  The proteins were transferred to Westran® Clear 
Signal membrane (Schleicher & Schuell BioScience, Inc., Keene, NH 03431) by 
electroblotting in 1X Towbin transfer buffer (25 mM Tris-HCl, pH 8.0; 0.2 M glycine; 
0.1% SDS; 10% methanol) for one hour in a Hoefer™ tank transfer unit (Amersham 
Pharmacia Biotech) according to the manufacturer’s instructions.  
 Upon completion of the protein transfer, the gel was washed twice for 10 minutes 
in 1X TBS buffer (10 mM Tris-HCl, pH 7.5; 150 mM NaCl).  It was then washed in 
blocking buffer (1% non-fat dry milk (NFDM), 1% fraction V Bovine Serum Albumin 
(BSA), 1X TBS, 0.05% Tween-20) with 20% 5X casein (Novagen), in a sealed bag 
overnight at 4 ºC.  The blot was then washed twice for 10 minutes in 1X TBSTT and 
once for 10 minutes in 1X TBS and was incubated for 1 hour at room temperature on an 
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orbital shaker with His-Tag Monoclonal Antibody (Novagen), resuspended in 600 μL of 
1X TBS and then diluted 1:50 in blocking buffer for a final dilution of 1:10,000 or rabbit 
polyclonal antisera diluted 1:250 in blocking buffer.  After antibody binding, the blot 
was washed twice in 1X TBSTT (1X TBS, 0.05% Tween-20, 0.2% Triton X-100) for 10 
minutes and once in 1X TBS for 10 minutes. Goat Anti-Mouse IgG-AP conjugate 
(Novagen) was diluted 1:3,500 in blocking buffer and incubated with the blot for 1 hour 
at room temperature on an orbital shaker.  The blot was then washed for 10 minutes five 
times in 1X TBSTT. Finally, it was developed for 1-10 minutes in Sigma-FAST™ 
(Sigma Aldrich Chemical Company, St. Louis, MO 63178) according to the 
manufacturer’s instructions.   
3.2.13.  Electromobility Shift Assay (EMSA) 
 
 Sua4 cells were lysed in ice-cold lysis buffer (50mM Tris, pH 7.8; 150 mM NaCl; 
1% IGEPAL CA360 (Sigma) with Complete Protease Inhibitor Cocktail (Roche, 
Indianapolis, IN 46250) and 1 mM PMSF.  Total protein of the cell lysate was 
quantitated using the BCA Protein Assay (Pierce, Rockford, IL 61105), aliquoted and 
frozen at -20 ºC.  The 5’HS4 and Fab8 probes for EMSA were amplified and 
simultaneously labelled with α-32P (Amersham) in a 50 µL PCR reaction with ~10 ng 
DNA template, 10X reaction buffer, 2 mM MgCl2, 8 µL of 0.5 mM 3dNTP mix (minus 
dCTP), 5 µL of 40 µM dCTP, 0.2 µM each primer (Table 4) and 2.5 µL of 10 mCi/mL 
(800 Ci/mmol) α32dCTP.  Amplifications were performed according to the following 
conditions:  95 ºC for 4’; 30 cycles of 95 ºC  for 30”, 55 ºC for 15”, 72 ºC for 30”; final 
extension at 72 ºC for 5’.  A scintillation counter was used to measure the specific 
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activity of the probe.  This number was used to calculate the amount of probe produced 
in the reaction given that the reaction conditions produce products with ~10% of the “C” 
nucleotides labelled (Pollock, 1996).  The binding reaction protocol was adapted from 
(Filippova et al., 1996).  Approximately 10 fmol of labelled probe was incubated for 15 
minutes on ice with 1, 5 or 10 µL of total cell lysate in binding buffer (1X PBS with 5 
mM MgCl2, 0.1 mM ZnSO4, 1mM DTT, 0.1% IGEPAL CA360 (Sigma), 10% glycerol) 
in the presence of a mixture of non-specific, cold, double-stranded competitor DNAs 
(500 ng polydI⋅polydC, 500 ng polydG⋅polydC, 500 ng SpI oligos, 500 ng Egr1 oligos).  
The SpI and Egr1 ds oligos contain strong, C/G-rich binding sites for the zinc-finger 
proteins SpI and Egr1 respectively.  Sample 5 contained 150-fold excess unlabeled 
specific competitor.  For the supershift, anti-sera against the An. gambiae CTCF was 
then added and the reactions incubated an additional 15 minutes on ice.  Complexes 
were separated from the free probe on a 5% native PAGE gel in 0.5X TBE.  The gel was 
run for 3.5 hours at 4 ºC at 10 V/cm.   
3.3.  Results 
 
3.3.1.  Cloning of Ae. aegypti and An. gambiae CTCF-like cDNAs 
 
 A BLAST search using the human CTCF protein sequence (Filippova et al., 1996) 
as a query uncovered a cDNA from D. melanogaster (AAL78208), subsequently 
characterized as an orthologous CTCF factor (Moon et al., 2005).  This sequence was 
then used to query the An. gambiae genome assembly at the Ensembl database 
(http://www.ensembl.org/) resulting in a highly significant hit of the predicted novel 
gene ENSANGG00000015222 (e-139).  These two dipteran sequences were aligned 
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with known vertebrate CTCF sequences, Gallus gallus (Klenova et al., 1993), Mus 
musculus and Homo sapiens (Filippova et al., 1996), Rattus norvegicus (NP_114012.1) 
and Xenopus laevis (Burke et al., 2002) using the ClustalW algorithm (Vector NTI™ 
Suite 8, InforMax, Inc., 1999).  This alignment was used for degenerate PCR primer 
design.  Degenerate PCR, using Ae. aegypti larval cDNA as a template, yielded a single 
PCR product of 504 base pairs, corresponding to a 168 amino acid  polypeptide 
containing six of the eleven predicted zinc-finger domains (Fig. 11A).  PCR 
amplification was initially performed with an An. gambiae larval cDNA template and 
primers corresponding to the 5’ and 3’ ends of the predicted novel coding sequence.  
This yielded a single product of 2040 base pairs, corresponding to a translated 
polypeptide of 680 amino acid residues (Fig. 12A).  Subsequent 5’ and 3’ RACE (rapid 
amplification of cDNA ends) in both species yielded putative full-length cDNAs of  
2616 and 4544 base pairs for Ae. aegypti (Fig. 11B and 11C) and An. gambiae (Fig. 12B 
and 12C) respectively.  Alignment of the corresponding polypeptide sequences with both 
the D. melanogaster and H. sapiens CTCFs revealed significant differences in the N-
terminal and C-terminal regions of the protein (Fig. 13), however there was 38% identity 
and 56% similarity across all eleven zinc finger domains (Fig. 14).  Furthermore, 68% of 
the critical binding residues were conserved, despite at least 500 million years of 
divergence between invertebrate and vertebrate species (Peterson et al., 2004). 
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Fig. 11.  Degenerate PCR and RACE products for Ae. aegypti CTCF.  (A) Nested reaction yielded ~580 
bp product that was cloned and sequenced.  (B) 3’ RACE product.  (C) 5’ RACE product.  The * indicates 
the RACE internal control fragment.   
 
 
 
Fig. 12.  Coding sequence and RACE products for An. gambiae CTCF.  (A) ~2 Kb product using primers 
designed from predicted CTCF sequence.  (B) 5’ RACE product.  The unboxed band is an internal PCR 
control amplified using 3’R1 and 5’R1 primers.  (C) 3’ RACE product. 
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Fig. 13.  ClustalW alignment of full-length, translated CTCF sequences for Ae. aegypti, An. gambiae, D. 
melanogaster and H. sapiens.  Each of the eleven C2H2 zinc-finger domains is underlined, and the highly-
conserved zinc-coordinating residues are indicated by the red arrowheads.   
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Fig. 14.  The zinc-finger (ZF) domain is highly conserved between the dipteran insects, Ae. aegypti, An. 
gambiae and D. melanogaster, and humans.  Each of the eleven ZFs is aligned using the ClustalW 
algorithm.  Identical and strongly conserved residues are highlighted in gray.  Weakly conserved residues, 
the zinc-coordinating residues, and the amino acids with identical binding site recognition are indicated in 
gray, red and blue font respectively.  Numbers indicate the position of each of the critical contact residues 
for DNA binding.  The arrow denotes the C2H2 to C2HC change seen in vertebrate sequences. 
 
 
3.3.2.  CTCF appears widespread in dipteran species 
 
 Available genome sequence for multiple drosophilid species was queried at 
Flybase (http://bugbane.bio.indiana.edu:7151/blast/) using the An. gambiae amino acid 
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sequence and the tBLASTx algorithm.  All species searched produced single hits of very 
high significance, ≤ e-126.  Each of these was submitted as a BLASTp query of the non-
redundant database at NCBI and confirmed to be a significant match to known CTCFs.  
Sequences with complete zinc finger regions were trimmed to the zinc-finger region plus 
five flanking amino acid residues and aligned with the corresponding region of CTCFs 
from H. sapiens, G. gallus, X. laevis, Danio rerio (NP_001001844), Tetraodon  
nigroviridis (CAF99566), and Fugu  rubripes (Ensembl novel gene 
SINFRUG00000147322).  The corresponding region of zinc finger protein 2 
Caenorhabditis elegans (NP_500033) with 11 C2H2 zinc finger domains, a coil-coil 
region and predicted nuclear localization sequence was also included in the alignment 
and used as an outgroup in the subsequent phylogenetic analysis.  Two consensus 
distance-based trees, Neighbor-Joining (Saitou and Nei, 1987) (Fig. 15A) and Fitch-
Margoliash (Fitch and Margoliash, 1967) (Fig. 15B), were generated with 5000 
bootstrap replicates using the Phylip software package (Felsenstein, 1989; Felsenstein, 
1996).  Additionally, a maximum-likelihood tree generated by 200,000 iterations of 
Tree-Puzzle (Strimmer and von Haeseler, 1996) (Fig. 15C) and a Bayesian analysis tree 
generated by 200,000 cycles of BAMBE (Larget and Simon, 1999) with 20,000 cycles 
of burn-in (Fig. 15D) yielded identical branch topologies.  
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Fig. 15.  Phylogenetic analysis of CTCF-like candidates in multiple species.  Dendrograms consensus trees 
for an alignment of the 11 ZF region of known and predicted CTCFs.  Four different trees were generated:  
(A) Neighbor-Joining (5000 bootstrap replicates), (B) Fitch-Margoliash (5000 bootstrap replicates), (C) 
Tree-Puzzle (200,000 iterations), (D) BAMBE (200,000 cycles).  The tree topology is consistent 
regardless of the method used and agrees with the taxonomic classification of the Drosophila species.   
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3.3.3.  CTCF is a single copy gene in Ae. aegypti 
 
 Available genome sequence data supports CTCF as a single copy gene within 
both D. melanogaster and An. gambiae.  A Southern blot with Ae. aegypti genomic 
DNA (Fig. 16) was then performed to confirm a single copy locus in this mosquito.  Ten 
micrograms of genomic DNA was digested with the restriction enzymes EcoRV, HindIII 
and XhoI, size-fractionated on a gel and probed with a radiolabeled 736 base pair 
fragment located upstream of the conserved zinc finger region.  As expected, the EcoRV 
lane shows two distinct bands consistent with two fragments hybridizing to the probe.  
Partial sequence of the first intron reveals an EcoRV restriction enzyme site consistent 
with this pattern.  The HindIII enzyme does not cut the region covered by the probe and 
produces the expected single band on the Southern blot, while the XhoI enzyme cuts the 
probed region once, and results in two bands.  Subsequent release of a genome sequence 
with 5-fold coverage (http://tigrblast.tigr.org/er-blast/index.cgi?project=aabe) supports 
the conclusion that CTCF is a single-copy gene in Ae. aegypti.  
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Fig. 16.  Southern blot analysis confirms that CTCF is likely a single-copy gene in Ae. aegypti.  Genomic 
DNA was digested with each of the following restriction enzymes, E = EcoRV, H = HindIII, X = XhoI, 
separated on a 1% agarose gel, transferred to a nylon membrane and probed with a 750 bp fragment 
(indicated by the double-headed arrow) corresponding to the 5’ UTR and the coding sequence 
corresponding to the N-terminal region of the protein. 
 
 
3.3.4.  Mosquito CTCF is constitutively expressed in all developmental stages and is 
 upregulated in early embryos and in the ovaries of blood-fed females 
Reverse-transcriptase (RT)-PCR amplifications of RNA isolated from embryos, 
ovaries, larvae, pupae and adults shows CTCF expression across all stages of 
development and in ovarian tissues of both Ae. aegypti and D. melanogaster (Fig. 17).  
Early Ae. aegypti embryos and ovarian tissues from both species clearly show increased 
CTCF expression.   
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Fig. 17.  Developmental expression profile of CTCF transcripts in Ae. aegypti and D. melanogaster.  The 
expression of CTCF was analyzed using RNA isolated from multiple individuals at each of the indicated 
stages:  E1 and E24 (embryos ≤ 1 hr and 24 hrs post-oviposition respectively), Lv (larvae), Pf (female 
pupae), Pm (male pupae), Pu (pupae), Af (adult females), Am (adult males), Ov- and Ov+ (ovaries from 
non-blood-fed and blood-fed females respectively).  –RT, no reverse-transcriptase.  (A) and (B) Ae. 
aegypti CTCF, 20 cycles and 30 cycles of PCR respectively.  (C) Ae. aegypti S17, 20 cycles.  (D) D. 
melanogaster CTCF, 25 cycles.  (E) D. melanogaster Rp49, 20 cycles. 
 
 
3.3.5.  Specificity of the polyclonal rabbit antisera raised against a C-terminal 
 fragment of An. gambiae CTCF 
 Immunoblot analysis of E. coli (BL21-DE3) cells expressing a His-tagged, C-
terminal fragment of An. gambiae CTCF with both a His-tag monoclonal antibody (data 
not shown) and the rabbit polyclonal antisera raised against a C-terminal fragment 
(amino acid residues 443-638) of An. gambiae CTCF (Fig. 18) reveals a single band 
migrating at ~47 kD.  The same band was identified in both total cell lysates (Fig. 18, 
lane 7) and in the His-purified fraction (Fig. 18, lane 9).  Furthermore, total cell lysates 
from untransformed cells (Fig. 18, lane 7) show no specific binding to the CTCF antisera.   
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Fig. 18.  Bacterial expression of the C-terminal fragment of An. gambiae CTCF.  1) size markers  2) 
untransformed cells  3) total cell protein  4) soluble fraction  5) His-tag purified  6) Western—
untransformed cells  7) Western—total cell protein  8) Western—soluble fraction  9) Western—His-tag 
purified.  Western anti body = polyclonal rabbit antisera diluted 1:250. 
 
 
3.3.6.  Mosquito CTCF binds in vitro to both the chicken 5’HS4 and the Drosophila 
 Fab8 insulators 
 As we were unable to express the full-length protein in bacteria, whole cell 
lysates were prepared from the Sua4 (Muller et al., 1999) An. gambiae cell line and used 
in an electrophoretic mobility shift assay (EMSA) to assess whether mosquito CTCF can  
bind to known CTCF-associated insulator sequences (Fig. 19).  The intensity of the 
shifted bands increased with application of greater amounts of protein lysate.  The 
detectable complex was competed by cold, unlabeled probe, indicating that the binding 
was indeed specific.  In addition, all reactions contained a 1200-fold excess of cold, non-
specific C/G-rich sequences, further illustrating specific binding.  Finally, the complex 
18.4 kD 
32.5 kD 
45.7 kD 
  78 kD 
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could be partially shifted by polyclonal antibody sera generated against the C-terminal 
region of An. gambiae CTCF. 
 
 
Fig. 19.  An. gambiae CTCF specifically binds the chicken 5’HS4 and Drosophila Fab8 insulator 
sequences.  Sua4 cells were lysed and increasing amounts of total cell lysate (1, 5, 10 µL, represented as 
the solid triangle) were incubated with radiolabeled insulator sequences as follows:  (A) Drosophila Fab8 
insulator sequence (Moon et al., 2005);  (B) chicken β-globin FII insulator sequence (Bell et al., 1999).  
The complex was competed, indicated by C,  with ~150-fold excess of cold, unlabeled probe DNA and 
supershifted, indicated by Ab, with polyclonal antibody sera raised against the C-terminal fragment of An. 
gambiae CTCF.  The probe only lane is indicated by P. 
 
3.4.  Discussion 
 
3.4.1.  Differing rates of molecular substitution rate heterogeneity, smaller genomes and 
 different genome organization may account for the decreased identity observed 
 among dipteran CTCFs 
 Vertebrate CTCFs, from fish to human, are ≥ 98% identical across the entire zinc 
finger core of the protein.  Comparison of the three dipteran CTCFs reveals 54% identity 
and 68% similarity within this same region.  In addition, amino acid residues considered 
critical for DNA binding (Suzuki et al., 1994) are 89% conserved among these three 
insect species.  This apparent discrepancy can be partially addressed by investigating the 
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molecular substitution rate heterogeneity among vertebrates and invertebrates.  Recent 
maximum likelihood analysis of a set of 50 nuclear genes for vertebrates and dipterans, 
with Arabidopsis as an outgroup, suggests that the rate of vertebrate molecular evolution 
slowed considerably with respect to that of dipterans, before the origin of the crown-
group Osteichthyes (Peterson et al., 2004).  The much shorter generation times of 
dipterans have undoubtedly facilitated significant differences in their genome sizes 
(ranging from 179 Mb in D. melanogaster (Holt et al., 2002) to 813 Mb in Ae. aegypti 
(Warren and Crampton, 1991)) and gene organization patterns, attributable primarily to 
the amount and pattern of repetitive sequences (Severson et al., 2004).  This would 
perhaps result in predictions of even greater sequence divergence than is observed in the 
CTCF genes.  It seems likely that at least some of the many attributed vertebrate 
functions of CTCF are ancestral. 
3.4.2.  Evidence for conservation of CTCF in multiple insect orders 
   
Each of the species examined yielded a single, extremely significant match 
followed by numerous matches of lesser significance, suggesting a single copy locus.   
Significant divergence in available N-terminal or C-terminal sequence supports the 
earlier observation that dipteran genomes have evolved very quickly, and thus these 
regions may not be critical to the conserved ancestral function(s) of this gene.  
Additionally, these regions may be more directly involved in protein-protein interactions 
with the interacting proteins having likewise undergone evolutionary adaptation.  High 
bootstrap support and essentially identical trees generated by four independent methods 
establishes the trees presented in Fig. 15 as representative of the evolution of this gene 
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sequence.  Less bootstrap support in the vertebrate clade is more indicative of the 
homogeneity of the sequence rather than uncertainty as to where these species should be 
located in the tree.  Clearly, CTCF is present in vertebrates from fish through mammals 
and is highly conserved.  Of interest is its consistent presence in all dipteran species 
queried.  The relatedness of the protein sequences mirror the accepted taxonomic 
relationships among these species as presented at FlyBase 
(http://bugbane.bio.indiana.edu:7151/blast/), likely indicative of a conserved critical 
function.  Significant EST evidence in the flour beetle, Tribolium castaneum, the honey 
bee, Apis mellifera, and in the silkworm moth, Bombyx mori, suggests the presence of 
CTCF-like genes in multiple insect orders.   
3.4.3.  Drosophila in situ hybridization and microarray data support the mosquito RT-
 PCR expression profile 
The RT-PCR data from both mosquito and fly are consistent with one another, 
repeatable, and in agreement with both in situ hybridization data (Tomancak et al., 2002) 
posted for the fly at the Berkeley Drosophila Genome Project website 
(http://www.fruitfly.org) and the fly microarray data summarized at Yale University’s 
Drosophila Developmental Gene Expression Timecourse website 
(http://genome.med.yale.edu/Lifecycle/query_gen.php?input1=FBgn0035769).  In situ 
hybridization shows high-levels of CTCF transcript ubiquitously distributed throughout 
stage 1-3 embryos.  mRNA levels then decrease until approximately stage 9 where they 
increase primarily in the developing nervous and sensory tissues.  The neural-specific 
expression pattern also corresponds to findings in X. laevis where in situ hybridization 
  
72
with staged embryos revealed weak homogeneous staining prior to stage 14, with 
subsequent upregulation in neural tissues and the sensory organs of the head (Burke et 
al., 2002).  Also, over-expression of CTCF in mice during early embryogenesis resulted 
in decreased expression of the highly conserved homeobox gene Pax6, causing ocular 
defects (Li et al., 2004).  Microarray data analysis clusters fly CTCF (CG8591) with 
genes exhibiting a single peak in expression during development, those showing 
significant expression increases in early embryogenesis, genes with expression changes 
of at least four-fold across development, and those expressed in the female germ-line 
(Arbeitman et al., 2002).  Taken together, these expression data and the corresponding 
functional data from vertebrates suggest that CTCF may indeed be multi-functional in 
insects as well.  Some possibilities include regulation of homeobox genes like Pax6, a 
role in the facilitation of chromatin organization during early development and 
establishment and/or maintenance of heterochromatic and euchromatic regions. 
3.4.4.  Conserved insulator function of mosquito CTCF is a promising tool for 
 mosquito transgenesis 
The EMSA data support a role for CTCF in endogenous mosquito insulator 
function and confirm recent findings that the insulator function of CTCF is conserved 
from invertebrate to vertebrate species (Moon et al., 2005).  Currently, position effect 
and postion-effect variegation complicate efforts to establish effective transgenic lines in 
Ae. aegypti and other mosquitoes.  Particularly problematic is the highly repetitive 
nature of much of the intergenic sequence, as well as the compact nature of the coding 
portion of the genome, which places regulatory elements from neighboring genes in 
  
73
close proximity to one another, where they may inappropriately impact the transgene of 
interest.  The ability to flank transgenes with short, conserved endogenous insulator 
sequences could significantly improve observed expression levels, and possibly increase 
the frequency of recovery of transgenic individuals.   
3.5.  Conclusions 
 
We have cloned the cDNAs for two putative mosquito CTCF proteins.  We have 
presented bioinformatics evidence that CTCF is likely present in many dipteran species 
and that the ancestral portion of the protein is clearly the zinc-finger region.  
Constitutively expressed in all life stages, mosquito CTCFs are distinctly upregulated in 
early embryos and in the ovarian tissues of blood-fed female mosquitoes.  Finally, 
mosquito CTCF specifically binds both the chicken 5’HS4 β-globin and the fly Fab8 
insulator sequences.  Further characterization of these CTCFs and their binding sites will 
provide a promising avenue for insulating transgenes in these medically-important 
mosquito species.   
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4.  CTCF EXPRESSION IN THE MOSQUITOES Aedes aegypti AND 
 Anopheles gambiae IS CONSISTENT WITH ITS POTENTIAL ROLE 
 AS AN INSULATOR-ASSOCIATED PROTEIN 
 
4.1.  Introduction 
 
 Given the large relative size of their genomes, eukaryotes must organize and 
package their chromatin such that expressed genes remain accessible to the cellular 
transcription machinery and repressed genes remain quiescent.  In addition, the effects of 
enhancers and repressors need to be restricted to their cognate genes, prohibiting 
inappropriate activation or repression of neighboring expression domains.  Finally, 
developmental and tissue-specific expression demands dynamic reorganization of 
chromatin domains at specific times and in specific subsets of cells.  This critical task of 
genome organization is attributed, in large part, to boundary elements or insulators, a 
diverse array of DNA sequences bound by one or more proteins (reviewed by Bell et al., 
2001).  Of several insulator-binding proteins characterized to date, only CTCF is 
common to both invertebrate and vertebrate organisms (Moon et al., 2005); Gray and 
Coates, in review).   
Widely characterized in vertebrates, CTCF binds a variety of DNA sequences via 
different subsets of its eleven zinc finger (ZF) domains, making it a key player in a range 
of regulatory events:  repression or activation of promoters, creation of hormone-
responsive silencers and insulation of transcription domains via enhancer-blocking 
(reviewed by Ohlsson et al., 2001).  In addition to the constitutive insulation of several  
genes, CTCF has recently been shown to be key to both the establishment and 
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maintenance of differentially methylated imprinting control regions (ICRs) that are 
critical to the proper expression of imprinted mammalian genes (reviewed by Lewis and 
Murrell, 2004).  Notably, CTCF plays a critical, though not yet well-understood role in 
the complex process of X-chromosome inactivation (Lee, 2003; Pugacheva et al., 2005) 
and in the insulation of  “escape” genes on inactive X-chromosomes (Filippova et al., 
2005).  Finally, a growing body of evidence supports the assertion that CTCF contributes 
to the structural and spatial organization of chromatin within the nucleus as a component  
of complex, multipartite boundary elements (Gombert et al., 2003; Yusufzai et al., 2004; 
Yusufzai and Felsenfeld, 2004; Ishihara and Morohashi, 2005).   
 CTCF orthologues with insulator-binding activity have recently been described 
in three dipteran species:  Drosophila melanogaster (Moon et al., 2005), Ae. aegypti and 
An. gambiae (Gray and Coates, in review).  Furthermore, there is bioinformatics 
evidence that CTCF is widely conserved across multiple insect species (data not shown).  
Here we present expression data here that support the role of CTCF as a conserved 
chromatin insulator protein, potentially associated with nuclear matrix scaffolds that are 
likely involved in chromatin domain organization.  Additionally, the data implicate 
mosquito CTCF in developmental gene regulation and perhaps in the establishment 
and/or maintenance of imprinted chromatin.   
4.2.  Materials and Methods 
 
4.2.1.  Cell fractionation 
 
 Anopheles gambiae Sua4 cells, ~1.8 x 107 cells/mL, were washed twice with 1X 
PBS and fractionated essentially as previously described (Sun et al., 2001).  Cells were 
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resuspended in TNM buffer (100 mM NaCl, 300 mM sucrose, 10 mM Tris-HCl, pH7.4, 
2 mM MgCl2, 1% thiodiglycol) containing 1 mM phenylmethylsulfonyl fluoride (PMSF) 
and Complete Protease Inhibitor Cocktail (Roche, Indianapolis, IN 46250).  Total cell 
protein (TCP) was obtained by sonicating a sample of the cells for three, 10 second 
cycles at 30% output power (Sonic Dismembranator 50, Fisher Scientific, Pittsburgh, PA 
15275).  Samples were cooled on ice between sonication cycles.  The remaining cells 
were lysed in a 15 mL dounce homogenizer with 100 strokes of pestle “B”.  The 
resulting lysate was centrifuged at 4500 x g for 10 minutes to separate the cytoplasmic 
and nuclear fractions.  The cytoplasmic fraction was aliquoted and snap-frozen, while 
the nuclei were resuspended in TNM buffer and extracted by adding 0.5% Triton X-100 
and incubating on ice for 5 minutes.  The extracted nuclei were centrifuged at 4500 x g 
for 10 minutes to separate the Triton-soluble nuclear fraction (NS) from the Triton-
insoluble nuclear fraction (NP).  The pellet was resuspended in an equal volume of TNM 
buffer with 0.5% Triton X-100, and both fractions were aliquoted and snap-frozen.    
4.2.2.  Immunoblotting 
 
 Bacterial pellets were resuspended and lysed as described in 3.2.12.  Cultured 
cells were washed two times in 1X PBS and lysed by resuspending the pellets in 1M 
Tris-Cl, 5M NaCl and 1% IGEPAL CA-630 (Sigma Aldrich Chemical Company, St. 
Louis, MO 63178), incubating 10 minutes on ice and sonicating at 30% power for 3 
cycles of 10 seconds each.  Samples were cooled on ice between sonication cycles. 
 Total protein was quantitated using a BCA Protein Assay Kit (Pierce, Rockford, 
IL 61105).  Equivalent amounts of total protein were separated on a denaturing gel and 
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immunoblotting was performed as described in 3.2.12.  Rabbit anti-sera against An. 
gambiae CTCF (Texas A&M Laboratory Animal Resources and Research Facility) was 
cleared by centrifugation and then diluted 1:250 in blocking buffer.  Anti-Rabbit IgG (Fc) 
AP conjugate (Promega, Madison, WI 53711) was used at a 1:7500 dilution. 
4.2.3.  Pre-adsorption of antibodies 
 
 Pre-immune rabbit sera or polyclonal rabbit anti-sera against a C-terminal 
fragment of An. gambiae CTCF (see 3.2.11) was diluted 1:15 in 1X BBT (10 mM Tris-
HCl, 55 mM NaCl, 40 mM KCl, 7 mM MgCl2, 5 mM CaCl2, 20 mM sucrose, 0.1% BSA, 
0.1% Tween-20), added to a confluent (80 cm2) flask of pre-washed Sua4 cells, and 
incubated with gentle rocking at 4 ºC for 24 hours.  The antibody solution was removed 
from the cells, cleared by centrifugation and stored at 4 ºC until use.   
4.2.4..  Immunocytochemistry 
 
 Sua4 cells (Muller et al., 1999) were seeded on single-well chamber slides 
(Nalge Nunc International, Rochester, NY 14625) in 2 mL of Schneider’s medium 
supplemented with 10% Fetal Bovine Serum (FBS).   Aedes aegypti ATC10 cells were 
seeded as above, but in 2 mL of L-15 medium supplemented with 10% FBS.  Cells were 
grown at 28 ºC for ~24 hours, yielding layers that were ~50% confluent.  This protocol 
was adapted from (Muller et al., 1999).  Cells were washed once with 1 volume of 1X 
PBS.  All washes were done at room temperature, for ten minutes, on an orbital shaker.  
The wash solution was removed, and the cells were fixed in 1X PBS with 4% 
formaldehyde for 20 minutes at room temperature with gentle rocking.  After the fixative 
was removed, cells were washed once more with one volume of 1X PBS, exposed for 2 
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minutes to 0.2% Triton X-100 in 1X PBS, and washed two more times in 1X PBS.  The 
slides were blocked at room temperature for 2 hours in 1X PBS with 3% BSA, 0.2% 
IGEPAL CA-630 (Sigma), 0.2% Tween-20, 10% NFDM.  After removing the blocking 
solution, slides were incubated overnight at 4 ºC with either pre-adsorbed rabbit pre-
immune or CTCF antisera diluted 1:16 in 1X PBS with 1% BSA.  The final dilution of 
the serum was 1:250.  After three washes in 1X PBS, slides were incubated, in the dark, 
for 1 hour with Rhodamine Red™-X goat anti-rabbit IgG (H + L) (Invitrogen, Carlsbad, 
CA 92008), diluted 1:1000 in 1X PBS with 1% BSA.  All of the remaining steps were 
done in the dark to prevent fading of the fluorescent conjugate.  After three washes in 1X 
PBS, samples were mounted in Slow Fade® Light Antifade mounting media with DAPI 
(Invitrogen) and visualized and photographed on a Zeiss Axiovert 135 microscope with 
a CARV confocal module (Zeiss Micro-Imaging and Atto Bioscience).  The slides were 
sealed with clear nail polish and stored at 4 ºC until image collection.   
4.2.5.  Whole-mount immunohistochemistry of embryos 
 
 Ae. aegypti embryos were collected for ~2 hours on damp filter paper and fixed 
essentially as described by Goltsev et al. (2004).  Eggs were bleached for 75 seconds in 
25% household bleach and immediately rinsed with copious amounts of deionized water.  
Approximately 100 embryos were placed in a scintillation vial with 1 part heptane and 1 
part 9% formaldehyde, pH = 7 and incubated at room temperature for 25 minutes on an 
orbital shaker.  Most of the fixative was then removed and replaced with 1 part heptane 
and 1 part deionized water and the embryos incubated an additional 30 minutes with 
gentle shaking.  The water phase was removed and the vial filled to the top with boiling, 
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deionized water and incubated for 30 seconds.  The water phase was removed once again, 
replaced with ice-cold deionized water and incubated on ice for 15 minutes.  The water 
phase was removed, the old heptane was replaced with fresh heptane, an equal volume 
of methanol was added and the mixture was incubated for 10-15 minutes at room 
temperature.  The embryos were washed several times with methanol and stored, ~25 per 
1 mL microfuge tube, at -20 ºC.   
 After removing the endochorion of each embryo using a pair of fine forceps and 
rolling over double-stick tape, most of the methanol was removed and the embryos were 
rehydrated by three, 20 minute washes in 1 mL 1X BBT with Protease Inhibitor Cocktail 
(Roche).  All washes were done by gently rocking the microfuge tubes at room 
temperature.  In situ localization of proteins in whole mount embryos was performed 
essentially as described by Gonzalez-Gaitan and Jackle (1997).  Rehydrated embryos 
were incubated overnight with 300 μL of pre-adsorbed primary antibody (pre-immune 
sera or polyclonal anti-sera against An. gambiae CTCF) diluted 1:16 in 1X BBT at 4 ºC.  
All remaining steps were carried out at room temperature.  The antibody solution was 
removed and the embryos were washed for 20 minutes in 1 mL of 1X BBT.  Non-
specific binding was reduced by washing the embryos twice in 0.5 mL of 1X BBT with 
3% goat serum.  All remaining steps were carried out in the dark to prevent 
photobleaching of the fluorescent conjugate.  Secondary antibody, Rhodamine Red™-X 
goat anti-rabbit IgG (H + L) (Invitrogen), was diluted 1:750 in 1X BBT and incubated 
with the embryos for 2 hours at room temperature with gentle shaking.  After removal of 
the secondary antibody solution, the embryos were washed four times for 10 minutes in 
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1 mL of 1X PBST (1X PBS with 0.1% Tween-20).  Embryos were mounted in Slow 
Fade® Light Antifade mounting media with DAPI (Invitrogen) on glass slides, in a 
narrow channel created by the edges of two coverslips adhered to the slide by double-
stick tape.  The embryos were covered by a third coverslip, the edges sealed with clear 
nail polish and the samples stored at 4 ºC.  Images were obtained using a Zeiss Axiovert 
135 microscope with a CARV confocal module (Zeiss Micro-Imaging and Atto 
Bioscience). 
4.2.6.  Whole-mount immunohistochemistry of ovaries 
 
 This procedure was performed essentially as described by Suter and Steward 
(1991).  Ovaries were dissected in 1X PBS with Complete Protease Inhibitor Cocktail 
(Roche), taking care to separate individual ovarioles from each other and to remove as 
much of the connective tissue as possible, and fixed in 4% paraformaldehyde 
(Polysciences EM grade) in PBST for 15-20 minutes at room temperature.  One half of 
the ovarioles from each female were used in the pre-immune control experiments while 
the remaining ovarioles were incubated with anti-sera against An. gambiae CTCF.  The 
fixative was removed by three brief rinses followed by three, 5 minute washes with 1X 
PBST.  Ovarioles were then incubated four times for 1 hour intervals with 1X PBST 
containing 1% BSA and 0.1% Triton X-100.  Pre-adsorbed antibody solution (pre-
immune sera or polyclonal anti-sera against An. gambiae CTCF) was diluted 1:2 in 1X 
PBST with 1% BSA and 0.1% Triton X-100 and incubated overnight at 4 ºC with gentle 
rocking.  The final serum dilution was 1:30.  After incubating for an additional 2 hours 
at room temperature, the primary antibody solution was removed, and the ovarioles were 
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washed three times for 10 minutes in 1X PBST.  The remaining steps were completed in 
the dark.  The secondary antibody, Rhodamine Red™-X goat anti-rabbit IgG (H + L) 
(Invitrogen), was diluted 1:1500 in 1X PBST and incubated with the ovarioles at room 
temperature for 1 hour.  The secondary antibody solution was removed, and the 
ovarioles were washed three times with 1X PBST at room temperature.  The ovarioles 
were mounted in Slow Fade® Light Antifade mounting media with DAPI (Invitrogen) 
on glass slides in a narrow channel bounded by two strips of double stick tape.  A 
coverslip was overlain, the edges sealed with clear nail polish and the slides stored at 4 
ºC until imaged on a Zeiss Axiovert 135 microscope with a CARV confocal module 
(Zeiss Micro-Imaging and Atto Bioscience).   
4.3.  Results 
 
4.3.1.  CTCF is expressed in cultured mosquito cell lines and in early Ae. aegypti 
 embryos 
 Since the CTCF transcript was constitutively expressed in all life stages, though 
at higher levels in early embryos and in the ovaries of blood-fed females (Gray and 
Coates, in review), we investigated whether the protein product was present at detectable 
levels in two different mosquito cell lines, An. gambiae Sua4 and Ae. aegypti ATC10, 
and in Ae. aegypti embryos, ≤ 1 hour post-oviposition (Fig. 20).  Immunoblot analysis 
reveals a single band for each lysate sample, migrating at ~84 kD for An. gambiae CTCF 
(680 amino acid residues) and at ~81 kD for Ae. aegypti CTCF (615 amino acid 
residues).   
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Fig. 20.  CTCF protein is expressed in the An. gambiae Sua4 and Ae. aegypti ATC10 cell lines and in Ae. 
aegypti early embryos.  Equivalent amounts of total protein from lysates of (1) An. gambiae Sua4 nuclei, 
(2) Ae. aegypti ATC10 total cell lysate, (3) Ae. aegypti embryos (<1hr post-oviposition) were fractionated 
on an 8% SDS-PAGE gel, electroblotted to a nylon membrane and incubated with rabbit antisera raised 
against a C-terminal fragment of An. gambiae CTCF.  A goat anti-rabbit IgG (Fc) AP conjugate was used 
to detect the antibody-protein complex.  The arrowhead indicates the 81.1 kD size marker. 
 
 
 
4.3.2.  CTCF is expressed in both the cytoplasmic and nuclear fractions of An. gambiae 
 Sua4 cultured cells, and is enriched in the Triton X-100-insoluble nuclear 
 fraction 
 In order to determine the subcellular distribution of CTCF, Sua4 cells were lysed 
in TNM buffer (Dunn et al., 2003) and separated into cytoplasmic (C) and nuclear (N) 
fractions.  The nuclei were then extracted with 0.5% Triton X-100 to produce Triton X-
100-insoluble (NP) and Triton X-100-soluble (TS) fractions.  Triton X-100 removes 
loosely bound nuclear proteins, but does not disrupt the association of proteins tightly-
bound to nuclear structures such as the matrix.  All of the fractions were then subjected 
to immunoblot analysis (Fig. 21).  CTCF was detected in all fractions; however,  
  
83
proportionally greater amounts were detected in the Triton X-100 insoluble fraction, 
suggesting that significant amounts of CTCF are tighly-bound to nuclear structures.  
 
 
 
Fig. 21.  CTCF protein is expressed in both the cytoplasmic and nuclear fractions of cultured cells, and is 
enriched in the Triton X-insoluble fraction associated with the nuclear matrix.  Equivalent amounts of total 
protein from the indicated cell fractions, TCP (total cell protein), C (cytoplasmic), N (nuclear), NP (Triton 
X-100-insoluble), NS (Triton X-100-soluble), were fractionated, electroblotted and the CTCF protein 
detected using a CTCF-specific polyclonal antibody as described in Fig. 20. 
 
 
 
4.3.3.  CTCF shows both cytoplasmic expression and localization to distinct nuclear foci 
 in Ae. aegypti ATC10 and An. gambiae Sua4 cell lines 
 If significant amounts of CTCF protein are indeed bound to nuclear structures, 
immunocytochemistry should reveal distinct nuclear foci rather than more homogenous 
staining.  Both Ae. aegypti ATC10 cells and An. gambiae Sua4 cells show this predicted 
pattern of CTCF distribution (Figs. 22 and 23).  Unlike vertebrates, mosquito cells also 
show some cytoplasmic localization, though most of this appears localized close to the 
nuclear membrane.  
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Fig. 22.  Immunofluorescent analysis of CTCF expression in Ae. aegypti ATC10 cultured cells.  Along 
with cytoplasmic expression, distinct foci within nuclei were seen after immunostaining using rabbit anti-
CTCF polyclonal antibodies.  CTCF was detected with a Rhodamine-conjugated 2º antibody (red) while 
nuclei were counterstained with DAPI (blue).  Magnification X 630.  (A and B) CTCF only, (C) 
preimmune control only, (D, E and F) DAPI only, (G and H) CTCF/DAPI merge, (I) preimmune 
control/DAPI merge, (J, K and L) bright-field, (M) CTCF/DAPI merge enlarged.  
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Fig. 23.  Immunofluorescent analysis of CTCF expression in An. gambiae Sua4 cultured cells.  As in Fig. 
22, distinct foci of expression are observable in the nucleus with most of the cytoplasmic expression 
directly adjacent to the nucleus.  Magnification X 630.  (A) CTCF only, (B) preimmune control only, (C 
and D) DAPI only, (E) CTCF/DAPI merge, (F) preimmune control/DAPI merge, (G and H) bright-field. 
 
 
 
4.3.4.  CTCF protein is expressed throughout Ae. aegypti syncytial, preblastoderm 
 embryos, but is restricted to the follicle cells of mature ovarioles 
 In order to further investigate the pattern of protein distribution during oogenesis 
and embryogenesis, CTCF protein was localized in Ae. aegypti mid-vitellogenic 
ovarioles, 36-48 hours after a second blood meal (Figs. 24 and 25), and in embryos 
collected ~4 hours post-oviposition (Fig. 26).  Consistent with a maternal transcript, 
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mid- to late-stage vitellogenic ovarioles show no detectable CTCF expression in the 
oocyte.  CTCF was, however, expressed markedly in regions occupied by both nurse 
cells and the single layer of follicular cells that envelops the oocyte.   
 
 
Fig. 24.  CTCF expression in Ae. aegypti mid- to late-stage vitellogenic ovarioles.  CTCF protein was 
immunolocalized in individually-fixed, mature ovarioles using rabbit anti-CTCF polyclonal antibodies and 
a Rhodamine-conjugated 2º antibody (red) as described in Fig. 3.  Magnification X 630.  (A and B) CTCF 
only, (C) preimmune control only, (D, E and F) DAPI only, (G and H) CTCF/DAPI merge, (I) preimmune 
control/DAPI merge, (J, K and L) bright-field.  
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Fig. 25.  Enlarged support cells from the tip of the ovariole pictured in Fig. 24G. 
 
Earlier attempts at immunostaining of whole ovaries met with limited success 
due to the presence of a proteinaceous sheath of connective tissue that became very 
“sticky” after formaldehyde fixation.  Earlier-stage ovarioles proved too fragile to 
separate, so we focused upon later stages of ovarian development.  In these stages, the 
tunica propria portion of this sheath thins markedly during vitellogenesis (Chapman, 
1998), making it more amenable to removal.  In addition, more mature ovarian tissues 
possess less fragile follicles where the oocyte takes up more of the follicular space, 
allowing the complete removal of the connective tissue, while leaving the ovarioles 
intact.   
 
  
88
 
Fig. 26.  CTCF expression in early Ae. aegypti embryos.  Embryos (2 to 4 hours post-oviposition) were 
fixed and incubated with rabbit polyclonal anti-sera raised against a C-terminal fragment of An. gambiae 
CTCF.  The antibody-protein complex was detected with Rhodamine-conjugated 2º antibody (red) while 
nuclei were counterstained with DAPI (blue).  Magnification X 630.  (A and B) CTCF only, (C) 
preimmune control only, (D, E and F) DAPI only, (G and H) CTCF/DAPI merge, (I) preimmune 
control/DAPI merge, (K, L and M) bright-field.  (A, D, G and K) show the anterior end and (B, E, H and L) 
show the posterior end of the same embryo.  (C, F, I and M) show the posterior end of a representative 
control embryo. 
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Because the eggs of this species develop tough, opaque endochorions, embryos 
must be hand-peeled prior to immunostaining.  With no vitelline membrane at 
oviposition (Raminani and Cupp, 1975), and with the cell membrane essentially fused to 
the endochorion, there is very little internal structure—only a few nuclei in a “sea” of 
cytoplasm, so younger embryos proved impossible to peel in the preparation stages.  The 
earliest time point at which embryos could be successfully manipulated for whole-mount 
immunolocalization was ~4 hours post-oviposition.  At this syncytial stage, roughly 
equivalent to Bownes’ stage 5 in Drosophila development, nuclei begin to migrate to the 
periphery of the embryo (Raminani and Cupp, 1975).  At this time, CTCF appears 
ubiquitously expressed throughout the entire embryo in both the nuclei and the common 
cytoplasm.   
4.4.  Discussion 
 
4.4.1.  Mosquito CTCFs migrate aberrantly in SDS-PAGE, consistent with those of  
            Drosophila and vertebrates 
 The mosquito CTCFs (81-84 kD) are considerably smaller than that of the D. 
melanogaster CTCF (~140 kD and 818 amino acid residues) previously reported (Moon 
et al., 2005), but they are consistent with the shorter polypeptides predicted for the 
mosquito transcripts (680 and 615 amino acid residues).  All three insect CTCF proteins, 
however, exhibit greater relative molecular mass than is predicted by their sequence 
alone, much like the CTCFs of chicken and mammals (Klenova et al., 1997).  This 
suggests that common structural features or post-translational modifications may be 
shared by all CTCF proteins.   
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4.4.2.  Mosquito CTCF expression is consistent with nuclear matrix association 
 
 Similar cell fractionation experiments with human breast cancer cells revealed 
that CTCF expression is almost exclusively nuclear, and that the protein is tightly bound 
to nuclear structures, with none detectable in the Triton-soluble fraction (Dunn et al., 
2003).  These researchers also determined that CTCF binds specifically to nuclear matrix 
proteins, suggesting that CTCF may be part of a functional MAR (matrix attachment 
region) involved in the 3-D spatial organization of chromatin within the nucleus.  An 
independent study subsequently confirmed that the 5’HS4 chicken β-globin insulator 
associates with the nuclear matrix in a CTCF-dependent manner (Yusufzai and 
Felsenfeld, 2004).  While we detected some expression in the cytoplasmic and Triton X-
100-soluble fractions, significantly greater amounts of CTCF were detected in the Triton 
X-100-insoluble fractions.  This suggests that the association of CTCF with the nuclear 
matrix may be conserved in mosquitoes.  Other researchers determined that CTCF 
expression is nuclear during interphase in HeLa cells, but that significant accumulations 
occur at the centrosomes and in the midbodies during mitotic cell division (Zhang et al., 
2004).   This data would be consistent with some cytoplasmic expression in actively 
dividing, asynchronous mosquito cells.  Alternatively, the differences in subcellular 
localization may simply be due to fundamental differences in the role of CTCF in 
mammalian cancer cells compared to insect cells.   
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4.4.3.  Vertebrate CTCF and other nuclear matrix-associated proteins show a similar 
 pattern of nuclear localization 
 Multiple new binding sites for vertebrate CTCF were recently identified across 
the mouse genome, in both euchromatic and heterochromatic domains, using a ChIP-on-
ChIP analysis (Mukhopadhyay et al., 2004).  This same group observed scattered nuclear 
foci of CTCF expression that colocalize with the expression of the heterochromatin 
protein HP1β.  HP1, identified as a mutant suppressor of PEV (position-effect-
variegation) in Drosophila (Eissenberg et al., 1990), also interacts with the lamin B 
receptor (LBR), an integral membrane protein of the inner nuclear membrane (Ye and 
Worman, 1996), implicating HP1 in a chromatin tethering role.  Finally, the gypsy 
insulator binding protein, suppressor of Hairy wing (su(Hw)), has been shown to be 
capable of bringing together otherwise distinct and distant chromatin domains by 
forming numerous, intensely-staining foci termed “insulator bodies”, at the nuclear 
periphery to form looped domains (Gerasimova et al., 2000; Byrd and Corces, 2003).  
These observations are consistent with proteins that function to form chromatin 
boundaries, some of which may be anchored to nuclear structures.   
4.4.4.  CTCF expression in mature ovarioles and during early embryogenesis is 
 consistent with that of a maternal gene 
Expression of CTCF in the support cells rather than in the developing oocyte, 
suggests that it may be involved as a global transcription factor in these active cells 
and/or in the rearrangement of chromatin in order to facilitate the expression of genes 
specifically involved in oocyte development and the production of extraembryonic 
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membranes.  The absence of the protein in the oocyte is also consistent with the 
expression pattern of maternal genes that are deposited in the developing oocyte as 
mRNA transcripts and are first translated post-fertilization, during early development.  
This observation appears to differ from mice where CTCF is expressed in both the 
germinal vesicle and in the cumulus cells (follicle cells) (Fedoriw et al., 2003).  These 
researchers also used an RNAi strategy to elucidate the central role CTCF plays in 
developmental competence, presumably by protecting hypomethylated regions of the 
genome, such as the imprinted H19 gene, from de novo methylation.  Although dipteran 
insect genomes do exhibit methylation, major differences occur:  the greatest levels of 
methylation are present during early embryonic development rather than in late 
development, the majority of methylation is asymmetrical CpA or CpT methylation 
rather than symmetrical CpG methylation, flies possess just one functional 
methyltransferase (Dmnt2) while vertebrates have at least four (Dmnt1, Dmnt2, Dmnt3a 
and Dmnt3b), and no parent-of-origin-specific imprinted genes have been described in 
insects, versus multiple genes in vertebrates (reviewed by Marhold et al., 2004).  
Collectively, the evidence suggests that CTCF acquired its function in imprinting after 
the divergence of protostomes and deuterostomes.   
 Despite no observable CTCF protein expression in the mature oocyte, significant 
amounts of CTCF expression were detected throughout early syncytial Ae. aegypti 
embryos (Fig. 18).  Such a dramatic and rapid increase likely results from the translation 
of abundant maternal RNA transcripts following fertilization and oviposition.  This 
observation is corroborated by immunolocalization of CTCF to the nuclei of stage 3  
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syncytial blastoderm Drosophila embryos (Moon et al., 2005).  RNA transcript levels in 
oocytes and/or mature ovarian tissues, as measured by RT-PCR and/or in situ 
hybridization, are consistently high in Ae. aegypti (Gray and Coates, in review), D. 
melanogaster (Moon et al., 2005) and X. laevis (Burke et al., 2002).  Maternal gene 
transcripts like bicoid and nanos often act as morphogens that impact the expression of 
downstream genes in a concentration dependent fashion, thus they localize specifically 
to different regions of the early embryo.  CTCF appears to be distributed in a more 
uniform fashion, consistent with a different role.  One specific insight into the 
developmental role of CTCF is the observation that CTCF regulates Pax6 expression in 
eye-development by binding to a repressor element, which in turn blocks the effect of an 
ectoderm enhancer tied to Pax6 expression in the eye tissues (Li et al., 2004).  Many 
developmental genes must be regulated in both the proper temporal and spatial context.  
Perhaps CTCF plays a pivotal role in mediating the expression these genes by binding 
“conditional” insulators that facilitate the proper interaction of enhancers with their 
cognate promoters.  These insulators may be regulated by binding of a ligand, such as a 
growth hormone.  This type of CTCF-regulated insulator occurs in vertebrates at 
CTCF/TRE (thyroid response element) composite sites that are bound by CTCF and 
either a thyroid hormone receptor (TR) homodimer or a heterodimer of TR and retinoid-
X-receptor (TR/RXR) in the absence of the thyroid hormone T3 (Lutz et al., 2003).  
Perhaps not coincidentally, insects possess an analogous type of ligand-activated system 
in the ecdysone receptor and ultraspiracle (EcR/USP) heterodimer that binds to 
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ecdysteroid-response elements (EcREs) within the regulatory regions of several early 
genes, which in turn regulate late gene expression (reviewed by Martin et al., 2001).   
4.5.  Conclusions 
 Newly identified in insect species, very little is known about the role(s) that 
CTCF may play in these species.  Our expression data support roles for CTCF in 
chromatin organization and in insulation via multiple possible mechanisms.  Mosquitoes 
impact human health worldwide by their superb ability to vector multiple pathogens.  
The identification of endogenous insulator sequences, with the ability to function early 
in development, could greatly benefit efforts to create transgenic strains refractory to 
pathogen transmission. 
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5.  PCR-ASSISTED IDENTIFICATION OF Anopheles gambiae  
CTCF DNA BINDING SITES 
 
5.1  Introduction 
 
 CTCF (CTCCC-binding factor) has been well-characterized in vertebrates as a 
ubiquitously-expressed, multivalent transcription factor and a key component of all 
known vertebrate insulators (reviewed by West et al., 2002).  It binds an array of distinct 
DNA sequences with critical contact guanine residues within chicken, human, mouse 
and rat via combinatorial use of its 11 highly-conserved zinc fingers and, unlike any 
other multi-zinc finger protein known, is also capable of protein-protein interaction (YB-
1, YY1 and RNP-K) via this same zinc-finger region (reviewed by Ohlsson et al., 2001).  
Recently, CTCF has been shown to bind differentially methylated DNA and to be key in 
both the maintenance of imprinted loci and in the process of X chromosome inactivation.  
In both instances, CTCF seems to act as a regulatable transcriptional switch within a 
chromatin boundary element (reviewed by Lee, 2003).  Human CTCF has been shown to 
be associated with the nuclear matrix, a structure bound by DNA sequences known as 
MARs (matrix attachment regions) and enriched in chromatin remodeling enzymes 
(Dunn et al., 2003).  To date, little is known about the role(s) of CTCF outside 
vertebrates, however recent evidence suggests that the role of CTCF in enhancer-
blocking insulators is conserved in dipteran insects (Moon et al., 2005) and (Gray and 
Coates, in review). 
 Insulators are DNA-protein complexes that protect genes from the influences of 
neighboring regulatory elements and functionally possess one or both of the following 
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key properties:  the ability to prevent the interaction between an enhancer and a 
promoter when juxtaposed between the two (enhancer-blocking) and the ability to 
protect genes from position effects by inhibiting the encroachment of heterochromatin 
into expressed euchromatic regions (barrier activity) (reviewed by Bell et al., 2001).  
Insulators clearly act via multiple, not always mutually exclusive, yet poorly understood 
mechanisms that may include:  enhancer blockers that mimic competent promoter 
complexes and interact with the enhancer to prevent its association with the neighboring 
promoter; tethering multiple chromatin fibers to an “insulator body” to effectively dilute 
the effects of an enhancer by bringing multiple targets into close proximity; tethering 
enhancers near the base of chromatin loops, sterically preventing them from interacting  
with promoters outside their own loop domain; tethering chromatin to fixed nuclear 
structures such as the nuclear membrane, nucleolus or nuclear scaffolds thus imposing a 
fixed barrier to polymerase tracking; masking nucleosomes whereby insulator-associated 
proteins compete with histone modifying enzymes; nucleosome displacement where the 
presence of insulator protein complexes excludes nucleosome deposition, effectively 
removing the substrate for heterochromatin nucleation; and/or recruitment of histone-
modifying enzymes to actively maintain an open chromatin conformation (reviewed by 
West and Fraser, 2005).  Increasingly, insulators are characterized as complex, 
multipartite regulatory elements with separable functions.  Two examples of insulators 
with separable CTCF-dependent enhancer-blocking and CTCF-independent barrier 
activities are the chicken 5’HS4 β-globin insulator (Recillas-Targa et al., 2002) and the 
MINE element at the 5’ end of the c-myc locus in humans and mice (Gombert et al., 
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2003).  Furthermore, not all insulators are constitutive—many are regulated in 
developmental or tissue-specific contexts by mechanisms such as binding to 
differentially methylated sequences, poly-ADP-ribosylation by poly-ADP-ribose 
polymerase (PARP), and interaction with numerous protein co-factors (reviewed by 
West and Fraser, 2005).  Insulators likely play a central role in the spatial organization of 
chromatin within the nucleus and are an integral part of ensuring the dynamic balance of 
interaction and segregation necessary for proper gene expression during an organisms  
life cycle. 
 DNA binding proteins with tandem zinc finger domains comprise one of the 
largest and most-diverse families of eukaryotic transcription factors.  Many efforts have 
been made to elucidate a general “binding site code” for C2H2 zinc finger proteins 
(reviewed by Pabo and Nekludova, 2000), however multiple variables such as side-chain 
size, stereochemistry, orientation with respect to the major groove of the DNA, 
orientation within the α helix and interaction with neighboring residues, both within and 
adjoining the α helix, make this task extremely difficult.  Additionally, recognition of 
zinc finger binding sites by multiple fingers in tandem array introduces the problem of 
neighboring domain influence, known as target site overlap (Segal, 2002).  Finally, 
combinatorial use of subsets of their zinc finger domains makes zinc-finger proteins 
extraordinarily versatile (Ladomery and Dellaire, 2002).  CTCF is one such protein, 
shown to bind divergent target sites in this manner (Filippova et al., 1996).  It is not 
surprising then that CTCF binding sites have been elusive to predict.   
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 CTCF-like cDNAs from the medically important mosquito species Aedes aegypti 
(AY935523) and Anopheles gambiae (AY939827) were recently cloned and 
characterized (Gray and Coates, in review).  Putative DNA binding sites for the An. 
gambiae orthologue were determined using two independent, PCR-assisted, in vitro 
binding site selection experiments.  Though not identical to core consensus sequences 
reported in vertebrates, the mosquito binding sites are C/G-rich and appear to be 14 bp in 
length, as reported for human, mouse and chicken CTCF (Chao et al., 2002; Ishihara and 
Sasaki, 2002; Bulger et al., 2003).  In silico analysis of the selected random-primed 
genomic fragments indicates distribution in intergenic sequences as well as within 
introns of genes, consistent with regulatory function.  The eventual identification of 
endogenous insulators associated with CTCF binding would provide valuable elements 
for protecting transgenes from the silencing effects of neighboring regulatory elements 
and unfavorable chromatin structure. 
5.2.  Materials and Methods 
 
5.2.1.  Generation of input fragment pools 
 
Two separate input fragment pools were generated (Fig. 27).  The first pool, termed R76, 
consists of a collection of radiolabeled, double-stranded oligonucleotides with a 26 base 
pair core of random DNA sequence, flanked by specific adaptor sequence with a BamHI 
restriction enzyme site at the 5’ end and an EcoRI restriction enzyme site at the 3’ end.  
Generally, the protocol outlined by (Pollock, 1996) was followed.  To generate this pool, 
the R76 oligonucleotide (Table 5) was made double-stranded by primer extension using 
primer F and simultaneously labeled to a specific activity of 3200 Ci/mmol 
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Fig. 27.  Input pools generated for PCR-assisted binding site selection.  (A) R76 oligo with known priming 
sequences and restriction sites, to allow PCR-amplification and subsequent cloning, flanking a randomized 
core of 26 nucleotides.  (B) Bind-select primers consisting of a T7 primer sequence to allow PCR-
amplification, a NotI restriction enzyme site for use in cloning, and the Sau3AI site which binds frequently 
within the An. gambiae genome, followed by a randomized hexamer.  Four pools of bind-select primers 
were generated and then mixed in equimolar amounts to ensure that the amplification was not biased due 
to the presence of a single base at the 3’-most position in the primer. 
 
 
with [α-32P]CTP in the following 20 µL reaction:  100 ng R76,  Taq DNA polymerase 
buffer (Continental Lab Products, San Diego, CA 92111), 1.5 mM MgCl2, 50 µM 
3dNTP mix (minus dCTP), 4 µM dCTP, 2 µL 80 ng/µL Primer F, 2 µL 10 Ci/mL (800 
Ci/mmol) [α-32P]dCTP (Amersham Pharmacia Biotech, Piscataway, NJ 08855), 5 units 
Taq DNA polymerase (CLP).  The reaction conditions were as follows:  1’ at 94 °C, 3’ 
at 62 °C and 9’ at 72 °C.  The reaction was chased by incubating an additional 9’ at 72 
°C after adding 50 µM dCTP.  Finally, the labeled DNA was purified on an 8% PAGE 
gel as described in 5.2.2. 
 
 
 
NNNNNNNNNNNNNNNNNNNNNNNNNN
         Randomized Core (26 nt) 
Primer R (25 nt) 
A 
B 
Primers:  5’ GTAATACGACTCACTATAGGGCGGCCGCGGATCNNNNNNC 
T 
A
GT7 primer sequence
NotI Sau3AI 
Random 
hexamer 
Equal mix 
of 4 
primers  
EcoRI 
BamH I 
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Table 5 
Primers for section 5 
Identifier Sequence 
Primer F 5’ gctgcagttgcactgaattcgcctc 3’ 
Primer R 5’ caggtcagttcagcggatcctgtcg 3’ 
R76 5’ caggtcagttcagcggatcctgtcg(N26)gaggcgaattcagtgcaactgcagc 3’
Bind-select “T” 5’ taatacgactcactatagggcggccgcgatc(N6)t 3’ 
Bind-select “G” 5’ taatacgactcactatagggcggccgcgatc(N6)g 3’ 
Bind-select “C” 5’ taatacgactcactatagggcggccgcgatc(N6)c 3’ 
Bind-select “A” 5’ taatacgactcactatagggcggccgcgatc(N6)a 3’ 
T7 5’ taatacgactcactataggg 3’ 
Bind-select primers were mixed in equimolar amounts prior to use.   
 
  
 The second pool consisted of random genomic fragments generated by Klenow-
mediated extension of an equimolar mix of “bind-select” primers (Table 5) hybridized to 
total An. gambiae genomic DNA in the following 50 µL reaction:  Taq DNA polymerase 
buffer (CLP), 2 mM MgCl2, 0.3 mM dNTPs, 2 µL of “bind-select” primer mix at a 
concentration of 80 pmol/µL, 1 µg genomic DNA and 5 units Klenow Polymerase 
(Promega, Madison, WI 53711).  The reaction was assembled, minus the Klenow 
polymerase, and incubated at room temperature for 30 minutes to allow the primers to 
bind.  The polymerase was then added and the reaction was incubated at room 
temperature for an additional 30 minutes to extend the primers and produce double-
stranded templates for PCR-amplification.  Finally, the reaction was denatured at 95 ºC 
for 5 minutes, 5 units Taq DNA polymerase (CLP) was added, and the newly-generated 
templates were PCR-amplified using the following reaction conditions:  95 ºC for 5’; 5 
cycles of 95 ºC for 30”, 45 ºC for 15”, 72 ºC for 15”; 20 cycles of 95 ºC for 30”, 65 ºC 
for 15”, 72 ºC for 15”.  A negative control was performed in an identical reaction with 
no genomic DNA template.  A single microliter of each reaction, experimental and 
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control, was subject to further amplification using T7 primer (Table 5).  Reactions were 
assembled as follows:  Taq polymerase buffer (CLP), 2 mM MgCl2, 0.3 mM dNTPs, 2 
µL 20 pmol/µL T7 primer and 2.5 units Taq DNA polymerase (CLP).  PCR-
amplification was performed according to the following reaction conditions:  95 ºC for 
3’; 30 cycles of 95 ºC for 30”, 55 ºC for 15”, 72 ºC for 15”.  The reaction products were 
separated on a 1.5% agarose gel in 1X TBE buffer, and two gel slices containing 
amplified DNA fragments corresponding to 300-400 base pairs (bp) and 400-500 bp 
were excised and gel extracted using the QIAquick® Gel Extraction Kit (Qiagen, 
Valencia, CA 91355).   
5.2.2.  Purification of amplified and selected DNA fragments 
Amplified or selected dsR76 fragments were purified on an 8% nondenaturing 
PAGE gel in 1X TBE buffer, dried and visualized by autoradiography (Fig. 28A).  
Typically, a clearly visible band was observed after 1.5 to 5 minutes of exposure.  The 
gel slice containing labeled dsR76 fragments was excised with a clean blade, cut finely, 
placed in a microcentrifuge tube containing 250 µL of elution buffer (0.5 M ammonium 
acetate, 1 mM EDTA, 0.1% SDS), and incubated overnight at 37 ºC.  After a brief 
centrifugation at 14,000 x g, the eluate was transferred to a new microcentrifuge tube, 1 
µg of glycogen added and the DNA precipitated with 3M sodium acetate and 100% 
ethanol.  The pellet was washed in 70% ethanol, dried and then resuspended in 10 µL of 
TE buffer.   
 Amplified or selected genomic DNA fragments (Fig. 28B) were purified on a 
1.5% TBE agarose gel and the gel exposed to film covered with a single sheet of plastic 
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wrap for ~5-10 minutes.  The labeled band was excised, gel-purified and ethanol 
precipitated in the presence of 1 µg glycogen as described above.   
 
 
 
 
Fig. 28.  Purification of input pools for PCR-assisted binding site selection.  (A) R76 oligonucleotides 
purified by 5% non-denaturing PAGE.  (B) An. gambiae genomic fragments purified on a 1.5% agarose 
gel.  Unincorporated nucleotides ran off the gel.   
 
 
5.2.3.  Quantification of amplified and selected DNA fragments 
 
 Following purification, 1 µL of DNA was added to 1 mL of scintillation fluid 
and the counts per minute (cpm) measured in a scintillation counter (LS6000IC, 
Beckman Coulter, Fullerton, CA  92834).  The amount of probe was calculated knowing 
that the molecular weight of R76 is 23,487 µg/µmol, the specific activity of the probe is 
3200 Ci/mmol, and 106 cpm ~ 1 µCi.   
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5.2.4.  PCR-assisted binding site selection 
 
 The protocol was followed as summarized in Fig. 29 and as outlined by (Pollock, 
1996).  Pre-swelled Protein G PLUS-Agarose beads (Oncogene Research Products, San 
Diego, CA 92121) were washed twice in 50 volumes of wash buffer (20 mM HEPES, 
pH 7.9; 100 mM KCl; 0.1 mM EDTA; 0.2 mM EGTA; 20% (v/v) glycerol) and then 
suspended in an equal volume of wash buffer containing 50 µg/mL BSA to produce a 
50% (v/v) slurry and allowed to equilibrate for 2-3 hours at 4 ºC.   
 Rabbit reticulocyte lysate (RRL, Promega) was used to transcribe and translate 
An. gambiae CTCF in a coupled reaction using AgaCTCFpET (described in 3.2.3.) 
linearized by digestion with SphI.  The reaction was performed according to the 
manufacturer’s instructions.  A parallel set of reactions, with and without plasmid 
template, were carried out in the presence of 35S-methionine (Amersham) and the 
products analyzed on an SDS-PAGE gel and visualized by autoradiography, in order to 
confirm the presence of a protein of the appropriate size (~81 kD).     
The following binding reaction was assembled in a 1.5 mL microcentrifuge tube 
on ice:  20 µL binding buffer with BSA, 2 µL 100 ng/µL poly (dI-dC)·poly (dI-dC), 2 
µL protein lysate (RRL), 2 µL 0.2 ng/µL radiolabeled dsR76 probe oligonucleotides or 
genomic fragments, and 1 µL rabbit polyclonal antisera raised against a C-terminal 
fragment of An. gambiae CTCF.  For subsequent rounds of selection, half of the amount 
of probe was used.  Protein-DNA complexes were allowed to form on ice for 20-30 
minutes.   
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Fig. 29.  Schematic of PCR-assisted binding site selection.   
 
 
 Beads were packed by adding 20 µL of 50% protein G-agarose slurry to a 1.5 mL 
microcentrifuge tube containing 250 µL of cold wash buffer without BSA, centrifuging 
at maximum speed for 15 seconds and aspirating off the wash buffer.  The complexes 
were immunoprecipitated by mixing with 10 µL of packed beads and rocking the tube 
overnight at 4 ºC.  The beads were washed three times with 250 µL cold binding buffer 
without BSA.  For each wash, the binding buffer and complexes were vortexed and the 
tube inverted twice followed centrifugation at maximum speed for 15 seconds.  The 
bound DNA was eluted from the protein G-agarose bead pellet by resuspending in 200 
µL of recovery buffer (50 mM Tris-Cl, pH 8; 100 mM sodium acetate; 5 mM EDTA; 
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0.5% SDS) and incubating at 45 ºC for 1 hour.  The DNA was purified by 
phenol/chloroform extraction followed by ethanol precipitation in the presence of 1 µg 
of glycogen as described in 5.2.2.  The recovered DNA was quantified as described in 
5.2.3. 
The selected and purified DNA was PCR-amplified in a 20 µL reaction with Taq 
DNA polymerase buffer (CLP), 1.5 mM MgCl2, 80 µM 3dNTP mix (minus dCTP), 4 
µM dCTP, 2 µL 80 ng/µL Primer F, 2 µL 80 ng/µL Primer R, 1 µL 10 Ci/mL (800 
Ci/mmol) [α-32P]dCTP (Amersham Pharmacia Biotech, Piscataway, NJ 08855), 2.5 units  
Taq DNA polymerase (CLP).  Reaction conditions were as follows:  15 cycles of 94 ºC 
for 1’, 62 ºC for 1’, 72 ºC for 1’.  Unincorporated nucleotides were removed by gel 
filtration on a Sephadex G-50 column.  The R76 oligonucleotide products were then 
PAGE purified, while the genomic fragments were fractionated and purified on an 
agarose gel as described in 5.2.2.  Binding site selection and PCR-amplification were 
repeated for a total of five rounds of selection for the R76 oligonucleotides and four 
rounds for the random genomic fragments.   
5.2.5.  Electromobility Shift Assay (EMSA) 
 
 The binding of the selected oligonucleotides or genomic fragments to An. 
gambiae CTCF was then confirmed by mobility shift analysis using the same binding 
buffer used in the binding site selection process.  Binding reactions were assembled on 
ice:  20 µL binding buffer with BSA, 2 µL 100 ng/µL poly (dI-dC)·poly (dI-dC), 2 µL 
0.2 ng/µL radiolabeled dsR76 probe oligonucleotide, 2 µL protein lysate (RRL).  One of 
three reactions was set up with just buffer, non-specific competitor DNA and the probe.  
  
106
After incubation at room temperature for 10 minutes, 1 µL antiserum was added to one 
of the two remaining reactions.  All reactions were incubated for an additional 20 
minutes at room temperature before loading onto a gel.  The R76 oligonucleotides were 
analyzed on a 5% non-denaturing page gel prepared with 1X TBE buffer and 2.5% 
glycerol, and pre-run for 20-30 minutes at 5V/cm.  The gel was run at 5V/cm and 4 ºC 
for ~2.5 hours, dried and exposed to film overnight.  The genomic fragments were 
analyzed on a 1.5% agarose gel with 2.5% glycerol.  The gel was run at 7.5 V/cm for ~2 
hours, dried and exposed to film overnight. 
5.2.6.  Extraction, amplification, cloning and sequencing of selected DNA fragments 
 confirmed by EMSA  
 The region of the gel containing the DNA-protein complexes was excised and 
divided into four squares.  Two squares were stored at -20 ºC.  The paper was removed 
from the remaining two squares before placing the dried gel slices into a PCR tube and 
the following 50 µL reaction assembled:  Taq DNA polymerase buffer (CLP), 1.5 mM 
MgCl2, 80 µM 3dNTP mix (minus dCTP), 4 µM dCTP, 5 µL 80 ng/µL primer F, 5 µL 
80 ng/µL primer R, 2.5 µL 10 Ci/mL (800 Ci/mmol) [α32-P]dCTP (Amersham), 7.5 units 
Taq DNA polymerase (CLP).  PCR was carried out for 17 cycles:  1’ at 94 ºC, 1’ at 62 
ºC, 1’ at 72 ºC.  The reaction products were cleaned up by gel filtration, PAGE-purified 
(R76) or agarose-purified (genomic fragments), eluted and precipitated as described in 
5.2.3.  Finally, the selected DNA (R76 or genomic fragments) and 1 µg of the plasmid 
pBCKS+ (Stratagene, LaJolla, CA 92037) were double-digested with EcoRI and BamHI 
restriction endonucleases, phenol/chloroform extracted and ethanol precipitated in the 
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presence of 1 µg glycogen before ligating in a 10 µL reaction with 7 µL selected DNA, 1 
µL pBCKS+, 1 µL 10X buffer and 1 µL T4 DNA ligase (Promega).  The ligation was 
incubated at 4 ºC overnight and then transformed into electrocompetent DH10B cells.  
White and light blue colonies were PCR-screened for the presence of an insert.  Insert-
positive clones were cultured overnight, plasmid DNA mini-preps performed using the 
Promega mini-prep kit and the sequence of the insert DNA determined on an ABI 3100 
capillary sequencer.   
5.2.7.   Motif searching and consensus representation 
 
 Several strategies were employed to determine a “consensus” binding site for the 
selected DNA oligonucleotides or fragments.  The selected pools were treated separately, 
because the R76 oligonucleotides are entirely synthesized, so they may not actually be 
represented in the An. gambiae genome, whereas the genomic fragments were directly  
amplified from genomic DNA.   
 For the selected R76 oligonucleotides, common sequences were removed, 
obvious A/T-rich stretches were trimmed and a ClustalW alignment 
(http://ch.embnet.org/software/ClustalW.html) was performed.  This alignment was 
manually inspected and edited with some of the flanking core sequence added back.  
This flanking sequence was available to be bound by CTCF in the selection process, but 
was removed initially so not to skew the alignment of the variable regions in the selected 
oligonucleotides.  Because several different subsets of sequences have been 
characterized for vertebrate CTCFs, a subset of the most C/G-rich oligonucleotides were 
chosen for further analysis.  The resultant alignment was submitted to WebLogo (Crooks 
  
108
et al., 2004).  The WebLogo profile was then used to formulate the 14 base pair 
“consensus” sequence 5’ CNCCTCMSCMNSMM 3’.  When there were only two 
nucleotides typically present at a given position, they were both incorporated (M = A or 
C, or S = C or G), while N was incorporated where there was no clear consensus.   
 For the larger genomic DNA fragments, the “consensus” sequence was used to 
identify similar sequences using the motif searching function of the Vector NTI™ Suite 
(InforMax, Inc., 1999).  Each fragment contained at least one sequence with >55% 
identity to the “consensus”.  Each fragment was then used as a BLAST query against the 
An. gambiae whole genome sequence at Ensembl 
(http://www.ensembl.org/Anopheles_gambiae/).   Two motif-searching algorithms, 
AlignACE (Roth et al., 1998) and MAST (Bailey and Gribskov, 1998) were employed to 
attempt to identify common elements within the selected genomic DNA fragments.   
 WebLogo was employed to visually represent the “consensus” sequences derived 
for the selected R76 oligonucleotides and genomic fragments.  For comparison, a 
WebLogo profile was generated for vertebrate CTCFs by searching the literature for 
experimentally verified CTCF binding sites and submitting these to build a “consensus”.   
5.2.8.  In silico identification of potential CTCF binding sites in the  An. gambiae 
 genome using the consensus sequence derived from selected R76 
 oligonucleotides 
A JAVA script was kindly written by Andrea Julian, a collaborating lab member, 
to extract 5000 base pairs upstream and downstream of ~700 known genes in the 
Ensembl database (http://www.ensembl.org./Anopheles_gambiae/).  Another JAVA 
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script was then written to search this flanking sequence for the “consensus” sequence 
derived from the selected R76 oligonucleotides. 
5.3.  Results 
 
5.3.1.  Many selected, double-stranded R76 oligonucleotides contain C/G-rich stretches 
 
 The final gel shift with the selected R76 oligonucleotide pool yielded two bands, 
a and b (Fig. 30A).  When these were PCR-amplified, only band b produced detectable 
product (Fig. 30B).  This product was excised, extracted and cloned.  In all, 36 out of 40 
clones submitted for sequencing resulted in unambiguous, unique sequences.  Hence, the 
selected pool was diverse.  These are presented in Table 6.  The unboxed band was not 
followed as the sequences were presumed to be oligonucleotide dimers. 
 
 
Fig. 30.  EMSA with the final, amplified pool of selected R76 oligonucleotides produces one amplifiable 
band.  (A)  Lane 1, probe only; Lane 2, final pool of amplified, selected R76 oligonucleotides.  (B) PCR-
amplification of bands a and b excised from Lane 2 of panel A.  * indicates the band excised, amplified 
and cloned into pBCKS+. 
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 The ClustalW alignment (Fig. 31) was done with a subset of the R76 
oligonucleotides in Table 6 as described in 5.2.7.  These fragments are indicated by ∞ in 
Table 6.  Some of the difficulties that arose in data analysis, and the assumptions that 
were consequently made are discussed in 5.4.1.  Of the R76 oligonucleotides in the 
ClustalW alignment, several were subsequently shown to bind An. gambiae CTCF in 
competitive EMSA experiments (Fig. 32).  These EMSA were performed as described in 
3.2.12, using conditions not yet published when these binding-site selection experiments 
were done.  Oligonucleotides shown to bind in these EMSAs are indicated by * in the 
ClustalW alignment (Fig. 31) and in Table 6.  
 
 
 
*BS10 CGCCTCCCGCCCCA 
 BS24 CTCTTCAATCCCAA 
*BS11 CGCCTCAGACCGCT 
 BS28 CGCCTCAGAACGCC 
 BS32 CGCCTCAGCCTGTC 
 BS15 CCTCTCAGCCACAC 
*BS25 GAAGGCTCCCAAAC 
*BS23 CTCTGCACCCAGAC 
*BS16 CATCACACCACGAC 
 BS27 CGCCTCACCCTGAA 
*BS36 CGCCTCCCCATGCA 
 BS38 CGCCTCCCCTATCA 
Consensus CNCCTCMSCMNSMM 
 
Fig. 31.  ClustalW alignment of a subset of selected R76 oligonucleotides.  *  indicates oligonucleotides 
that specifically bind An. gambiae CTCF as confirmed by EMSA.  The consensus sequence was used to 
search the sequence flanking ~700 known An. gambiae genes. 
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Table 6 
R76 oligonucleotides selected in PCR-assisted binding site selection 
Identifier Sequence—Forward strand 
BS1 5’ agccatacatacaacttcgataaaaa 3’ 
BS3 5’ aatgacaacgcacgcacaaacaaaac 3’
BS4 5’ tcctcatacttgcaagattaattgc 3’ 
BS5 5’ acaaatgtaaactcgtttaaccagca 3’ 
BS6 5’ cctacgaaaatgccaatattaaataa 3’ 
BS7 5’ catccagcagggactgaagtcaagaa 3’ 
BS9 5’ atcacaccacaaccatgatacaataa 3’ 
BS10*∞ 5’ ccgccccacaataacaaacaccaata 3’ 
BS11*∞ 5’ agaccgctgtatgaatcaataatgag 3’ 
BS12 5’ gtcagaaagactagcatcaatattaa 3’ 
BS13 5’ taaaattacatttaaagatacaaca 3’ 
BS15∞ 5’ aatcagccacaccacactaaggccaa 3’ 
BS16*∞ 5’ acactctaacacatcacacca 3’ 
BS17 5’ cacaattacaaaagctttaaagaata 3’ 
BS18 5’ tgcaagtctaacaatgctgctaagat 3’ 
BS19 5’ aacacgtattcctataaagcaggaat 3’ 
BS20 5’ gatacagacacacatgaatataacaa 3’ 
BS21 5’ cacagatggatgcctattagacagac 3’ 
BS23*∞ 5’ tgcacccagacaatgagtagcatgac 3’ 
BS24∞ 5’ ttcaatcccaacattaaccccataag 3’ 
BS25*∞ 5’ gaaggctcccaaacaacaacaagtaa 3’ 
BS27∞ 5’ accctgaaacacactagaaataataa 3’ 
BS28∞ 5’ agaacgccatcacttcgataaaataa 3’ 
BS29 5’ atcaaacagctagcaaaacaacttaa 3’ 
BS30 5’ cacaaacgaagcaaaacaataggtcc 3’ 
BS31 5’ tagacggttaagaaaataactgaata 3’ 
BS32∞ 5’ agcctgtctaaagtaataatgcaca 3’ 
BS33 5’ actacgtcactcataaaaaatgaaat 3’ 
BS34 5’ agcatgaacacctaaaataacaaaga 3’ 
BS35 5’ tgggaacatagaaaaaataaagcaag 3’ 
BS36*∞ 5’ cccatgcagctacatgaaaaattttc 3’ 
BS37 5’ acaaagatcctaactagacacaaaat 3’ 
BS38∞ 5’ ccctatcacccgaacgttaattataa 3’ 
BS39 5’ tctagcaaatcatcagaatacgatac 3’ 
* indicates that binding to An. gambiae CTCF was confirmed by competitive EMSA. 
∞ indicates the oligonucleotide was used to determine the “consensus” binding site used 
for in silico analysis.   
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Fig. 32.  Competitive EMSA for two of the selected R76 oligonucleotides.  Probe only lane is indicated by 
“P”; >500-fold specific cold competitor is indicated by “C”; Polyclonal antisera against An. gambiae 
CTCF is indicated by “Ab”.  Increasing amounts of Sua4 cell lysate are indicated by the triangle.  (A) 
BS25; (B) BS36. 
 
5.3.2.  Selected genomic DNA fragments are distributed across the genome and occur in 
 several different contexts 
 In an effort to get a better representation of sites that An. gambiae CTCF binds in 
vivo, the PCR-assisted binding-site selection experiment was repeated with an input pool 
generated from An. gambiae genomic DNA.  This time the input consisted of sequences 
that occur naturally in the genome rather than all possible combinations of nucleotides 
within the variable region of R76.  Only five unique fragments were selected from the 
random An. gambiae genomic fragment pool, however.  This is reflected in the poor 
EMSA result and subsequent amplification at the conclusion of this experiment (Fig. 33).  
The selected fragments were used to query the An. gambiae genome.  The selected 
fragments and their respective genomic contexts as determined by BLAST results are 
summarized in Table 7.   
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Fig. 33.  EMSA with the final, amplified pool of random genomic DNA fragments yields a single, faint 
amplified band of products.  (A) EMSA after the final round of selection.  Lane 1 is probe only; Lane 2 
shows a slight increase in the intensity of the shifted band.  (B)  A single, PCR-amplified band of products 
corresponding to the band of the same size in A-2.   
 
 
 
 
 
Table 7 
Summary of genomic DNA selection 
 Intergenic Intron CpG Island Class II 
Transposon 
Position in 
Genome 
BS1a* √ √  √ X, 2L, UNKN ¶
BS1b  √   2L 
BS3 √ √  √ 2L, 2R, 3L, 
3R, X   ¶ 
BS5 √   √ 2L, 2R, 3L, 
3R, X ¶ 
BS17   √  3R 
* indicates that this sequence was represented 8 times in the selected pool.  ¶ indicates multiple hits within 
the genome. 
 
 
5.3.3.  Consensus WebLogo profiles reveal C/G-rich core binding sites in vertebrates 
 and in the An. gambiae-selected fragment pools 
 In order to compare the An. gambiae CTCF selected core binding sites from both 
PCR-assisted in vitro binding site selection experiments presented in 5.3.1. and 5.3.2. 
with each other and with known CTCF core binding sites in vertebrates, WebLogo 
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profiles were generated.  In order to generate a vertebrate profile, the literature was 
searched for known vertebrate CTCF core binding sites.  These are summarized in Table 
8.  WebLogo profiles for vertebrate CTCF core binding sites and for both binding site 
selection experiments are presented in Fig. 34.  Though not identical, all appear C/G-rich 
and approximately 14 base-pairs in length.  This is particularly significant given the 
>60% A/T composition of the An. gambiae genome.     
 
 
 
 
Table 8 
Vertebrate CTCF DNA binding sites 
Binding-site 
Identifier 
Sequence Reference  
CTCF site “A” 5’ ccgccccctagcgg 3’ (Chao et al., 2002) 
CTCF site “B” 5’ ctgccccctagcgg 3’ (Chao et al., 2002) 
CTCF site “C” 5’ ctgccgccgtgcgg 3’ (Chao et al., 2002) 
CTCF site “D” 5’ ctgccaccacgcgg 3’ (Chao et al., 2002) 
Mouse H19m1 5’ ctgccaccggggac 3’ (Hark et al., 2000) 
Mouse H19m2 5’ ctgccgcataacgg 3’ (Hark et al., 2000) 
β-globin 5’ ctgccgccgccagg 3’ (Farrell et al., 2002) 
DM1-site 1 5’ ccgccccctagcgg 3’ (Filippova et al., 2001) 
DM1-site 2 5’ cccccacctatcgt 3’ (Filippova et al., 2001) 
Human Igf2-H19 5’ ctgccgccgcgcgg 3’ (Bell and Felsenfeld, 2000) 
Chicken 5’HS4 FII 5’ ctgccccctagcgg 3’ (Bell et al., 1999) 
Mouse HS-85.5 5’ ctgccctctcctgg 3’ (Farrell et al., 2000) 
Mouse HS-62.5 5’ cttccccctggtgg 3’ (Farrell et al., 2000) 
Human HS-III 5’ gctccccctggtgg 3’ (Farrell et al., 2000) 
Mouse 5’HS5 5’ cttccctctagtgg 3’ (Farrell et al., 2002) 
Human 5’HS5 5’ cttccctctagtgg 3’ (Farrell et al., 2002) 
Mouse 3’HS1 5’ ctgccccctactgg 3’ (Farrell et al., 2002) 
Human 3’HS1 5’ ctgacccctagtgg 3’ (Farrell et al., 2002) 
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Fig. 34.  WebLogo profiles of CTCF “consensus” binding-sites.  (A)  Vertebrate sequences presented in 
Table 8; (B) Selected R76 oligonucleotides presented in Table 6; (C) Selected genomic fragments 
presented in Table 7.  The WebLogo software utilized was developed by (Crooks et al., 2004). 
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5.3.4. In silico mining of the An. gambiae genome yields potential CTCF binding sites 
 in the flanking regions of many genes 
 Though it is likely representative of only a subset of binding sites for An. 
gambiae CTCF, the “consensus” site derived from 12 of the selected R76 
oligonucleotides shown in Fig. 31 and Fig. 34B was used to search sequence flanking 
known An. gambiae genes in an effort to identify sequences with potential insulating 
activity.  Known insulators, as discussed in sections 3 and 4, protect genes within their 
boundaries.  A set of 124 putative CTCF targets was generated.  These are presented in 
Appendix B.  Several binding sites flank genes that encode proteins that are regulated in 
conjunction with specific biological processes that are mediated by the sequential and/or 
coordinate expression of multiple genes.  Insulators have recently been associated with a 
number of such genes.  These sites are summarized in Table 9.   
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Table 9 
Putative, in silico CTCF binding-sites associated with specific biological processes 
Major Function Putative, in silico  CTCF binding-sites 
Cytochrome P450s CTCCTCACCCACCA 
CTCCTCCGCCGGAA 
CTCCTCCGCAACAA 
CACCTCCGCCCGCA 
CCCCTCCCCCCCCC 
CCCCTCCCCCCCCC  
Caspases CCCCTCCCCACCCA 
CTCCTCCCCACCAC 
CTCCTCCCCACCAC 
CTCCTCCCCACCAC 
CTCCTCCCCAGGCC  
GCPR—odorant  CGCCTCCGCCGGAA
CCCCTCCCCCCCCC 
CCCCTCCCCCCCCC 
CTCCTCCCCCGGAC 
CCCCTCCCCACCCA 
CCCCTCCCCCTCCA 
CTCCTCACCACCCA 
CACCTCAGCCGCCA 
CCCCTCCCCCTCCC  
Pheromone/general odorant CCCCTCACCAGCCA 
CCCCTCCCCCCCCC 
CGCCTCCGCATGAC 
CGCCTCACCATGCC 
CACCTCCCCAACAA  
Immunity CACCTCCGCCACCA 
CCCCTCCCCCTCCA 
CGCCTCCGCATGAC  
Blood feeding CCCCTCACCCACAC 
CCCCTCCCCACCCC 
CTCCTCCGCAACAA 
CCCCTCCGCCCCCC 
GCPR—opsin CACCTCCCCACGCA 
CTCCTCCGCACCAC 
CCCCTCCCCACCCA  
Development CGCCTCCCCCCGCC 
CCCCTCCCCCTCCC 
CGCCTCACCAGGAA 
CGCCTCCCCCCGAA  
Serpins CGCCTCCCCAGGCC
CTCCTCCCCACCCC 
CCCCTCCCCCACAC  
  
118
5.4.  Discussion 
 
5.4.1.  Selected, short oligonucleotides appear biased by the common adaptor sequence 
 at the 5’ end of the input fragments 
 Alignment of the selected R76 oligonucleotides has proven to be a daunting task.  
There are common sequences that flank the 26 base pair randomized core of the 
oligonucleotides that were subjected to the selection process.  This is a consequence of 
the technique as these sequences are needed for both PCR-amplification and cloning. 
Nonetheless, if they are not removed prior to alignment, they will skew the alignment so 
much that the actual binding site will either appear significantly altered or will be missed 
altogether.  Most of the C/G-rich sites are extensions of one of the two flanking regions.  
This flanking region consists of an EcoRI restriction enzyme site (GAATTC) followed 
by GCCTC(N26).  Omitting the flanking sequence prior to analysis allowed identification 
of oligonucleotides such as BS16, BS23 and BS25 that have internal binding sites for 
CTCF.  All of these bind CTCF in competitive EMSA experiments (Fig. 32 and data not 
shown).  Nonetheless, oligonucleotides with significant stretches of C/G-rich sequence 
adjacent to this flanking sequence, such as BS10, BS11 and BS36, also bind CTCF 
specifically.  In retrospect, the known flanking sequences should probably have been 
designed to contain >60% A/T as zinc-finger proteins typically bind targets that are 
>50% C/G-rich (Ladomery and Dellaire, 2002). 
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5.4.2.  The presence of endogenous CTCF in the rabbit reticulocyte lysate interferes with 
 the identification of DNA-mosquito CTCF complexes in agarose gels 
 CTCF is highly-conserved among vertebrate organisms, thus rabbits would be 
predicted to possess a CTCF gene and to produce a CTCF protein of similar size to that 
seen in other vertebrates.  In SDS-PAGE gels, this protein migrates at ~140 kD (Dunn et 
al., 2003).  Added difficulty arises with the variable sizes of the genomic fragments 
selected (300-400 bp).  This required the use of 1.5% agarose gels rather than 5% 
acrylamide to resolve the DNA-CTCF complexes.  The resulting EMSA did not give a 
distinct shifted band that was unique to the programmed lysate.  The shifted band from 
the An. gambiae CTCF lane did amplify by PCR, but this does not exclude the 
possibility that the rabbit CTCF protein could have bound the mosquito genomic DNA 
fragments.  Even so, the varied contexts of the selected genomic fragments raise a 
number of intriguing possibilities that warrant further investigation.   
5.4.3.  Possible association of CTCF with transposable elements could reveal yet 
 another function of CTCF in mosquitoes 
 Of particular interest is the number of times that several of the selected genomic 
fragments were found at or near TE boundaries (Table 7).  Mosquitoes possess a diverse 
array of DNA TEs, many of which are uncharacterized (Tu and Coates, 2004).  TE 
regulation is currently a “black box” in many organisms, but it is evident that some type 
of negative regulation must be employed by host genomes in order to prevent the 
mutagenic effects of excessive TE movement.  Perhaps CTCF is functioning to block the 
binding of proteins necessary for transposition, is recruiting other proteins that block the 
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propagation of heterochromatin formation often associated with TEs, and/or is blocking 
the interaction of transcription factor necessary for expression of the transposase that 
catalyzes excision and movement of the TE.  Flanking transgenes with known 
endogenous CTCF sites could provide a powerful means of shielding them from the very 
silencing that the TE-associated elements required for genome integration may evoke.   
5.4.4.  Putative, in silico sites are consistent with CTCF function as a boundary element 
 protein 
 Boundary elements are often positioned between two differentially regulated 
genes or on the flanking edges of a group of coordinately-regulated genes.  Both 
situations are illustrated by the in silico data presented in Table 9 and in Appendix B.  A 
specific example is the cluster of serpin genes found on An. gambiae chromosome 2L 
(Fig. 35).  There are five known serpins and at least one predicted serpin arranged in two 
sub-groups separated by ~9.2 megabases (Mb) of DNA.  At either end of the entire 
cluster is an array of several putative CTCF binding sites, identified by the in silico 
JAVA script employed in this study and by visual inspection of the surrounding 
sequence for closely-related sites.  Just upstream of the 5’-most putative CTCF binding 
site, lies a putative connective tissue growth factor orthologue, while several kilobases 
downstream of the 3’most putative CTCF binding site, lies a putative Syntaxin 1A 
orthologue.  Syntaxin 1A is believed to be involved in neurotransmitter transport 
(http://www.ensembl.org/).  Clearly, both the upstream and the downstream genes would 
be expected to exhibit expression profiles distinct from that of serine-protease inhibitors 
(serpins).  The upstream sub-cluster is thought to be involved in embryonic patterning 
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(Rushlow, 2004), while the downstream sub-cluster contains serpins known to be 
involved in innate immunity in dipteran insects (DeGregorio et al., 2002; Danielli et al., 
2003).  The annotation of the An. gambiae genome is very much a work in progress, and 
will likely be furthered by the impending release of the Ae. aegypti complete genome 
sequence.  Further analysis of the in silico dataset in light of improved annotation will 
likely reveal other gene clusters that may also be insulated by CTCF.   
 
 
Fig. 35.  Putative, in silico  CTCF binding-sites within the serpin gene cluster of An. gambiae. 
 
 
5.5.  Conclusions 
 Vertebrate CTCF binds a diverse array of binding sites in vivo, not always with 
the same affinity seen in vitro.  This is likely due to the potential role of CTCF in the 
SRPN 14 
CCCTCCCCtAtCg (39,321,732 -) 
CCCTCtCCACatA (39,319,352 +) 
CACCTCTACCCCCA (39,318,132 -) 
CACCTCCCtCGCAA (39,317,271 +) 
SRPN3 SRPN2 
CTCCTCCCCACCCC (39,325,750 -) tCCCTCCACAACCA (39,331,200 +)
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arrangement of chromatin into domains within the three-dimensional space of the 
nucleus.  Mosquito CTCF appears capable of binding similar C/G-rich sites that are 
likewise scattered across the genome.  Ultimately, these predictions must be confirmed 
with in vivo experiments.  Though very preliminary, the data presented provide 
promising avenues for further investigation.  Understanding the native context of CTCF 
function in mosquitoes will be important in developing effective methods to employ it 
for transgene insulation.   
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6.  GENERAL CONCLUSIONS AND FUTURE DIRECTIONS 
 
6.1 General Conclusions 
 
 Over the past six years, much effort has been put forth to develop germ-line 
transformation in non-drosophilid insects, in particular for several mosquito species that 
vector pathogens responsible for a great deal of human morbidity and mortality.  It has 
become increasingly apparent that each target species poses unique challenges arising 
from different genome organization, habitat impact and evolutionary pressures imposed 
both by its pathogen(s) and human control efforts.  Much remains to be done before 
genetic transformation in Ae. aegypti and An. gambiae becomes routine.  Routine 
transformation would provide not only a powerful tool for genetic control, but would 
enable gene discovery and characterization on a scale that would rival what is currently 
possible in Drosophila.  It is certainly a work in progress. 
 In this study, it has been shown that exogenous promoter/enhancer combinations 
can be employed to increase the expression of a reporter gene in cultured mosquito cells.  
Furthermore, a viral transactivating protein can be used to further increase expression.  
Data presented in this work confirms the hypothesis that some exogenous regulatory 
elements may function as predicted in a mosquito background.  Unanticipated increases 
in expression resulting from the presence of the IE1 transactivating protein also 
highlight the necessity of testing exogenous regulatory elements in each new target 
species.  Cultured mosquito cells provide one powerful tool to evaluate novel regulatory 
regions for potential transgene expression. 
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 Mosquito CTCFs were cloned from the mosquitoes, Ae. aegypti and An. gambiae.  
They were shown to be expressed at detectable levels in all stages of development, with 
increased expression in early embryonic development and during oogenesis.  The 
mosquito CTCFs were shown to bind two known insulator sequences in a manner 
similar to that of Drosophila CTCF.  Thus, it is likely that the insulator function of 
CTCF is conserved in mosquitoes.  This is the first potential insulator identified in 
mosquitoes.   
 Studies of CTCF expression in Ae. aegypti reveal high levels of protein in the 
support cells of the ovarian follicle and thoughout early syncytial embryos, consistent 
with the RT-PCR transcriptional profile.  Cell lines show expression in both the 
cytoplasmic and nuclear fractions, with enrichment of the protein in the insoluble 
nuclear fraction.  This is consistent with CTCF association with a nuclear structure, 
perhaps the nuclear matrix.  Further investigation of CTCF and its native binding sites 
may yield valuable insight into the patterns of chromatin organization in these 
mosquitoes.   
 Finally, CTCF appears to bind C/G-rich sites in An. gambiae that are very similar 
to those bound by vertebrate CTCF.  In silico analysis reveals many putative targets for 
CTCF, consistent with what has been observed in humans.  Further studies will be 
needed to characterize the binding preferences of mosquito CTCF in vivo.  Once known, 
these binding preferences may be exploited to craft effective insulating sequences for 
transgenes, potentially increasing the number of usable stable lines recovered per 
experiment.    
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6.2 For Future Consideration 
 A caveat of using exogenous promoter sequences is that they must always be 
tested in the species of interest.  This is not trivial when transgenic lines are difficult to 
generate.  Cell lines can be useful when considering general promoters, but many cell 
lines do not transcribe from tissue-specific or temporal-specific promoters very well, if 
at all.  The transactivating protein, IE1, is a mixed “bag”.  It is effective in upregulating 
expression from its target enhancer/promoter, however it appears to be promiscuous in 
its binding activity.  This could result in the misregulation of important endogenous 
genes.  Of particular concern are those involved in development.  For expression of the 
transposase, more may actually not be better, due to the tendency of host genomes to 
negatively regulate active TEs.  With the whole genome sequencing efforts in both An. 
gambiae and Ae. aegypti, endogenous genes will be much easier to identify and 
characterize in their native contexts.  Better candidates for transgene expression and 
transposase regulation would probably be stage- and tissue-specific endogenous 
promoters.   
 Given the number of different insulators described in Drosophila, it is reasonable 
to assume that there will also be additional insulators within mosquito genomes.  In 
general, Dipteran genomes are much more compact than vertebrate genomes, so 
insulators may actually be more critical for appropriate gene expression in “tighter 
quarters”.  Some of these insulators may be conserved in mosquitoes, others may be 
uncovered that are novel, perhaps related to the management of the cadre of genes 
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specific to anantogeny.  It will be important to exploit the newly available sequence 
information to identify other potential candidates for investigation.   
 Identification of endogenous binding sites for CTCF would provide valuable 
clues to additional functions of this protein in mosquitoes.  The limiting factor in this 
study was the polyclonal antibody produced.  The antibody was produced prior to the 
realization that there were an additional 33 amino acid residues at the C-terminal end of 
the protein not predicted by the gene annotation algorithms.  Perhaps this additional 
sequence or other regions of the endogenous protein partially obscure the dominant 
epitopes for the antibody when the protein folds.  Vertebrate CTCF has been shown to 
bind DNA via combinatorial use of subsets of its zinc finger domains, so it was assumed 
that mosquito CTCF probably bound in a similar fashion.  Another group also 
communicated that they had produced a good antibody in Drosophila against this region 
of the protein.  However, little is known about the function of the C-terminal region of 
CTCF in any species.  The antibody produced does recognize a protein of the expected 
molecular mass in Western blots, however the binding was relatively weak, even with 
embryo lysates.  Also, the antibody was able to shift DNA-CTCF complexes only 
weakly in gel shift assays.  Typically, the shifted band weakened or disappeared, rather 
than producing a more typical supershift,  perhaps indicating that the major epitope 
recognized by the antibody overlapped part or all of the DNA binding domain when the 
protein was in its native conformation.  If this is true, then the protein can potentially 
bind DNA and the antibody, but not both very efficiently.  The binding site selection 
experiments were dependent upon the formation of a stable DNA-protein-antibody 
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complex.  Chromatin Immunoprecipitation (ChIP) assays were repeatedly attempted 
with some of the genomic fragments and the putative serpin cluster targets.  These did 
not produce consistent results.  Finally, attempts to immunolocalize CTCF on meiotic 
chromosomes in Ae. aegypti with this antibody did not produce detectable signal.  Taken 
together, the data indicate that this particular antibody may not be appropriate for 
investigating the DNA binding of mosquito CTCF.   
 In the future, the first priority would be to produce an antibody that binds the 
DNA-protein complex more efficiently.  In the short term, the N-terminus of the protein 
could be tagged with an epitope and subjected to Western blot analysis with both cell 
and embryo lysates.  The EMSAs with the known boundary elements, chicken 5’HS and 
Drosophila Fab8, could be repeated to assess its ability to shift the DNA-protein 
complex.  If successful, a peptide antibody could be generated against this region of the 
protein.  This antibody would be a valuable reagent to investigate the in vivo targets of 
mosquito CTCF via genome-wide ChIP experiments such as those done in Drosophila 
with Engrailed (Solano et al., 2003) and in humans with CTCF (Mukhopadhyay et al., 
2004).  Alternatively, the chromatin profiling method DamID could be used to identify 
CTCF targets in a manner similar to that recently done with the transcription factor 
Hairy in Drosophila (Bianchi-Frias et al., 2004).  Confirmation of any identified targets 
however, will require an antibody capable of tightly binding the entire DNA-protein 
complex.  Ultimately, it would be advantageous to identify specific genomic targets for 
this protein that might then be used to insulate a transgene.  
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 Despite the difficulties outlined above, the identification of mosquito CTCF 
orthologues provides an avenue of much promise.  Once thought to be exclusive to 
vertebrates, this protein likely possesses critical functions in mosquito development and 
in the establishment of chromatin domains via an insulator function.  Knowledge of this 
protein will allow identification of target DNA insulating sequences for future use in 
mosquito transgenesis.  Better transgenesis is pivotal in designing new control strategies 
for these potent disease vectors.   
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Location Gene ID Gene Name/Description Gene Start Gene End CTCF site 
start 
CTCF site 
end 
CTCF BS sequence 
X ENSANGG00000006157.2 STAT2 1609333 1620712 1624289 1624302 CCCCTCCCCACCCC 
X ENSANGG00000017521.2 GPRnpy4 1865162 1866412 1867380 1867393 CCCCTCACCCCCCC 
Xr ENSANGG00000017521.2 GPRnpy4 1865162 1866412 1863193 1863180 CTCCTCCCCCCCCC 
X ENSANGG00000016966.2 Q9BIH5 2405694 2406041 2403313 2403326 CCCCTCACCCCCCC 
X ENSANGG00000010238.2 Q17010 3484517 3493483 3494647 3494660 CCCCTCCCCAACAC 
X ENSANGG00000018273.2 CTL5 7812685 7814127 7818994 7819007 CACCTCCCCAACCC 
X ENSANGG00000018253.2 GPRads 7834240 7835574 7836137 7836150 CACCTCCCCCCCCC 
X ENSANGG00000016765.2 GPRNNA19 11100509 11101428 11096265 11096278 CCCCTCCCCCCCCC 
X ENSANGG00000016765.2 GPRNNA19 11100509 11101428 11099549 11099562 CCCCTCCCCACCCC 
X ENSANGG00000009474.2 CEC2 12437472 12438056 12435464 12435477 CCCCTCCCCATCCC 
X ENSANGG00000001622.2 
Q8WQN7/Cytochrome P450 
CYP4G17 16619145 16621029 16621381 16621394 CTCCTCACCCACCA 
X ENSANGG00000010645.2 
Q8MUQ2/Glutathione S-
Transferase 16746632 16747761 16750958 16750971 CTCCTCCCCACCCC 
Xr ENSANGG00000014941.1 NFI 1050327 1053595 1054532 1054519 CTCCTCCCCCGCCC 
Xr ENSANGG00000014941.1 NFI 1050327 1053595 1054743 1054730 CCCCTCCCCCCGCC 
Xr ENSANGG00000005522.2 White gene 9874701 9882383 9872157 9872170 CCCCTCCCCCCCCC 
Xr ENSANGG00000007830.2 CASPS7 15364447 15364469 15364460 15364447 CCCCTCCCCACCCA 
Xr ENSANGG00000004098.2 CTLSE1  17503854 17514772 17501810 17501797 CACCTCCGCCACCA 
Xr ENSANGG00000015554.2 TOLL1A 190057424 19061018 19061600 19061587 CGCCTCCCCCCGCC 
2L ENSANGG00000020802.2 
RL7A_ANOGA/60S Ribosomal 
Protein L7A 23486056 23486871 23491349 23491362 CCCCTCCGCCACCC 
2L ENSANGG00000022240.1 PGRPS2 29404371 29405108 29407898 29407911 CTCCTCCCCCCCCC 
2L ENSANGG00000018546.2 76810 31220036 31225567 31229078 31229091 CCCCTCACCCACAC 
2L ENSANGG00000011567.2 SUI1_ANOGA 31801749 31806393 31811163 31811176 CTCCTCCCCCCGAA 
2L ENSANGG00000019041.2 AAP78790/TMCA-like prot frag 47897833 47901140 47904556 47904569 CTCCTCCCCCCCCC 
2L ENSANGG00000019060.2 
Ianb2/LAMININ GAMMA 1 
PRECURSOR 47906096 47914547 47904557 47904570 CTCCTCCCCCCCCC 
2L ENSANGG00000019032.2 SRPN14  48515573 48517224 48514370 48514383 CGCCTCCCCAGGCC 
2Lr ENSANGG00000008181.2 GALE6 3261147 3262162 3258664 3258677 CGCCTCCCCCTCCC 
2Lr ENSANGG00000002705.2 GALE7 3262708 3263040 3258664 3258677 CGCCTCCCCCTCCC 
2Lr ENSANGG00000008306.2 GPRor31  6920607 6921966 6916411 6916424 CGCCTCCGCCGGAA 
2Lr ENSANGG00000017989.2 Q8I952 SMC3 PROTEIN 30474811 30478413 30478420 30478433 CACCTCCCCCGCCC 
2Lr ENSANGG00000017771.1 GNBPA1 37354962 37357227 37361331 37361344 CTCCTCCGCCGGAA 
2Lr ENSANGG00000019161.2 ? 39322889 39324625 39325749 39325762 CTCCTCCCCACCCC 
2Lr ENSANGG00000005827.2 SRPN3  39325990 39327093 39325750 39325763 CTCCTCCCCACCCC 
2Lr ENSANGG00000019323.2 SRPN2 39327636 39330513 39325750 39325763 CTCCTCCCCACCCC 
2Lr ENSANGG00000019032.2 SRPN14 48515573 48517224 48519148 48519161 CCCCTCCCCCACAC 
2Lr ENSANGG00000018236.2 SRPN7  48521426 48522681 48519149 48519162 CCCCTCCCCCACAC 
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Location Gene ID Gene Name/Description Gene Start Gene End CTCF site 
start 
CTCF site 
end 
CTCF BS sequence 
2R ENSANGG00000011456.2 O45048 Serine Protease 1275476 1276466 1271134 1275489 CCCCTCCGCCACCC 
2R ENSANGG00000008988.2 GPRopr  5668629 5670745 5667453 5667466 CCCCTCCGCAACAC 
2R ENSANGG00000009167.2 GPRmtn1  5680842 5682419 5683377 5683390 CACCTCCGCATCCA 
2R ENSANGG00000009190.2 GPRgnr3  5890398 5895766 5886432 5886445 CCCCTCCCCACCCC 
2R ENSANGG00000006494.2 Q8T5I0 F25C8.3 PROTEIN 6308197 6324138 6327714 6327727 CTCCTCCGCCTCCC 
2R ENSANGG00000014878.2 
Q86LB8 MULTISUBSTRATE 
DEOXYRIBONUCLEOSIDE 
KINASE 6479830 6482286 6485171 6485184 CCCCTCCCCAGGAA 
2R ENSANGG00000015653.2 
Q8T5K3 HYPOTHETICAL 34.1 
KDA PROTEIN 6483108 6484745 6485171 6485184 CCCCTCCCCAGGAA 
2R ENSANGG00000022236.1 
Q8T5K2 PUTATIVE V-
ATPASE 6485798 6488932 6485172 6485184 CCCCTCCCCAGGAA 
2R ENSANGG00000021197.2 
Q8T5J1 HYPOTHETICAL 29.2 
KDA PROTEIN 6581887 6585340 6579845 6579858 CGCCTCCCCACCCC 
2R ENSANGG00000024946.1 
Q8T5H5 PUTATIVE 
APYRASE/NUCLEOTIDASE 6634530 6636230 6639306 6639319 CTCCTCCCCAAGCA 
2R ENSANGG00000014879.2 
Q8T5H4 PUTATIVE SODIUM 
CHANNEL 6641935 6644418 6639306 6639319 CTCCTCCCCAAGCA 
2R ENSANGG00000014879.2 
Q8T5H4 PUTATIVE SODIUM 
CHANNEL 6641935 6644418 6645641 6645654 CCCCTCCCCCCCCC 
2R ENSANGG00000023897.1 
Q86PT6 PUTATIVE 
ANTENNAL CARRIER 
PROTEIN A5 14551198 14552501 14550899 14550912 CTCCTCCCCCTCCC 
2R ENSANGG00000023897.1 
Q86PT6 PUTATIVE 
ANTENNAL CARRIER 
PROTEIN A5 14551198 14552501 14550905 14550918 CCCCTCCCCCCCAC 
2R ENSANGG00000020751.2 PBD1 No description 20508177 20510100 20504339 20504352 CCCCTCCGCCAGCC 
2Rr ENSANGG00000020751.2 PBD1 No description 20508177 20510100 20513044 20513057 CCCCTCCCCCCCCC 
2R ENSANGG00000019506.2 GPRop8 21814019 21815244 21813455 21813468 CACCTCCCCACGCA 
2Rr ENSANGG00000019506.2 GPRop8 21814019 21815244 21818384 21818397 CTCCTCCGCACCAC 
2R ENSANGG00000019663.2 
VATF_ANOGA VACUOLAR 
ATP SYNTHASE SUBUNIT F 21850799 21851844 21853447 21853460 CTCCTCCCCCGGCA 
2R ENSANGG00000018528.2 GPRor39  24850237 24851844 24849444 24849457 CCCCTCCCCCCCCC 
2R ENSANGG00000002327.2 IAP6 25143234 25161646 25139780 25139793 CCCCTCCCCACCCC 
2R ENSANGG00000014466.2 PPO1 PROPHENOLOXIDASE 28007271 28014859 28015680 28015693 CCCCTCCCCCTCCA 
2R ENSANGG00000013691.2 
CYP6AA1 CYTOCHROME 
P450 28280942 28482563 28480090 28480103 CTCCTCCGCAACAA 
2R ENSANGG00000013691.2 
CYP6AA1 CYTOCHROME 
P450 28280942 28482563 28483859 28483872 CACCTCCGCCCGCA 
2R ENSANGG00000016123.2 GPRmgl4  28945454 28948945 28953662 28953675 CACCTCCCCACCCC 
2R ENSANGG00000017835.2 
Q9Y1K7 SERINE PROTEASE 
14A 31605800 31609313 31603454 31603467 CACCTCCCCACCAC 
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Location Gene ID Gene Name/Description Gene Start Gene End CTCF site 
start 
CTCF site 
end 
CTCF BS sequence 
2R ENSANGG00000012025.2 
OBP17 ODORANT-BINDING 
PROTEIN G.15B.B 36735531 36736092 36734641 36734654 CCCCTCACCAGCCA 
2R ENSANGG00000011782.2 
Q8WR27 HYPOTHETICAL 6.2 
KDA PROTEIN 39819450 39820087 39814655 39814668 CCCCTCCCCATCCA 
2Rr ENSANGG00000009071.2 
Q8T5I9 PUTATIVE NA-K-CL 
SYMPORTER 6186532 6193122 6194616 6194629 CCCCTCACCCCCAA 
2Rr ENSANGG00000015655.2 
Q8T5I7 PUTATIVE TPR-
CONTAINING 
PHOSPHOPROTEIN 6237596 6241453 6236424 6236437 CTCCTCCCCCACCA 
2Rr ENSANGG00000015671.2 
Q8T5H3 HYPOTHETICAL 
PROTEIN 6644506 6645721 6650403 6650416 CCCCTCCCCCACCC 
2Rr ENSANGG00000019659.2 CLIPB17 7278265 7280367 7273874 7273887 CACCTCCCCAGCAA 
2Rr ENSANGG00000005982.2 GPROR8  12012990 12014364 12009441 12009454 CCCCTCCCCCCCCC 
2Rr ENSANGG00000015920.2 GPRvpr2  12906983 12909642 12904238 12904251 CACCTCCCCCACCC 
2Rr ENSANGG00000005919.2 
AAP47144 RH-LIKE 
GLYCOPROTEIN 13892586 13895365 13899215 13899228 CCCCTCCCCACCCC 
2Rr ENSANGG00000010972.2 GPR5HT2a  17828578 17861840 17845507 17845520 CTCCTCCCCCACCC 
2Rr ENSANGG00000019167.2 CLIPB7  18407723 18410962 18403600 18403613 CTCCTCCCCCCCCC 
2Rr ENSANGG00000020872.2 
CC42_ANOGA CDC42 
HOMOLOG  21425187 21429628 21420412 21420425 CCCCTCCCCCCCCC 
2Rr ENSANGG00000008375.2 
O77457 TRYPTOPHAN 
OXYGENASE 26234851 26238589 26231739 26231752 CCCCTCCCCCCCCC 
2Rr ENSANGG00000013732.2 GNBPB4 27635819 27637107 27637430 27637443 CTCCTCCCCCCCCC 
2Rr ENSANGG00000016173.2 GPRNNA3 28844791 28860913 28842819 28842832 CACCTCCCCCCGCC 
2Rr ENSANGG00000025143.1 CLIPB3 34682300 34685780 34689468 34689481 CCCCTCCCCCCCCC 
2Rr ENSANGG00000011053.2 
CLIPB4; SERINE PROTEASE 
14D 34686920 34688767 34689468 34689481 CCCCTCCCCCCCCC 
2Rr ENSANGG00000011095.2 
CLIPB1; SERINE PROTEASE 
14D2 34690716 34692394 34689468 34689481 CCCCTCCCCCCCCC 
2Rr ENSANGG00000022725.1 CLIPB6 34694291 34695024 34694291 34695024 CCCCTCCCCCCCCC 
2Rr ENSANGG00000000822.2 FABP_ANOGA  37222206 37227086 37218008 37218021 CTCCTCACCCGCAA 
2Rr ENSANGG00000020422.2 GPRor42  55538917 55540341 55542891 55542904 CTCCTCCCCCGGAC 
2Rr ENSANGG00000020422.2 GPRor42  55538917 55540341 55542941 55542964 CCCCTCCCCACCCA 
2Rr ENSANGG00000021070.2 GPRor26 56797729 56799189 56804096 56804109 CCCCTCCCCCTCCA 
2Rr ENSANGG00000010687.2 GPRor27 56801631 56803102 56804096 56804109 CCCCTCCCCCTCCA 
2Rr ENSANGG00000021023.2 GPRor56 56807102 56808927 56804096 56804109 CCCCTCCCCCTCCA 
3L ENSANGG00000015625.2 CASPS9  10454293 10455302 10459950 10459963 CTCCTCCCCACCAC 
3L ENSANGG00000022587.1 CASPS9 10463619 10464634 10459950 10459963 CTCCTCCCCACCAC 
3L ENSANGG00000022587.1 CASPS9 10463619 10464634 10469180 10469193 CTCCTCCCCACCAC 
3L ENSANGG00000024683.1 GPRNND1  15598369 15599280 15596927 15596940 CCCCTCCCCACCAA 
3L ENSANGG00000003778.2 GPR5HT1b 24312828 24335160 24310154 24310167 CCCCTCCCCCCCCC 
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Location Gene ID Gene Name/Description Gene Start Gene End CTCF site 
start 
CTCF site 
end 
CTCF BS sequence 
3L ENSANGG00000020781.2 GPRor54 33022150 33023656 33026860 33026873 CTCCTCACCACCCA 
3L ENSANGG00000021236.2 GPRor64 35255007 35256433 3256980 3256993 CACCTCAGCCGCCA 
3L ENSANGG00000010870.2 GPRnpr4  37561676 37562691 37558148 37558161 CCCCTCCCCACCCA 
3Lr ENSANGG00000006278.2 TOLL10  17692277 17695780 17699166 17699179 CGCCTCCCCCCGAA 
3Lr ENSANGG00000008873.2 GPRfz1b 22120465 22121010 22116729 22116742 CGCCTCACCAGGAA 
3Lr ENSANGG00000020666.2 
Q8WRX3 ODORANT BINDING 
PROTEIN 1  30074263 30075132 30078626 30078639 CCCCTCCCCCCCCC 
3Lr ENSANGG00000012893.2 
Q9TW03 PUTATIVE 
APYRASE PRECURSOR  35018973 35021033 35014051 35014064 CCCCTCCGCCCCCC 
3Lr ENSANGG00000012715.2 SCRC1  35035447 35038293 35035048 35035061 CCCCTCACCAGCCC 
3Lr ENSANGG00000013240.2 
AAP78792 TMCC-LIKE 
PROTEIN 35762268 35764652 35758384 35758397 CCCCTCCCCAGGCC 
3R ENSANGG00000007441.2 
Q8I9N3 XANTHINE 
DEHYDROGENASE 
(FRAGMENT) 2793002 2805222 274311 274324 CGCCTCCGCCGGAC 
3R ENSANGG00000019362.2 CLIPD2  6442215 6443979 6447988 6448001 CTCCTCCGCCAGCC 
3R ENSANGG00000015841.2 
Q9UB32 D7-RELATED 3 
PROTEIN PRECURSOR 8561538 8562255 8566971 8566984 CGCCTCCGCATGAC 
3R ENSANGG00000015851.2 
Q9UB30 D7-RELATED 1 
PROTEIN PRECURSOR 8562777 8563560 8566971 8566984 CGCCTCCGCATGAC 
3R ENSANGG00000016684.2 IAP5  10567005 10567740 10568590 10568603 CGCCTCCGCAGCAC 
3R ENSANGG00000010559.2 GPRsmo  14073205 14076818 14079479 14079492 CCCCTCCCCCTCCC 
3R ENSANGG00000010766.2 
Q9XZN6 PUTATIVE 
INFECTION RESPONSIVE 
SHORT PEPTIDE 14236771 14237628 14240366 14240379 CTCCTCCCCCAGCA 
3R ENSANGG00000014070.2 O61469 TU37B2 25789693 25790986 25794881 25794894 CGCCTCACCCCCAA 
3R ENSANGG00000014039.2 
PSD3_ANOGA  PROBABLE 
26S PROTEASOME NON-
ATPASE REGULATORY 
SUBUNIT 3 (26S 
PROTEASOME SUBUNIT S3) 
(DIPHENOL OXIDASE A2 
COMPONENT) (DOX-A2) 25791318 25792808 25794881 25794894 CGCCTCACCCCCAA 
3R ENSANGG00000019014.2 SCRAC1 27750928 27772019 27750005 27750018 CACCTCACCAGCAC 
3R ENSANGG00000016394.2 GPRor21 32811715 32813100 32818022 32818035 CCCCTCCCCCTCCC 
3R ENSANGG00000009816.1 SCRBQ1 49974623 49976167 49973952 49973965 CACCTCCCCAACAC 
3Rr ENSANGG00000020665.2 
Q86QN5 CYTOCHROME P450 
CYP12F4 4318878 4320925 4317145 4317158 CCCCTCCCCCCCCC 
3Rr ENSANGG00000021908.1 
Q86QN4 CYTOCHROME P450 
CYP12F3 4321531 4323866 4317145 4317158 CCCCTCCCCCCCCC 
3Rr ENSANGG00000020684.2 
OBP21 ODORANT-BINDING 
PROTEIN G.29A.A 10317255 10317835 10315426 10315439 CGCCTCACCATGCC 
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Location Gene ID Gene Name/Description Gene Start Gene End CTCF site 
start 
CTCF site 
end 
CTCF BS sequence 
3Rr ENSANGG00000016684.2 IAP5 10567005 10567740 10565975 10565988 CGCCTCAGCAGGAA 
3Rr ENSANGG00000014695.2 CLIPD7 23268448 23269709 23272208 23272221 CACCTCACCAGCAC 
3Rr ENSANGG00000003995.2 
RL5_ANOGA 60S 
RIBOSOMAL PROTEIN L5 24695660 24698102 24690985 24690998 CTCCTCCCCAACCC 
3Rr ENSANGG00000008612.2 REL1 IMMUNE FACTOR 35618914 35640927 35643379 35643392 CCCCTCCCCCTCCC 
3Rr ENSANGG00000012629.2 CASPS8 44732403 44733366 44729161 44729174 CTCCTCCCCAGGCC 
3Rr ENSANGG00000013326.2 CLIPB15 SERINE PROTEASE 44790480 44791914 447995611 44795624 CGCCTCACCAGCCA 
UNKN ENSANGG00000018728.2 Q868R5 GAG-LIKE PROTEIN 43987402 43998734 44002778 44002791 CTCCTCACCACCCC 
UNKN ENSANGG00000011193.2 
Q818S7 ODORANT-BINDING 
PROTEIN G.15D 55771575 55772264 55775526 55775539 CACCTCCCCAACAA 
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